ES2535516T3 - Agentes antifúngicos de pirrol - Google Patents
Agentes antifúngicos de pirrol Download PDFInfo
- Publication number
- ES2535516T3 ES2535516T3 ES09734928.6T ES09734928T ES2535516T3 ES 2535516 T3 ES2535516 T3 ES 2535516T3 ES 09734928 T ES09734928 T ES 09734928T ES 2535516 T3 ES2535516 T3 ES 2535516T3
- Authority
- ES
- Spain
- Prior art keywords
- phenyl
- dimethyl
- oxo
- piperazin
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003429 antifungal agent Substances 0.000 title claims 8
- 229940121375 antifungal agent Drugs 0.000 title claims 8
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 title 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims abstract description 141
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 82
- 239000001257 hydrogen Substances 0.000 claims abstract description 81
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims abstract description 55
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 55
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 49
- 150000002367 halogens Chemical class 0.000 claims abstract description 49
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 48
- 150000002431 hydrogen Chemical group 0.000 claims abstract description 39
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 30
- 150000001875 compounds Chemical class 0.000 claims abstract description 30
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims abstract description 23
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims abstract description 18
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims abstract description 16
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims abstract description 15
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 15
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims abstract description 14
- 150000003839 salts Chemical class 0.000 claims abstract description 14
- 125000000041 C6-C10 aryl group Chemical group 0.000 claims abstract description 10
- 125000000168 pyrrolyl group Chemical group 0.000 claims abstract description 4
- 208000031888 Mycoses Diseases 0.000 claims abstract 4
- 229910006069 SO3H Inorganic materials 0.000 claims abstract 3
- 230000002265 prevention Effects 0.000 claims abstract 3
- -1 4,6-Dimethyl-pyridin-2-yl Chemical group 0.000 claims description 121
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 30
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims description 25
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 21
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 20
- 125000004076 pyridyl group Chemical group 0.000 claims description 17
- 125000002971 oxazolyl group Chemical group 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 8
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 150000003233 pyrroles Chemical class 0.000 claims description 7
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 5
- 241000228212 Aspergillus Species 0.000 claims description 4
- 125000005394 methallyl group Chemical group 0.000 claims description 4
- WRCFEZPORJAOBE-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-2-oxo-n-(4-piperidin-1-ylphenyl)acetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N1CCCCC1 WRCFEZPORJAOBE-UHFFFAOYSA-N 0.000 claims description 2
- HRFXENCACZGVTF-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-2-oxo-n-(6-pyrrolidin-1-ylpyridin-3-yl)acetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=N1)=CC=C1N1CCCC1 HRFXENCACZGVTF-UHFFFAOYSA-N 0.000 claims description 2
- ARXWZGZNLVYAHN-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-(2-fluoro-4-morpholin-4-ylphenyl)-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C(=C1)F)=CC=C1N1CCOCC1 ARXWZGZNLVYAHN-UHFFFAOYSA-N 0.000 claims description 2
- CBDKZGHORXPJHJ-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-(2-fluoro-4-piperidin-1-ylphenyl)-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C(=C1)F)=CC=C1N1CCCCC1 CBDKZGHORXPJHJ-UHFFFAOYSA-N 0.000 claims description 2
- VNVMVZMOEOBNRL-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-(4-morpholin-4-ylphenyl)-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N1CCOCC1 VNVMVZMOEOBNRL-UHFFFAOYSA-N 0.000 claims description 2
- NSAOGQDXWSDQQL-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-(5-fluoronaphthalen-1-yl)-2-oxoacetamide Chemical compound C=1C=CC2=C(F)C=CC=C2C=1NC(=O)C(=O)C=1N(C)C(C)=CC=1C1=CC=CC=C1 NSAOGQDXWSDQQL-UHFFFAOYSA-N 0.000 claims description 2
- WOJXHNKXQCQNAO-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[2-fluoro-4-(4-pyridin-2-ylpiperazin-1-yl)phenyl]-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C(=C1)F)=CC=C1N(CC1)CCN1C1=CC=CC=N1 WOJXHNKXQCQNAO-UHFFFAOYSA-N 0.000 claims description 2
- BRBNGXDBNCANJB-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[2-fluoro-4-[4-(2-methylpropyl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound C1CN(CC(C)C)CCN1C(C=C1F)=CC=C1NC(=O)C(=O)C1=C(C=2C=CC=CC=2)C=C(C)N1C BRBNGXDBNCANJB-UHFFFAOYSA-N 0.000 claims description 2
- VGWWKAXQRUNNQV-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[3-fluoro-4-(4-pyridin-2-ylpiperazin-1-yl)phenyl]-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1F)=CC=C1N(CC1)CCN1C1=CC=CC=N1 VGWWKAXQRUNNQV-UHFFFAOYSA-N 0.000 claims description 2
- KLDLUFHOSJIHHY-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[4-(2,2-dimethylpropyl)piperazin-1-yl]-2-fluorophenyl]-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C(=C1)F)=CC=C1N1CCN(CC(C)(C)C)CC1 KLDLUFHOSJIHHY-UHFFFAOYSA-N 0.000 claims description 2
- IRZZDNPZJGCJAJ-UHFFFAOYSA-N 2-[1-(2-methoxyethyl)-3-phenylpyrrol-2-yl]-2-oxo-n-propylacetamide Chemical compound C1=CN(CCOC)C(C(=O)C(=O)NCCC)=C1C1=CC=CC=C1 IRZZDNPZJGCJAJ-UHFFFAOYSA-N 0.000 claims description 2
- LBMJOSSFSUKUMQ-UHFFFAOYSA-N 2-[1-(2-methoxyethyl)-4-phenylpyrrol-2-yl]-2-oxo-n-propylacetamide Chemical compound COCCN1C(C(=O)C(=O)NCCC)=CC(C=2C=CC=CC=2)=C1 LBMJOSSFSUKUMQ-UHFFFAOYSA-N 0.000 claims description 2
- UKVQQACHWJPINJ-UHFFFAOYSA-N 2-[1-[2-(dimethylamino)ethyl]-3-phenylpyrrol-2-yl]-n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound CN(C)CCN1C=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 UKVQQACHWJPINJ-UHFFFAOYSA-N 0.000 claims description 2
- WPESEBQKEAQUKN-UHFFFAOYSA-N 2-[1-[2-(dimethylamino)ethyl]-4-phenylpyrrol-2-yl]-n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound CN(C)CCN1C=C(C=2C=CC=CC=2)C=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 WPESEBQKEAQUKN-UHFFFAOYSA-N 0.000 claims description 2
- JANCVXXUFONDHF-UHFFFAOYSA-N 2-[1-[2-(dimethylamino)ethyl]-5-methyl-3-phenylpyrrol-2-yl]-n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound CN(C)CCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 JANCVXXUFONDHF-UHFFFAOYSA-N 0.000 claims description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- MHJZZBLLXRDATA-UHFFFAOYSA-N n-(2-fluoro-4-piperidin-1-ylphenyl)-2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C(=C1)F)=CC=C1N1CCCCC1 MHJZZBLLXRDATA-UHFFFAOYSA-N 0.000 claims description 2
- RQVVFXYFIMRKMK-UHFFFAOYSA-N n-(3-fluoro-4-morpholin-4-ylphenyl)-2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1F)=CC=C1N1CCOCC1 RQVVFXYFIMRKMK-UHFFFAOYSA-N 0.000 claims description 2
- JEPYJULVOSONMU-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-(4-fluoro-1,5-dimethyl-3-phenylpyrrol-2-yl)-2-oxoacetamide Chemical compound CN1C(C)=C(F)C(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 JEPYJULVOSONMU-UHFFFAOYSA-N 0.000 claims description 2
- TXASQBGLKATSJU-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[1-(2-methoxyethoxymethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCOCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 TXASQBGLKATSJU-UHFFFAOYSA-N 0.000 claims description 2
- UHZJPSUDDKOEPF-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[1-(2-methoxyethyl)-3-(2-methylpropyl)pyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C=CC(CC(C)C)=C1C(=O)C(=O)NC1=CC=C(N2CCN(CC2)C=2N=C(C)C=C(C)C=2)C=C1 UHZJPSUDDKOEPF-UHFFFAOYSA-N 0.000 claims description 2
- SEACKQPRYJUTJY-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[1-(2-methoxyethyl)-3-propan-2-ylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C=CC(C(C)C)=C1C(=O)C(=O)NC1=CC=C(N2CCN(CC2)C=2N=C(C)C=C(C)C=2)C=C1 SEACKQPRYJUTJY-UHFFFAOYSA-N 0.000 claims description 2
- RXGQCLISOFMEGJ-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[1-(4-methoxybut-2-enyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCC=CCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 RXGQCLISOFMEGJ-UHFFFAOYSA-N 0.000 claims description 2
- JFPQZYZBRZQSLM-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[1-(ethoxymethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound CCOCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 JFPQZYZBRZQSLM-UHFFFAOYSA-N 0.000 claims description 2
- HPEMQAHKNXEZQH-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[3-(2-methoxyethyl)-5-methyl-1-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCC=1C=C(C)N(C=2C=CC=CC=2)C=1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 HPEMQAHKNXEZQH-UHFFFAOYSA-N 0.000 claims description 2
- VOXHOSPQIOIKKF-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[4-fluoro-1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C(C)=C(F)C(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 VOXHOSPQIOIKKF-UHFFFAOYSA-N 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 25
- 150000004702 methyl esters Chemical class 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 239000003085 diluting agent Substances 0.000 claims 3
- 239000003112 inhibitor Substances 0.000 claims 3
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- NPWGVCVUVZNVLC-DFAYQTQMSA-N (2s,5r,6r)-3,3-dimethyl-6-[[2-(1-methylpyrrol-2-yl)-2-oxoacetyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound CN1C=CC=C1C(=O)C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 NPWGVCVUVZNVLC-DFAYQTQMSA-N 0.000 claims 1
- SQSZDAKBYLOPBM-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-2-oxo-n-[4-[5-(piperidin-1-ylmethyl)-1,3-oxazol-2-yl]phenyl]acetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1C(O1)=NC=C1CN1CCCCC1 SQSZDAKBYLOPBM-UHFFFAOYSA-N 0.000 claims 1
- UCPPHQPMZRIEOI-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-(1-ethyl-4-fluoroindol-5-yl)-2-oxoacetamide Chemical compound C=1C=C2N(CC)C=CC2=C(F)C=1NC(=O)C(=O)C(N(C(C)=C1)C)=C1C1=CC=CC=C1 UCPPHQPMZRIEOI-UHFFFAOYSA-N 0.000 claims 1
- BNXXIRKYNDXWCC-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-(2-oxo-1h-quinolin-5-yl)acetamide Chemical compound C=1C=CC=2NC(=O)C=CC=2C=1NC(=O)CC=1N(C)C(C)=CC=1C1=CC=CC=C1 BNXXIRKYNDXWCC-UHFFFAOYSA-N 0.000 claims 1
- LAFKQWCUDROAKN-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-(1,3-oxazol-2-yl)phenyl]-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1C1=NC=CO1 LAFKQWCUDROAKN-UHFFFAOYSA-N 0.000 claims 1
- RLLCFCQTXMNTBG-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[4-(1-methoxypropan-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound C1CN(C(C)COC)CCN1C(C=C1)=CC=C1NC(=O)C(=O)C1=C(C=2C=CC=CC=2)C=C(C)N1C RLLCFCQTXMNTBG-UHFFFAOYSA-N 0.000 claims 1
- OPWJAFXVADXACB-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[4-(2-methylpropanoyl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound C1CN(C(=O)C(C)C)CCN1C(C=C1)=CC=C1NC(=O)C(=O)C1=C(C=2C=CC=CC=2)C=C(C)N1C OPWJAFXVADXACB-UHFFFAOYSA-N 0.000 claims 1
- ZLCVPTOQPHIHDY-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[4-(3-methylbutan-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound C1CN(C(C)C(C)C)CCN1C(C=C1)=CC=C1NC(=O)C(=O)C1=C(C=2C=CC=CC=2)C=C(C)N1C ZLCVPTOQPHIHDY-UHFFFAOYSA-N 0.000 claims 1
- NJWPGJWDZLVATO-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[4-[1-(furan-2-yl)propan-2-yl]piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound C1CN(C=2C=CC(NC(=O)C(=O)C=3N(C(C)=CC=3C=3C=CC=CC=3)C)=CC=2)CCN1C(C)CC1=CC=CO1 NJWPGJWDZLVATO-UHFFFAOYSA-N 0.000 claims 1
- AJFMUGKHIUSQMI-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[4-[5-(morpholin-4-ylmethyl)pyridin-2-yl]piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C(N=C1)=CC=C1CN1CCOCC1 AJFMUGKHIUSQMI-UHFFFAOYSA-N 0.000 claims 1
- XUVOGOSQPSCBIF-UHFFFAOYSA-N 2-[1,5-bis(methoxymethyl)-3-phenylpyrrol-2-yl]-n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound COCN1C(COC)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 XUVOGOSQPSCBIF-UHFFFAOYSA-N 0.000 claims 1
- JUJSFMVDWJNOFK-UHFFFAOYSA-N 2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-n-[4-(1,3-oxazol-2-yl)phenyl]-2-oxoacetamide Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1C1=NC=CO1 JUJSFMVDWJNOFK-UHFFFAOYSA-N 0.000 claims 1
- HSFJYIMKGKDABE-UHFFFAOYSA-N 2-[1-(butoxymethyl)-5-methyl-3-phenylpyrrol-2-yl]-n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound CCCCOCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 HSFJYIMKGKDABE-UHFFFAOYSA-N 0.000 claims 1
- MWOHKSXJLINCEU-UHFFFAOYSA-N 2-[3-(3-chlorophenyl)-1-(2-methoxyethyl)pyrrol-2-yl]-n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound COCCN1C=CC(C=2C=C(Cl)C=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 MWOHKSXJLINCEU-UHFFFAOYSA-N 0.000 claims 1
- SCXMPDPNLKQBLD-UHFFFAOYSA-N 2-[4-(3-chlorophenyl)-1-(2-methoxyethyl)pyrrol-2-yl]-n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound COCCN1C=C(C=2C=C(Cl)C=CC=2)C=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 SCXMPDPNLKQBLD-UHFFFAOYSA-N 0.000 claims 1
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims 1
- VNRPWFYXGPQIMN-UHFFFAOYSA-N 3-(hydroxymethyl)-8-oxo-7-[[2-oxo-2-(1H-pyrrol-2-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound C1C(=C(N2C(S1)C(C2=O)NC(=O)C(=O)C3=CC=CN3)C(=O)O)CO VNRPWFYXGPQIMN-UHFFFAOYSA-N 0.000 claims 1
- DTBDAFLSBDGPEA-UHFFFAOYSA-N 3-Methylquinoline Natural products C1=CC=CC2=CC(C)=CN=C21 DTBDAFLSBDGPEA-UHFFFAOYSA-N 0.000 claims 1
- DFLFESABTKVYOW-UHFFFAOYSA-N 4,6-dimethylpyridine Chemical compound CC1=C=C(C)N=C[CH]1 DFLFESABTKVYOW-UHFFFAOYSA-N 0.000 claims 1
- 241001480043 Arthrodermataceae Species 0.000 claims 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims 1
- 108010049047 Echinocandins Proteins 0.000 claims 1
- 229940123047 Elongation factor inhibitor Drugs 0.000 claims 1
- 229920000057 Mannan Polymers 0.000 claims 1
- 229930182764 Polyoxin Natural products 0.000 claims 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical class [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims 1
- 230000000172 allergic effect Effects 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 150000003851 azoles Chemical class 0.000 claims 1
- 230000037304 dermatophytes Effects 0.000 claims 1
- 230000002538 fungal effect Effects 0.000 claims 1
- 230000000855 fungicidal effect Effects 0.000 claims 1
- 239000000417 fungicide Substances 0.000 claims 1
- 229950003053 icofungipen Drugs 0.000 claims 1
- 239000000411 inducer Substances 0.000 claims 1
- HICZMUGTAHOPLJ-UHFFFAOYSA-N n-(2-fluoro-4-morpholin-4-ylphenyl)-2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C(=C1)F)=CC=C1N1CCOCC1 HICZMUGTAHOPLJ-UHFFFAOYSA-N 0.000 claims 1
- JOMBOYIOHZAZSB-UHFFFAOYSA-N n-(2-nitro-4-phenylphenyl)-2-oxo-2-(1h-pyrrol-2-yl)acetamide Chemical compound [O-][N+](=O)C1=CC(C=2C=CC=CC=2)=CC=C1NC(=O)C(=O)C1=CC=CN1 JOMBOYIOHZAZSB-UHFFFAOYSA-N 0.000 claims 1
- YGFAOJVSZKUTFK-UHFFFAOYSA-N n-[2-fluoro-5-[4-(2-methylpropyl)piperazin-1-yl]phenyl]-2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C(=CC=1)F)=CC=1N1CCN(CC(C)C)CC1 YGFAOJVSZKUTFK-UHFFFAOYSA-N 0.000 claims 1
- RVLWWBGAIPGMSF-UHFFFAOYSA-N n-[4-[4-(2,2-dimethylpropyl)piperazin-1-yl]-2-fluorophenyl]-2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C(=C1)F)=CC=C1N1CCN(CC(C)(C)C)CC1 RVLWWBGAIPGMSF-UHFFFAOYSA-N 0.000 claims 1
- SJZRTHFHGSXFEO-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[1-(2-methoxyethyl)-3-phenyl-5-propan-2-ylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C(C(C)C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 SJZRTHFHGSXFEO-UHFFFAOYSA-N 0.000 claims 1
- JCTKGZHIEASGGU-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[1-(4-methoxybutyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 JCTKGZHIEASGGU-UHFFFAOYSA-N 0.000 claims 1
- MPXPWSONPWGHRQ-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[5-(methoxymethyl)-1-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound CN1C(COC)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 MPXPWSONPWGHRQ-UHFFFAOYSA-N 0.000 claims 1
- IZUNHQDLVJZEHE-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[5-methyl-1-(methylsulfanylmethyl)-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound CSCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 IZUNHQDLVJZEHE-UHFFFAOYSA-N 0.000 claims 1
- CGTRRUHEHOEKPH-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[5-methyl-3-phenyl-1-(2-propan-2-yloxyethyl)pyrrol-2-yl]-2-oxoacetamide Chemical compound CC(C)OCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 CGTRRUHEHOEKPH-UHFFFAOYSA-N 0.000 claims 1
- IBAYDVBNDQGNDF-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[5-methyl-3-phenyl-1-(2-propoxyethyl)pyrrol-2-yl]-2-oxoacetamide Chemical compound CCCOCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 IBAYDVBNDQGNDF-UHFFFAOYSA-N 0.000 claims 1
- QCIBJJWCWDOMIR-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[5-methyl-3-phenyl-1-(propoxymethyl)pyrrol-2-yl]-2-oxoacetamide Chemical compound CCCOCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 QCIBJJWCWDOMIR-UHFFFAOYSA-N 0.000 claims 1
- MIFYWNHHJIZMAH-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[5-methyl-3-phenyl-1-(pyridin-3-ylmethyl)pyrrol-2-yl]-2-oxoacetamide Chemical compound C=1C=CN=CC=1CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 MIFYWNHHJIZMAH-UHFFFAOYSA-N 0.000 claims 1
- UFQNBRYIBHEJRE-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[5-methyl-3-phenyl-1-(pyridin-4-ylmethyl)pyrrol-2-yl]-2-oxoacetamide Chemical compound C=1C=NC=CC=1CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 UFQNBRYIBHEJRE-UHFFFAOYSA-N 0.000 claims 1
- RKOUGZGFAYMUIO-RITPCOANSA-N pdl 118 Chemical compound N[C@H]1CC(=C)C[C@H]1C(O)=O RKOUGZGFAYMUIO-RITPCOANSA-N 0.000 claims 1
- 230000035699 permeability Effects 0.000 claims 1
- 150000004291 polyenes Chemical class 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- 239000002213 purine nucleotide Substances 0.000 claims 1
- 125000000561 purinyl group Chemical class N1=C(N=C2N=CNC2=C1)* 0.000 claims 1
- 239000002719 pyrimidine nucleotide Substances 0.000 claims 1
- 150000003230 pyrimidines Chemical class 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 abstract description 11
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 abstract description 6
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 abstract description 5
- 125000001624 naphthyl group Chemical group 0.000 abstract description 4
- 229910052760 oxygen Inorganic materials 0.000 abstract description 4
- 125000004450 alkenylene group Chemical group 0.000 abstract description 3
- 125000004419 alkynylene group Chemical group 0.000 abstract description 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract description 3
- 101100490437 Mus musculus Acvrl1 gene Proteins 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 302
- 238000005160 1H NMR spectroscopy Methods 0.000 description 153
- 125000001424 substituent group Chemical group 0.000 description 38
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 13
- 229920006395 saturated elastomer Polymers 0.000 description 13
- 239000002904 solvent Substances 0.000 description 13
- 241001225321 Aspergillus fumigatus Species 0.000 description 12
- 241001465318 Aspergillus terreus Species 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 125000004193 piperazinyl group Chemical group 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 11
- 125000000304 alkynyl group Chemical group 0.000 description 11
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 9
- 238000005481 NMR spectroscopy Methods 0.000 description 9
- 125000002757 morpholinyl group Chemical group 0.000 description 9
- 125000004433 nitrogen atom Chemical group N* 0.000 description 9
- 238000001228 spectrum Methods 0.000 description 9
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 8
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 8
- 229910052731 fluorine Inorganic materials 0.000 description 8
- 239000011737 fluorine Substances 0.000 description 8
- 125000003386 piperidinyl group Chemical group 0.000 description 8
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 7
- 125000004093 cyano group Chemical group *C#N 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 125000005960 1,4-diazepanyl group Chemical group 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 241000228197 Aspergillus flavus Species 0.000 description 6
- 241000228245 Aspergillus niger Species 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 125000003342 alkenyl group Chemical group 0.000 description 6
- 125000003118 aryl group Chemical group 0.000 description 6
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 6
- 125000005842 heteroatom Chemical group 0.000 description 6
- 125000002950 monocyclic group Chemical group 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 239000012267 brine Substances 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 125000002541 furyl group Chemical group 0.000 description 5
- 125000005843 halogen group Chemical group 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- 125000001544 thienyl group Chemical group 0.000 description 5
- DMIGDALTMDJPQF-UHFFFAOYSA-N 1-phenyl-5,6,7,8-tetrahydropyrrolo[1,2-a]azepin-9-one Chemical compound C=12C(=O)CCCCN2C=CC=1C1=CC=CC=C1 DMIGDALTMDJPQF-UHFFFAOYSA-N 0.000 description 4
- HTCHVONMOKTWIJ-UHFFFAOYSA-N 2-phenyl-5,6,7,8-tetrahydropyrrolo[1,2-a]azepin-9-one Chemical compound C1=C2C(=O)CCCCN2C=C1C1=CC=CC=C1 HTCHVONMOKTWIJ-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 150000001721 carbon Chemical group 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 3
- PZYIJRSFWXQALO-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 PZYIJRSFWXQALO-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 125000003725 azepanyl group Chemical group 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 3
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 125000000714 pyrimidinyl group Chemical group 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- YOJIBLSZAXYSEY-UHFFFAOYSA-N 1-(2-methoxyethyl)-2-methyl-4-phenylpyrrole Chemical compound C1=C(C)N(CCOC)C=C1C1=CC=CC=C1 YOJIBLSZAXYSEY-UHFFFAOYSA-N 0.000 description 2
- LPSLJFHOQXWTIX-UHFFFAOYSA-N 1-phenyl-6,7,8,9-tetrahydro-5h-pyrrolo[1,2-a]azepine Chemical compound C1=CN2CCCCCC2=C1C1=CC=CC=C1 LPSLJFHOQXWTIX-UHFFFAOYSA-N 0.000 description 2
- NXJOUTPSXXQRBI-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-2-oxo-n-[4-(4-pyridin-2-ylpiperazin-1-yl)phenyl]acetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC=CC=N1 NXJOUTPSXXQRBI-UHFFFAOYSA-N 0.000 description 2
- SVJJYVLRMURKLO-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-2-oxo-n-quinolin-5-ylacetamide Chemical compound C=1C=CC2=NC=CC=C2C=1NC(=O)C(=O)C=1N(C)C(C)=CC=1C1=CC=CC=C1 SVJJYVLRMURKLO-UHFFFAOYSA-N 0.000 description 2
- XEWKXYQRHIAICT-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]-3-[3-(4-methylpiperazin-1-yl)propoxymethyl]phenyl]-2-oxoacetamide Chemical compound C1CN(C)CCN1CCCOCC1=CC(NC(=O)C(=O)C=2N(C(C)=CC=2C=2C=CC=CC=2)C)=CC=C1N1CCN(C=2N=C(C)C=C(C)C=2)CC1 XEWKXYQRHIAICT-UHFFFAOYSA-N 0.000 description 2
- VPDZEVBAMHNYDB-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]-3-hydroxyphenyl]-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1O)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 VPDZEVBAMHNYDB-UHFFFAOYSA-N 0.000 description 2
- ZNMPKPKDMKSINY-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[4-(4-methylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC=N1 ZNMPKPKDMKSINY-UHFFFAOYSA-N 0.000 description 2
- SEJNZEACZSATGF-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[4-(6-methylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC=CC(C)=N1 SEJNZEACZSATGF-UHFFFAOYSA-N 0.000 description 2
- YBQBOWFTHDGUKE-UHFFFAOYSA-N 2-[1-(2-amino-2-oxoethyl)-3-phenylpyrrol-2-yl]-n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound CC1=CC(C)=NC(N2CCN(CC2)C=2C=CC(NC(=O)C(=O)C=3N(C=CC=3C=3C=CC=CC=3)CC(N)=O)=CC=2)=C1 YBQBOWFTHDGUKE-UHFFFAOYSA-N 0.000 description 2
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 2
- DWIKMZNPKRMARB-UHFFFAOYSA-N 2-methyl-4-phenyl-1-(propoxymethyl)pyrrole Chemical compound C1=C(C)N(COCCC)C=C1C1=CC=CC=C1 DWIKMZNPKRMARB-UHFFFAOYSA-N 0.000 description 2
- DJYSAFSMULLJRV-UHFFFAOYSA-N 2-phenyl-6,7,8,9-tetrahydro-5h-pyrrolo[1,2-a]azepine Chemical compound C=1N2CCCCCC2=CC=1C1=CC=CC=C1 DJYSAFSMULLJRV-UHFFFAOYSA-N 0.000 description 2
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 2
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical group C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 125000000842 isoxazolyl group Chemical group 0.000 description 2
- 125000004458 methylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])[H] 0.000 description 2
- JFAXUXHPAYCRLI-UHFFFAOYSA-N n-(2,3-dihydro-1-benzofuran-4-yl)-2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-2-oxoacetamide Chemical compound C=1C=CC=2OCCC=2C=1NC(=O)C(=O)C=1N(C)C(C)=CC=1C1=CC=CC=C1 JFAXUXHPAYCRLI-UHFFFAOYSA-N 0.000 description 2
- QPYKQGKMFOZNLQ-UHFFFAOYSA-N n-[2-chloro-4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C(=C1)Cl)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 QPYKQGKMFOZNLQ-UHFFFAOYSA-N 0.000 description 2
- QJWPGJUMKSMZNJ-UHFFFAOYSA-N n-[2-chloro-4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C(=C1)Cl)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 QJWPGJUMKSMZNJ-UHFFFAOYSA-N 0.000 description 2
- JNNTZPJXAIGYGO-UHFFFAOYSA-N n-[3-chloro-4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1Cl)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 JNNTZPJXAIGYGO-UHFFFAOYSA-N 0.000 description 2
- PCFKTGUEFIIGJX-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-(1,5-dimethyl-3-thiophen-2-ylpyrrol-2-yl)-2-oxoacetamide Chemical compound C=1C=C(N2CCN(CC2)C=2N=C(C)C=C(C)C=2)C=CC=1NC(=O)C(=O)C=1N(C)C(C)=CC=1C1=CC=CS1 PCFKTGUEFIIGJX-UHFFFAOYSA-N 0.000 description 2
- GCSIHDZWHOAFFA-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-(1-methyl-3-phenyl-5-propan-2-ylpyrrol-2-yl)-2-oxoacetamide Chemical compound CN1C(C(C)C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 GCSIHDZWHOAFFA-UHFFFAOYSA-N 0.000 description 2
- FBJNSYVLFIGLBL-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-(5-methyl-1h-pyrrol-2-yl)-2-oxoacetamide Chemical compound N1C(C)=CC=C1C(=O)C(=O)NC1=CC=C(N2CCN(CC2)C=2N=C(C)C=C(C)C=2)C=C1 FBJNSYVLFIGLBL-UHFFFAOYSA-N 0.000 description 2
- DZROLLLYVYHWHV-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-(5-methyl-3-phenyl-1-propan-2-ylpyrrol-2-yl)-2-oxoacetamide Chemical compound CC(C)N1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 DZROLLLYVYHWHV-UHFFFAOYSA-N 0.000 description 2
- DDDCINQBRVDZHJ-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[1-(2-ethoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound CCOCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 DDDCINQBRVDZHJ-UHFFFAOYSA-N 0.000 description 2
- IAZPKQLLWHNNCX-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 IAZPKQLLWHNNCX-UHFFFAOYSA-N 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- 125000006413 ring segment Chemical group 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- CBIZQSHHRXHNRO-UHFFFAOYSA-N 1-(2-ethoxyethyl)-2-methyl-4-phenylpyrrole Chemical compound C1=C(C)N(CCOCC)C=C1C1=CC=CC=C1 CBIZQSHHRXHNRO-UHFFFAOYSA-N 0.000 description 1
- QJFPLDNMJDCCDK-UHFFFAOYSA-N 1-(2-methoxyethoxymethyl)-5-methyl-3-phenylpyrrole-2,4-dicarboxylic acid Chemical compound COCCOCN1C(C)=C(C(O)=O)C(C=2C=CC=CC=2)=C1C(O)=O QJFPLDNMJDCCDK-UHFFFAOYSA-N 0.000 description 1
- PVKHXTQSPAHOTB-UHFFFAOYSA-N 1-(2-methoxyethyl)-3-(2-methylpropyl)pyrrole Chemical compound COCCN1C=CC(CC(C)C)=C1 PVKHXTQSPAHOTB-UHFFFAOYSA-N 0.000 description 1
- DBJMTTFJPJHSFL-UHFFFAOYSA-N 1-(2-methoxyethyl)-3-phenyl-5-propan-2-ylpyrrole-2,4-dicarboxylic acid Chemical compound COCCN1C(C(C)C)=C(C(O)=O)C(C=2C=CC=CC=2)=C1C(O)=O DBJMTTFJPJHSFL-UHFFFAOYSA-N 0.000 description 1
- RNAGENOXCXGIRD-UHFFFAOYSA-N 1-(2-methoxyethyl)-3-phenylpyrrole Chemical compound COCCN1C=CC(C=2C=CC=CC=2)=C1 RNAGENOXCXGIRD-UHFFFAOYSA-N 0.000 description 1
- KLJCBFIDGYGOBL-UHFFFAOYSA-N 1-(2-methoxyethyl)-4-(2-methylpropyl)pyrrole-3-carboxylic acid Chemical compound COCCN1C=C(CC(C)C)C(C(O)=O)=C1 KLJCBFIDGYGOBL-UHFFFAOYSA-N 0.000 description 1
- PLNKAFGQABWKTQ-UHFFFAOYSA-N 1-(2-methoxyethyl)-4-phenyl-2-propan-2-ylpyrrole Chemical compound C1=C(C(C)C)N(CCOC)C=C1C1=CC=CC=C1 PLNKAFGQABWKTQ-UHFFFAOYSA-N 0.000 description 1
- HUBMQFHFHSGTLC-UHFFFAOYSA-N 1-(2-methoxyethyl)-4-phenylpyrrole-2-carboxylic acid Chemical compound C1=C(C(O)=O)N(CCOC)C=C1C1=CC=CC=C1 HUBMQFHFHSGTLC-UHFFFAOYSA-N 0.000 description 1
- GTSQOSDMUSPRLP-UHFFFAOYSA-N 1-(2-methoxyethyl)-5-methyl-3-phenylpyrrole-2,4-dicarboxylic acid Chemical compound COCCN1C(C)=C(C(O)=O)C(C=2C=CC=CC=2)=C1C(O)=O GTSQOSDMUSPRLP-UHFFFAOYSA-N 0.000 description 1
- UTUZBRZGQUXBLG-UHFFFAOYSA-N 1-(3-hydroxypropyl)-5-methyl-3-phenylpyrrole-2,4-dicarboxylic acid Chemical compound OCCCN1C(C)=C(C(O)=O)C(C=2C=CC=CC=2)=C1C(O)=O UTUZBRZGQUXBLG-UHFFFAOYSA-N 0.000 description 1
- GHYKHEBGSBVMHY-UHFFFAOYSA-N 1-(3-methoxypropyl)-2-methyl-4-phenylpyrrole Chemical compound C1=C(C)N(CCCOC)C=C1C1=CC=CC=C1 GHYKHEBGSBVMHY-UHFFFAOYSA-N 0.000 description 1
- NGVNMOXRAAAMHK-UHFFFAOYSA-N 1-(butoxymethyl)-2-methyl-4-phenylpyrrole Chemical compound C1=C(C)N(COCCCC)C=C1C1=CC=CC=C1 NGVNMOXRAAAMHK-UHFFFAOYSA-N 0.000 description 1
- UCEPRSCXOUSFMH-UHFFFAOYSA-N 1-(butoxymethyl)-5-methyl-3-phenylpyrrole-2,4-dicarboxylic acid Chemical compound CCCCOCN1C(C)=C(C(O)=O)C(C=2C=CC=CC=2)=C1C(O)=O UCEPRSCXOUSFMH-UHFFFAOYSA-N 0.000 description 1
- QYQQRLBYQXRSBU-UHFFFAOYSA-N 1-(ethoxymethyl)-2-methyl-4-phenylpyrrole Chemical compound C1=C(C)N(COCC)C=C1C1=CC=CC=C1 QYQQRLBYQXRSBU-UHFFFAOYSA-N 0.000 description 1
- BOELXHPJSRKIFY-UHFFFAOYSA-N 1-(ethoxymethyl)-5-methyl-3-phenylpyrrole-2,4-dicarboxylic acid Chemical compound CCOCN1C(C)=C(C(O)=O)C(C=2C=CC=CC=2)=C1C(O)=O BOELXHPJSRKIFY-UHFFFAOYSA-N 0.000 description 1
- ITWSESZABAZHDP-UHFFFAOYSA-N 1-(methoxymethyl)-2-methyl-4-phenylpyrrole Chemical compound C1=C(C)N(COC)C=C1C1=CC=CC=C1 ITWSESZABAZHDP-UHFFFAOYSA-N 0.000 description 1
- PCLMJTGUQIEMEY-UHFFFAOYSA-N 1-(methoxymethyl)-3-phenylpyrrole Chemical compound COCN1C=CC(C=2C=CC=CC=2)=C1 PCLMJTGUQIEMEY-UHFFFAOYSA-N 0.000 description 1
- GRWZDQOQSVVSNB-UHFFFAOYSA-N 1-(methoxymethyl)-4-phenylpyrrole-2-carboxylic acid Chemical compound C1=C(C(O)=O)N(COC)C=C1C1=CC=CC=C1 GRWZDQOQSVVSNB-UHFFFAOYSA-N 0.000 description 1
- UYUAZTDLZWHLDY-UHFFFAOYSA-N 1-benzyl-2-methyl-4-phenylpyrrole Chemical compound CC1=CC(C=2C=CC=CC=2)=CN1CC1=CC=CC=C1 UYUAZTDLZWHLDY-UHFFFAOYSA-N 0.000 description 1
- HUZGGRKXINJWSS-UHFFFAOYSA-N 1-benzyl-5-methyl-3-phenylpyrrole-2,4-dicarboxylic acid Chemical compound CC1=C(C(O)=O)C(C=2C=CC=CC=2)=C(C(O)=O)N1CC1=CC=CC=C1 HUZGGRKXINJWSS-UHFFFAOYSA-N 0.000 description 1
- MVOVGJXEUKBCFX-UHFFFAOYSA-N 1-butyl-2-methyl-4-phenylpyrrole Chemical compound C1=C(C)N(CCCC)C=C1C1=CC=CC=C1 MVOVGJXEUKBCFX-UHFFFAOYSA-N 0.000 description 1
- YAISUJHIDUTWCV-UHFFFAOYSA-N 1-butyl-5-methyl-3-phenylpyrrole-2,4-dicarboxylic acid Chemical compound CCCCN1C(C)=C(C(O)=O)C(C=2C=CC=CC=2)=C1C(O)=O YAISUJHIDUTWCV-UHFFFAOYSA-N 0.000 description 1
- KTMYDPGMFCUHQE-UHFFFAOYSA-N 1-ethyl-2-methyl-4-phenylpyrrole Chemical compound C1=C(C)N(CC)C=C1C1=CC=CC=C1 KTMYDPGMFCUHQE-UHFFFAOYSA-N 0.000 description 1
- UTXCVYLBCAJHMR-UHFFFAOYSA-N 1-methyl-3-phenyl-5-propylpyrrole-2,4-dicarboxylic acid Chemical compound CN1C(CCC)=C(C(O)=O)C(C=2C=CC=CC=2)=C1C(O)=O UTXCVYLBCAJHMR-UHFFFAOYSA-N 0.000 description 1
- RIAJNRHROUYNKE-UHFFFAOYSA-N 1-methyl-3-phenylpyrrole Chemical compound CN1C=CC(C=2C=CC=CC=2)=C1 RIAJNRHROUYNKE-UHFFFAOYSA-N 0.000 description 1
- HZMUJEPMOMXVOD-UHFFFAOYSA-N 1-methyl-4-phenyl-2-propylpyrrole Chemical compound CN1C(CCC)=CC(C=2C=CC=CC=2)=C1 HZMUJEPMOMXVOD-UHFFFAOYSA-N 0.000 description 1
- ZCTZBXTZTAQFRU-UHFFFAOYSA-N 1-methyl-4-phenylpyrrole-2-carboxylic acid Chemical compound C1=C(C(O)=O)N(C)C=C1C1=CC=CC=C1 ZCTZBXTZTAQFRU-UHFFFAOYSA-N 0.000 description 1
- FGRBYDKOBBBPOI-UHFFFAOYSA-N 10,10-dioxo-2-[4-(N-phenylanilino)phenyl]thioxanthen-9-one Chemical compound O=C1c2ccccc2S(=O)(=O)c2ccc(cc12)-c1ccc(cc1)N(c1ccccc1)c1ccccc1 FGRBYDKOBBBPOI-UHFFFAOYSA-N 0.000 description 1
- JYYNAJVZFGKDEQ-UHFFFAOYSA-N 2,4-Dimethylpyridine Chemical compound CC1=CC=NC(C)=C1 JYYNAJVZFGKDEQ-UHFFFAOYSA-N 0.000 description 1
- BFXRZEKISRQAAD-UHFFFAOYSA-N 2-(1,4-dimethyl-3-phenylpyrrol-2-yl)-2-oxoacetyl chloride Chemical compound CC1=CN(C)C(C(=O)C(Cl)=O)=C1C1=CC=CC=C1 BFXRZEKISRQAAD-UHFFFAOYSA-N 0.000 description 1
- CXXYZMXWDQIVND-UHFFFAOYSA-N 2-(1,4-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound C=1C=CC=CC=1C=1C(C)=CN(C)C=1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 CXXYZMXWDQIVND-UHFFFAOYSA-N 0.000 description 1
- WXSDWVSRGINUEK-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-2-oxo-n-pyridin-4-ylacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC1=CC=NC=C1 WXSDWVSRGINUEK-UHFFFAOYSA-N 0.000 description 1
- RCHZTQVMKQRWGM-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-2-oxo-n-quinolin-3-ylacetamide Chemical compound C=1N=C2C=CC=CC2=CC=1NC(=O)C(=O)C=1N(C)C(C)=CC=1C1=CC=CC=C1 RCHZTQVMKQRWGM-UHFFFAOYSA-N 0.000 description 1
- FQHDSPGLJUPWDD-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-2-oxo-n-quinolin-8-ylacetamide Chemical compound C=1C=CC2=CC=CN=C2C=1NC(=O)C(=O)C=1N(C)C(C)=CC=1C1=CC=CC=C1 FQHDSPGLJUPWDD-UHFFFAOYSA-N 0.000 description 1
- AQSGVCHEXHYYJH-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-2-oxoacetyl chloride Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O AQSGVCHEXHYYJH-UHFFFAOYSA-N 0.000 description 1
- DDPIPPGIERCZGM-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-(3-fluoro-4-piperidin-1-ylphenyl)-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1F)=CC=C1N1CCCCC1 DDPIPPGIERCZGM-UHFFFAOYSA-N 0.000 description 1
- NRYAUQFGYDZUPU-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[3-fluoro-4-[4-(2-methylpropyl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound C1CN(CC(C)C)CCN1C(C(=C1)F)=CC=C1NC(=O)C(=O)C1=C(C=2C=CC=CC=2)C=C(C)N1C NRYAUQFGYDZUPU-UHFFFAOYSA-N 0.000 description 1
- DQPKTPBHEDLPLP-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[2-(4,6-dimethylpyridin-2-yl)oxyethoxy]phenyl]-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1OCCOC1=CC(C)=CC(C)=N1 DQPKTPBHEDLPLP-UHFFFAOYSA-N 0.000 description 1
- NNSALEVQWITZJL-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[2-(4,6-dimethylpyridin-2-yl)oxyethylamino]phenyl]-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1NCCOC1=CC(C)=CC(C)=N1 NNSALEVQWITZJL-UHFFFAOYSA-N 0.000 description 1
- YCILYBDYIHXJDQ-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[2-[(4,6-dimethylpyridin-2-yl)-methylamino]ethoxy]phenyl]-2-oxoacetamide Chemical compound C=1C(C)=CC(C)=NC=1N(C)CCOC(C=C1)=CC=C1NC(=O)C(=O)C(N(C(C)=C1)C)=C1C1=CC=CC=C1 YCILYBDYIHXJDQ-UHFFFAOYSA-N 0.000 description 1
- QRYDDJXNPYOVCF-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[2-[(4,6-dimethylpyridin-2-yl)-methylamino]ethyl-methylamino]phenyl]-2-oxoacetamide Chemical compound C=1C=C(NC(=O)C(=O)C=2N(C(C)=CC=2C=2C=CC=CC=2)C)C=CC=1N(C)CCN(C)C1=CC(C)=CC(C)=N1 QRYDDJXNPYOVCF-UHFFFAOYSA-N 0.000 description 1
- TXYXIJCSJRBPKQ-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[2-[(4,6-dimethylpyridin-2-yl)-methylamino]ethylamino]phenyl]-2-oxoacetamide Chemical compound C=1C(C)=CC(C)=NC=1N(C)CCNC(C=C1)=CC=C1NC(=O)C(=O)C(N(C(C)=C1)C)=C1C1=CC=CC=C1 TXYXIJCSJRBPKQ-UHFFFAOYSA-N 0.000 description 1
- ZENQMJRNLWIBJE-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[2-[(4,6-dimethylpyridin-2-yl)amino]ethyl-methylamino]phenyl]-2-oxoacetamide Chemical compound C=1C=C(NC(=O)C(=O)C=2N(C(C)=CC=2C=2C=CC=CC=2)C)C=CC=1N(C)CCNC1=CC(C)=CC(C)=N1 ZENQMJRNLWIBJE-UHFFFAOYSA-N 0.000 description 1
- UUEBDWUFTRJOOG-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[2-[(4,6-dimethylpyridin-2-yl)amino]ethylamino]phenyl]-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1NCCNC1=CC(C)=CC(C)=N1 UUEBDWUFTRJOOG-UHFFFAOYSA-N 0.000 description 1
- VFDFLQPQGWKUFV-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[4-(4,6-dimethylpyridin-2-yl)-1,4-diazepan-1-yl]phenyl]-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCCN1C1=CC(C)=CC(C)=N1 VFDFLQPQGWKUFV-UHFFFAOYSA-N 0.000 description 1
- OMWHXVPPZKMPKS-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]-3-(3-morpholin-4-ylpropoxymethyl)phenyl]-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1COCCCN2CCOCC2)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 OMWHXVPPZKMPKS-UHFFFAOYSA-N 0.000 description 1
- UYTKQSGOIWRVPN-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]-3-methylphenyl]-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1C)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 UYTKQSGOIWRVPN-UHFFFAOYSA-N 0.000 description 1
- HGEBYMJEHCWKMZ-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[4-[4-(5-methylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound CN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC=C(C)C=N1 HGEBYMJEHCWKMZ-UHFFFAOYSA-N 0.000 description 1
- DUJIPIQZKMYJIN-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-[5-(4-methylpiperazin-1-yl)naphthalen-1-yl]-2-oxoacetamide Chemical compound C1CN(C)CCN1C(C1=CC=C2)=CC=CC1=C2NC(=O)C(=O)C1=C(C=2C=CC=CC=2)C=C(C)N1C DUJIPIQZKMYJIN-UHFFFAOYSA-N 0.000 description 1
- VMUJEAVLHFSRQN-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-isoquinolin-8-yl-2-oxoacetamide Chemical compound C=1C=CC2=CC=NC=C2C=1NC(=O)C(=O)C=1N(C)C(C)=CC=1C1=CC=CC=C1 VMUJEAVLHFSRQN-UHFFFAOYSA-N 0.000 description 1
- KGPPCDBIJQEGMK-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-naphthalen-1-yl-2-oxoacetamide Chemical compound C=1C=CC2=CC=CC=C2C=1NC(=O)C(=O)C=1N(C)C(C)=CC=1C1=CC=CC=C1 KGPPCDBIJQEGMK-UHFFFAOYSA-N 0.000 description 1
- AIAJVPHTVVBOMJ-UHFFFAOYSA-N 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-n-naphthalen-2-yl-2-oxoacetamide Chemical compound C=1C=C2C=CC=CC2=CC=1NC(=O)C(=O)C=1N(C)C(C)=CC=1C1=CC=CC=C1 AIAJVPHTVVBOMJ-UHFFFAOYSA-N 0.000 description 1
- MRCKITSNFNICNL-UHFFFAOYSA-N 2-(1,5-dimethyl-3-propan-2-ylpyrrol-2-yl)-2-oxoacetyl chloride Chemical compound CC(C)C=1C=C(C)N(C)C=1C(=O)C(Cl)=O MRCKITSNFNICNL-UHFFFAOYSA-N 0.000 description 1
- ZSAHUCIDDHZZLC-UHFFFAOYSA-N 2-(1,5-dimethyl-3-thiophen-2-ylpyrrol-2-yl)-2-oxo-n-[4-(4-pyridin-2-ylpiperazin-1-yl)phenyl]acetamide Chemical compound C=1C=C(N2CCN(CC2)C=2N=CC=CC=2)C=CC=1NC(=O)C(=O)C=1N(C)C(C)=CC=1C1=CC=CS1 ZSAHUCIDDHZZLC-UHFFFAOYSA-N 0.000 description 1
- UTKSHBAJMQSOBR-UHFFFAOYSA-N 2-(1,5-dimethyl-3-thiophen-2-ylpyrrol-2-yl)-2-oxoacetyl chloride Chemical compound CN1C(C)=CC(C=2SC=CC=2)=C1C(=O)C(Cl)=O UTKSHBAJMQSOBR-UHFFFAOYSA-N 0.000 description 1
- FLYOAFWANVRAKY-UHFFFAOYSA-N 2-(1,5-dimethyl-3-thiophen-2-ylpyrrol-2-yl)-n-[4-[4-(4-methylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound C=1C=C(N2CCN(CC2)C=2N=CC=C(C)C=2)C=CC=1NC(=O)C(=O)C=1N(C)C(C)=CC=1C1=CC=CS1 FLYOAFWANVRAKY-UHFFFAOYSA-N 0.000 description 1
- WWTYCYVHEPHJCE-UHFFFAOYSA-N 2-(1,5-dimethyl-3-thiophen-2-ylpyrrol-2-yl)-n-[4-[4-(6-methylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound C=1C=C(N2CCN(CC2)C=2N=C(C)C=CC=2)C=CC=1NC(=O)C(=O)C=1N(C)C(C)=CC=1C1=CC=CS1 WWTYCYVHEPHJCE-UHFFFAOYSA-N 0.000 description 1
- HTVCIIJFGFTLOQ-UHFFFAOYSA-N 2-(1-methyl-3-phenyl-5-propan-2-ylpyrrol-2-yl)-2-oxoacetyl chloride Chemical compound CN1C(C(C)C)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O HTVCIIJFGFTLOQ-UHFFFAOYSA-N 0.000 description 1
- JEZCDTOQZURPKI-UHFFFAOYSA-N 2-(1-methyl-3-phenyl-5-propylpyrrol-2-yl)-2-oxoacetyl chloride Chemical compound CN1C(CCC)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O JEZCDTOQZURPKI-UHFFFAOYSA-N 0.000 description 1
- GPSNTJOFXHQNKL-UHFFFAOYSA-N 2-(2-methoxyethyl)-1-methyl-4-phenylpyrrole Chemical compound CN1C(CCOC)=CC(C=2C=CC=CC=2)=C1 GPSNTJOFXHQNKL-UHFFFAOYSA-N 0.000 description 1
- DJQXXETWLQWKKD-UHFFFAOYSA-N 2-(2-methyl-7-phenyl-3,4-dihydro-1h-pyrrolo[1,2-a]pyrazin-6-yl)-2-oxoacetyl chloride Chemical compound C1N(C)CCN(C=2C(=O)C(Cl)=O)C1=CC=2C1=CC=CC=C1 DJQXXETWLQWKKD-UHFFFAOYSA-N 0.000 description 1
- WDKCYSNTWJHLIN-UHFFFAOYSA-N 2-(4-fluoro-1,5-dimethyl-3-phenylpyrrol-2-yl)-2-oxoacetyl chloride Chemical compound CN1C(C)=C(F)C(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O WDKCYSNTWJHLIN-UHFFFAOYSA-N 0.000 description 1
- FRKWNJKRNHWDNI-UHFFFAOYSA-N 2-(5-ethyl-1-methyl-3-phenylpyrrol-2-yl)-2-oxoacetyl chloride Chemical compound CN1C(CC)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O FRKWNJKRNHWDNI-UHFFFAOYSA-N 0.000 description 1
- XFLHNTFIKADYHT-UHFFFAOYSA-N 2-(5-methyl-1h-pyrrol-2-yl)-2-oxoacetyl chloride Chemical compound CC1=CC=C(C(=O)C(Cl)=O)N1 XFLHNTFIKADYHT-UHFFFAOYSA-N 0.000 description 1
- ZPTXYFYPBLHASB-UHFFFAOYSA-N 2-(5-methyl-3-phenyl-1-propan-2-ylpyrrol-2-yl)-2-oxoacetyl chloride Chemical compound CC(C)N1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O ZPTXYFYPBLHASB-UHFFFAOYSA-N 0.000 description 1
- PPSIPNHFSOIKAH-UHFFFAOYSA-N 2-[(2-methyl-4-phenylpyrrol-1-yl)methyl]pyridine Chemical compound CC1=CC(C=2C=CC=CC=2)=CN1CC1=CC=CC=N1 PPSIPNHFSOIKAH-UHFFFAOYSA-N 0.000 description 1
- JQMNDQPRUQGOKQ-UHFFFAOYSA-N 2-[1,5-dimethyl-3-(oxan-4-yl)pyrrol-2-yl]-2-oxoacetyl chloride Chemical compound CN1C(C)=CC(C2CCOCC2)=C1C(=O)C(Cl)=O JQMNDQPRUQGOKQ-UHFFFAOYSA-N 0.000 description 1
- FKYLWWIHQQAYAW-UHFFFAOYSA-N 2-[1,5-dimethyl-3-(oxan-4-yl)pyrrol-2-yl]-n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound C=1C=C(N2CCN(CC2)C=2N=C(C)C=C(C)C=2)C=CC=1NC(=O)C(=O)C=1N(C)C(C)=CC=1C1CCOCC1 FKYLWWIHQQAYAW-UHFFFAOYSA-N 0.000 description 1
- JEZJBKNOFVOELX-UHFFFAOYSA-N 2-[1-(2-acetamidoethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound CC(=O)NCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O JEZJBKNOFVOELX-UHFFFAOYSA-N 0.000 description 1
- WYRATDRAXMVQFT-UHFFFAOYSA-N 2-[1-(2-acetamidoethyl)-5-methyl-3-phenylpyrrol-2-yl]-n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound CC(=O)NCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 WYRATDRAXMVQFT-UHFFFAOYSA-N 0.000 description 1
- NCWNNXJOMNFHHO-UHFFFAOYSA-N 2-[1-(2-ethoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound CCOCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O NCWNNXJOMNFHHO-UHFFFAOYSA-N 0.000 description 1
- MTIWVQNSSCEQKN-UHFFFAOYSA-N 2-[1-(2-methoxyethoxymethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound COCCOCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O MTIWVQNSSCEQKN-UHFFFAOYSA-N 0.000 description 1
- SOMPTUPDENUERF-UHFFFAOYSA-N 2-[1-(2-methoxyethyl)-3-(2-methylpropyl)pyrrol-2-yl]-2-oxoacetyl chloride Chemical compound COCCN1C=CC(CC(C)C)=C1C(=O)C(Cl)=O SOMPTUPDENUERF-UHFFFAOYSA-N 0.000 description 1
- ZUQGWMIKFPHKRI-UHFFFAOYSA-N 2-[1-(2-methoxyethyl)-3-phenyl-5-propan-2-ylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound COCCN1C(C(C)C)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O ZUQGWMIKFPHKRI-UHFFFAOYSA-N 0.000 description 1
- YLSOAYJXWPJOGJ-UHFFFAOYSA-N 2-[1-(2-methoxyethyl)-3-phenylpyrrol-2-yl]-2-oxo-n-phenylacetamide Chemical compound COCCN1C=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC1=CC=CC=C1 YLSOAYJXWPJOGJ-UHFFFAOYSA-N 0.000 description 1
- DXMOLALRPTVLAU-UHFFFAOYSA-N 2-[1-(2-methoxyethyl)-3-phenylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound COCCN1C=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O DXMOLALRPTVLAU-UHFFFAOYSA-N 0.000 description 1
- GSCQYQIRSNRKFV-UHFFFAOYSA-N 2-[1-(2-methoxyethyl)-3-propan-2-ylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound COCCN1C=CC(C(C)C)=C1C(=O)C(Cl)=O GSCQYQIRSNRKFV-UHFFFAOYSA-N 0.000 description 1
- HLJWCHHIBHFEAQ-UHFFFAOYSA-N 2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxo-n-[4-(4-pyridin-2-ylpiperazin-1-yl)phenyl]acetamide Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC=CC=N1 HLJWCHHIBHFEAQ-UHFFFAOYSA-N 0.000 description 1
- JMMHVMBLNHJFHE-UHFFFAOYSA-N 2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxo-n-quinolin-5-ylacetamide Chemical compound C=1C=CC2=NC=CC=C2C=1NC(=O)C(=O)C=1N(CCOC)C(C)=CC=1C1=CC=CC=C1 JMMHVMBLNHJFHE-UHFFFAOYSA-N 0.000 description 1
- FDFSSWQSIVRCRI-UHFFFAOYSA-N 2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O FDFSSWQSIVRCRI-UHFFFAOYSA-N 0.000 description 1
- QYGDSTNETCQGSR-UHFFFAOYSA-N 2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-n-[4-[4-(4-methylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC=N1 QYGDSTNETCQGSR-UHFFFAOYSA-N 0.000 description 1
- UWTZVUZAFAPSFS-UHFFFAOYSA-N 2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-n-[4-[4-(6-methylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC=CC(C)=N1 UWTZVUZAFAPSFS-UHFFFAOYSA-N 0.000 description 1
- DJUSHQIRIYRPLR-UHFFFAOYSA-N 2-[1-(2-methoxyethyl)-5-methyl-3-propan-2-ylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound COCCN1C(C)=CC(C(C)C)=C1C(=O)C(Cl)=O DJUSHQIRIYRPLR-UHFFFAOYSA-N 0.000 description 1
- AWOOZWSXLWISGA-UHFFFAOYSA-N 2-[1-(3-ethoxypropyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound CCOCCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O AWOOZWSXLWISGA-UHFFFAOYSA-N 0.000 description 1
- HMBJTPJNMQNZDZ-UHFFFAOYSA-N 2-[1-(3-methoxypropyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound COCCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O HMBJTPJNMQNZDZ-UHFFFAOYSA-N 0.000 description 1
- RPDYFCKQJLUJPB-UHFFFAOYSA-N 2-[1-(ethoxymethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound CCOCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O RPDYFCKQJLUJPB-UHFFFAOYSA-N 0.000 description 1
- AGKJXDGWGMHISG-UHFFFAOYSA-N 2-[1-(methoxymethyl)-3-phenylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound COCN1C=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O AGKJXDGWGMHISG-UHFFFAOYSA-N 0.000 description 1
- IVVFHPNGYFRTQU-UHFFFAOYSA-N 2-[1-[2-(dimethylamino)ethyl]-3-phenylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound CN(C)CCN1C=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O IVVFHPNGYFRTQU-UHFFFAOYSA-N 0.000 description 1
- MGIJZIVOVQTFKA-UHFFFAOYSA-N 2-[1-[2-(dimethylamino)ethyl]-4-phenylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound C1=C(C(=O)C(Cl)=O)N(CCN(C)C)C=C1C1=CC=CC=C1 MGIJZIVOVQTFKA-UHFFFAOYSA-N 0.000 description 1
- OKXGKVMIBNWTOT-UHFFFAOYSA-N 2-[1-[2-(dimethylamino)ethyl]-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound CN(C)CCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O OKXGKVMIBNWTOT-UHFFFAOYSA-N 0.000 description 1
- WXPNHEPALKDFGB-UHFFFAOYSA-N 2-[3-(2-chlorophenyl)-1-(2-methoxyethyl)pyrrol-2-yl]-2-oxoacetyl chloride Chemical compound COCCN1C=CC(C=2C(=CC=CC=2)Cl)=C1C(=O)C(Cl)=O WXPNHEPALKDFGB-UHFFFAOYSA-N 0.000 description 1
- QRGOTVKLMKGUGG-UHFFFAOYSA-N 2-[3-(2-methoxyethyl)-5-methyl-1-phenylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound ClC(=O)C(=O)C1=C(CCOC)C=C(C)N1C1=CC=CC=C1 QRGOTVKLMKGUGG-UHFFFAOYSA-N 0.000 description 1
- AZUVOTDASWSRGH-UHFFFAOYSA-N 2-[3-(3-chlorophenyl)-1-(2-methoxyethyl)pyrrol-2-yl]-2-oxoacetyl chloride Chemical compound COCCN1C=CC(C=2C=C(Cl)C=CC=2)=C1C(=O)C(Cl)=O AZUVOTDASWSRGH-UHFFFAOYSA-N 0.000 description 1
- CRGIZSKOYMHORV-UHFFFAOYSA-N 2-[3-(4-chlorophenyl)-1-(2-methoxyethyl)pyrrol-2-yl]-2-oxoacetyl chloride Chemical compound COCCN1C=CC(C=2C=CC(Cl)=CC=2)=C1C(=O)C(Cl)=O CRGIZSKOYMHORV-UHFFFAOYSA-N 0.000 description 1
- LNOXLMKQLMFEOM-UHFFFAOYSA-N 2-[3-(furan-2-yl)-1,5-dimethylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound CN1C(C)=CC(C=2OC=CC=2)=C1C(=O)C(Cl)=O LNOXLMKQLMFEOM-UHFFFAOYSA-N 0.000 description 1
- MLJKVACJUSYOKF-UHFFFAOYSA-N 2-[3-cyclobutyl-1-(2-methoxyethyl)pyrrol-2-yl]-2-oxoacetyl chloride Chemical compound COCCN1C=CC(C2CCC2)=C1C(=O)C(Cl)=O MLJKVACJUSYOKF-UHFFFAOYSA-N 0.000 description 1
- KICVFUGSSHDVTQ-UHFFFAOYSA-N 2-[4-(2-chlorophenyl)-1-(2-methoxyethyl)pyrrol-2-yl]-2-oxoacetyl chloride Chemical compound C1=C(C(=O)C(Cl)=O)N(CCOC)C=C1C1=CC=CC=C1Cl KICVFUGSSHDVTQ-UHFFFAOYSA-N 0.000 description 1
- HEBRFJQMLORGRL-UHFFFAOYSA-N 2-[4-fluoro-1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound COCCN1C(C)=C(F)C(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O HEBRFJQMLORGRL-UHFFFAOYSA-N 0.000 description 1
- QUIMZGDJJLRGQT-UHFFFAOYSA-N 2-[5-ethyl-1-(2-methoxyethyl)-3-phenylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound COCCN1C(CC)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O QUIMZGDJJLRGQT-UHFFFAOYSA-N 0.000 description 1
- QWQDRERVXQAAOI-UHFFFAOYSA-N 2-[5-ethyl-1-(methoxymethyl)-3-phenylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound COCN1C(CC)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O QWQDRERVXQAAOI-UHFFFAOYSA-N 0.000 description 1
- MCZFBCUXOOGKGB-UHFFFAOYSA-N 2-[5-methyl-1-(2-methylsulfanylethyl)-3-phenylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound CSCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O MCZFBCUXOOGKGB-UHFFFAOYSA-N 0.000 description 1
- PIYSGBKXZDVZBX-UHFFFAOYSA-N 2-[5-methyl-1-(2-phenoxyethyl)-3-phenylpyrrol-2-yl]-2-oxoacetyl chloride Chemical compound CC1=CC(C=2C=CC=CC=2)=C(C(=O)C(Cl)=O)N1CCOC1=CC=CC=C1 PIYSGBKXZDVZBX-UHFFFAOYSA-N 0.000 description 1
- KBZMCMGKHHGYPM-UHFFFAOYSA-N 2-[5-methyl-3-phenyl-1-(2-propan-2-yloxyethyl)pyrrol-2-yl]-2-oxoacetyl chloride Chemical compound CC(C)OCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O KBZMCMGKHHGYPM-UHFFFAOYSA-N 0.000 description 1
- FYFPOWCAHTWQEY-UHFFFAOYSA-N 2-[5-methyl-3-phenyl-1-(propoxymethyl)pyrrol-2-yl]-2-oxoacetyl chloride Chemical compound CCCOCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O FYFPOWCAHTWQEY-UHFFFAOYSA-N 0.000 description 1
- YVFKPDOCFWUMGC-UHFFFAOYSA-N 2-[5-methyl-3-phenyl-1-(pyridin-2-ylmethyl)pyrrol-2-yl]-2-oxoacetyl chloride Chemical compound Cc1cc(c(C(=O)C(Cl)=O)n1Cc1ccccn1)-c1ccccc1 YVFKPDOCFWUMGC-UHFFFAOYSA-N 0.000 description 1
- PAXNJSZVYMCWEL-UHFFFAOYSA-N 2-[5-methyl-3-phenyl-1-(pyridin-3-ylmethyl)pyrrol-2-yl]-2-oxoacetyl chloride Chemical compound CC1=CC(C=2C=CC=CC=2)=C(C(=O)C(Cl)=O)N1CC1=CC=CN=C1 PAXNJSZVYMCWEL-UHFFFAOYSA-N 0.000 description 1
- XPCZZLSQSHDOOU-UHFFFAOYSA-N 2-[5-methyl-3-phenyl-1-(pyridin-4-ylmethyl)pyrrol-2-yl]-2-oxoacetyl chloride Chemical compound CC1=CC(C=2C=CC=CC=2)=C(C(=O)C(Cl)=O)N1CC1=CC=NC=C1 XPCZZLSQSHDOOU-UHFFFAOYSA-N 0.000 description 1
- FEHYRPLXGWCVKM-UHFFFAOYSA-N 2-ethyl-1-(2-methoxyethyl)-4-phenylpyrrole Chemical compound COCCN1C(CC)=CC(C=2C=CC=CC=2)=C1 FEHYRPLXGWCVKM-UHFFFAOYSA-N 0.000 description 1
- XBZHIPLQKNAXKV-UHFFFAOYSA-N 2-ethyl-1-(methoxymethyl)-4-phenylpyrrole Chemical compound COCN1C(CC)=CC(C=2C=CC=CC=2)=C1 XBZHIPLQKNAXKV-UHFFFAOYSA-N 0.000 description 1
- GASFNUJKLCNDKB-UHFFFAOYSA-N 2-ethyl-1-methyl-4-phenylpyrrole Chemical compound CN1C(CC)=CC(C=2C=CC=CC=2)=C1 GASFNUJKLCNDKB-UHFFFAOYSA-N 0.000 description 1
- JRVHHILDIANICS-UHFFFAOYSA-N 2-methyl-1-(2-methylsulfanylethyl)-4-phenylpyrrole Chemical compound C1=C(C)N(CCSC)C=C1C1=CC=CC=C1 JRVHHILDIANICS-UHFFFAOYSA-N 0.000 description 1
- QSLWQPVOSFFZHD-UHFFFAOYSA-N 2-methyl-1-(2-phenoxyethyl)-4-phenylpyrrole Chemical compound CC1=CC(C=2C=CC=CC=2)=CN1CCOC1=CC=CC=C1 QSLWQPVOSFFZHD-UHFFFAOYSA-N 0.000 description 1
- QBEBMOSZQOPWHM-UHFFFAOYSA-N 2-methyl-1-(methylsulfanylmethyl)-4-phenylpyrrole Chemical compound C1=C(C)N(CSC)C=C1C1=CC=CC=C1 QBEBMOSZQOPWHM-UHFFFAOYSA-N 0.000 description 1
- RQKXNOFLDHOGAP-UHFFFAOYSA-N 2-methyl-4-[(2-methyl-4-phenylpyrrol-1-yl)methyl]-1,3-oxazole Chemical compound O1C(C)=NC(CN2C(=CC(=C2)C=2C=CC=CC=2)C)=C1 RQKXNOFLDHOGAP-UHFFFAOYSA-N 0.000 description 1
- GBCLPFQRMVPTKY-UHFFFAOYSA-N 2-methyl-4-phenyl-1-propylpyrrole Chemical compound C1=C(C)N(CCC)C=C1C1=CC=CC=C1 GBCLPFQRMVPTKY-UHFFFAOYSA-N 0.000 description 1
- WEEKSQBGSMJFMW-UHFFFAOYSA-N 2-methyl-4-phenyl-1h-pyrrole Chemical compound N1C(C)=CC(C=2C=CC=CC=2)=C1 WEEKSQBGSMJFMW-UHFFFAOYSA-N 0.000 description 1
- HCFSSRSQYCDITA-UHFFFAOYSA-N 2-oxo-2-(2-phenyl-6,7-dihydro-5h-pyrrolizin-3-yl)acetyl chloride Chemical compound C1=C2CCCN2C(C(=O)C(=O)Cl)=C1C1=CC=CC=C1 HCFSSRSQYCDITA-UHFFFAOYSA-N 0.000 description 1
- CALSQEKRBWZDPN-UHFFFAOYSA-N 2-oxo-2-(7-phenyl-3,4-dihydro-1h-pyrrolo[2,1-c][1,4]oxazin-6-yl)acetyl chloride Chemical compound C1=C2COCCN2C(C(=O)C(=O)Cl)=C1C1=CC=CC=C1 CALSQEKRBWZDPN-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- VQVVCXOTBQEDAL-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(2-methoxyethyl)pyrrole Chemical compound COCCN1C=CC(C=2C(=CC=CC=2)Cl)=C1 VQVVCXOTBQEDAL-UHFFFAOYSA-N 0.000 description 1
- ULJGPUKQZQKYRC-UHFFFAOYSA-N 3-(2-methoxyethyl)-5-methyl-1-phenylpyrrole-2,4-dicarboxylic acid Chemical compound OC(=O)C1=C(CCOC)C(C(O)=O)=C(C)N1C1=CC=CC=C1 ULJGPUKQZQKYRC-UHFFFAOYSA-N 0.000 description 1
- CGGOKAYNDMHZTJ-UHFFFAOYSA-N 3-(2-methyl-4-phenylpyrrol-1-yl)propan-1-ol Chemical compound OCCCN1C(C)=CC(C=2C=CC=CC=2)=C1 CGGOKAYNDMHZTJ-UHFFFAOYSA-N 0.000 description 1
- GCUDANCEKWHJRX-UHFFFAOYSA-N 3-(2-methylpropyl)-1h-pyrrole Chemical compound CC(C)CC=1C=CNC=1 GCUDANCEKWHJRX-UHFFFAOYSA-N 0.000 description 1
- MOAMMOIYBMPMRE-UHFFFAOYSA-N 3-(3-chlorophenyl)-1-(2-methoxyethyl)pyrrole Chemical compound COCCN1C=CC(C=2C=C(Cl)C=CC=2)=C1 MOAMMOIYBMPMRE-UHFFFAOYSA-N 0.000 description 1
- SIGIBEBHDNGUMB-UHFFFAOYSA-N 3-(4-chlorophenyl)-1-(2-methoxyethyl)pyrrole Chemical compound COCCN1C=CC(C=2C=CC(Cl)=CC=2)=C1 SIGIBEBHDNGUMB-UHFFFAOYSA-N 0.000 description 1
- VHZMULAOGHVDME-UHFFFAOYSA-N 3-bromo-1,2-dimethyl-4-phenylpyrrole Chemical compound CN1C(C)=C(Br)C(C=2C=CC=CC=2)=C1 VHZMULAOGHVDME-UHFFFAOYSA-N 0.000 description 1
- SFBZICGWMCHSPX-UHFFFAOYSA-N 3-bromo-2-methyl-4-phenyl-1h-pyrrole Chemical compound BrC1=C(C)NC=C1C1=CC=CC=C1 SFBZICGWMCHSPX-UHFFFAOYSA-N 0.000 description 1
- TUANJYVVVVMZFG-UHFFFAOYSA-N 3-cyclobutyl-1h-pyrrole Chemical compound C1CCC1C1=CNC=C1 TUANJYVVVVMZFG-UHFFFAOYSA-N 0.000 description 1
- LJDRAKFYYGCAQC-UHFFFAOYSA-N 3-phenyl-1h-pyrrole Chemical compound N1C=CC(C=2C=CC=CC=2)=C1 LJDRAKFYYGCAQC-UHFFFAOYSA-N 0.000 description 1
- GAKOZCKPFUHTNN-UHFFFAOYSA-N 3-phenylpyrrole-1-carboxylic acid Chemical compound OC(=O)N1C=CC(C=2C=CC=CC=2)=C1 GAKOZCKPFUHTNN-UHFFFAOYSA-N 0.000 description 1
- DVCXAZNRWJRKHF-UHFFFAOYSA-N 3-propan-2-yl-1h-pyrrole Chemical compound CC(C)C=1C=CNC=1 DVCXAZNRWJRKHF-UHFFFAOYSA-N 0.000 description 1
- LQRWRUZIICPGJD-UHFFFAOYSA-N 3-thiophen-2-yl-1h-pyrrole Chemical compound C1=CSC(C2=CNC=C2)=C1 LQRWRUZIICPGJD-UHFFFAOYSA-N 0.000 description 1
- BEACEBNWQDTIJM-UHFFFAOYSA-N 3-thiophen-3-yl-1h-pyrrole Chemical compound N1C=CC(C2=CSC=C2)=C1 BEACEBNWQDTIJM-UHFFFAOYSA-N 0.000 description 1
- MPIOUKWWCLOEEY-UHFFFAOYSA-N 4-(2-chlorophenyl)-1-(2-methoxyethyl)pyrrole-2-carboxylic acid Chemical compound C1=C(C(O)=O)N(CCOC)C=C1C1=CC=CC=C1Cl MPIOUKWWCLOEEY-UHFFFAOYSA-N 0.000 description 1
- KSEIZENXRLDEDT-UHFFFAOYSA-N 4-(2-methoxyethyl)-2-methyl-1-phenylpyrrole Chemical compound C1=C(CCOC)C=C(C)N1C1=CC=CC=C1 KSEIZENXRLDEDT-UHFFFAOYSA-N 0.000 description 1
- FBWKPSXYDIRVQV-UHFFFAOYSA-N 4-(2-methylpropyl)-1h-pyrrole-3-carboxylic acid Chemical compound CC(C)CC1=CNC=C1C(O)=O FBWKPSXYDIRVQV-UHFFFAOYSA-N 0.000 description 1
- SEUKFOMDVJIJQO-UHFFFAOYSA-N 4-(3-chlorophenyl)-1-(2-methoxyethyl)pyrrole-2-carboxylic acid Chemical compound C1=C(C(O)=O)N(CCOC)C=C1C1=CC=CC(Cl)=C1 SEUKFOMDVJIJQO-UHFFFAOYSA-N 0.000 description 1
- RPZNIFIHONJJPP-UHFFFAOYSA-N 4-[(2-methyl-4-phenylpyrrol-1-yl)methyl]pyridine Chemical compound CC1=CC(C=2C=CC=CC=2)=CN1CC1=CC=NC=C1 RPZNIFIHONJJPP-UHFFFAOYSA-N 0.000 description 1
- OROCDRZNJMPHID-UHFFFAOYSA-N 4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]aniline Chemical compound CC1=CC(C)=NC(N2CCN(CC2)C=2C=CC(N)=CC=2)=C1 OROCDRZNJMPHID-UHFFFAOYSA-N 0.000 description 1
- ZAQVYQZREWUUCP-UHFFFAOYSA-N 4-cyclobutyl-1h-pyrrole-3-carboxylic acid Chemical compound OC(=O)C1=CNC=C1C1CCC1 ZAQVYQZREWUUCP-UHFFFAOYSA-N 0.000 description 1
- ZMXWMQCUAZUMFB-UHFFFAOYSA-N 4-methoxycarbonyl-1-(3-methoxypropyl)-5-methyl-3-phenylpyrrole-2-carboxylic acid Chemical compound COCCCN1C(C)=C(C(=O)OC)C(C=2C=CC=CC=2)=C1C(O)=O ZMXWMQCUAZUMFB-UHFFFAOYSA-N 0.000 description 1
- USTKWYVBYDXQPG-UHFFFAOYSA-N 4-phenyl-1h-pyrrole-2-carboxylic acid Chemical compound N1C(C(=O)O)=CC(C=2C=CC=CC=2)=C1 USTKWYVBYDXQPG-UHFFFAOYSA-N 0.000 description 1
- QCEFVFJIAIAKAD-UHFFFAOYSA-N 4-propan-2-yl-1h-pyrrole-3-carboxylic acid Chemical compound CC(C)C1=CNC=C1C(O)=O QCEFVFJIAIAKAD-UHFFFAOYSA-N 0.000 description 1
- OSGFPZNPRWTXKU-UHFFFAOYSA-N 4-thiophen-2-yl-1h-pyrrole-3-carboxylic acid Chemical compound OC(=O)C1=CNC=C1C1=CC=CS1 OSGFPZNPRWTXKU-UHFFFAOYSA-N 0.000 description 1
- OWHUOHUVAKSDDI-UHFFFAOYSA-N 4-thiophen-3-yl-1h-pyrrole-3-carboxylic acid Chemical compound OC(=O)C1=CNC=C1C1=CSC=C1 OWHUOHUVAKSDDI-UHFFFAOYSA-N 0.000 description 1
- XFOFUQPANILVMA-UHFFFAOYSA-N 5-(2-methoxyethyl)-1-methyl-3-phenylpyrrole-2,4-dicarboxylic acid Chemical compound CN1C(CCOC)=C(C(O)=O)C(C=2C=CC=CC=2)=C1C(O)=O XFOFUQPANILVMA-UHFFFAOYSA-N 0.000 description 1
- OMMFWPGBDWQGHJ-UHFFFAOYSA-N 5-(3-phenylpyrrol-1-yl)pentanenitrile Chemical compound N#CCCCCN1C=CC(C=2C=CC=CC=2)=C1 OMMFWPGBDWQGHJ-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- YTRNPLCETQTBPY-UHFFFAOYSA-N 5-ethyl-1-(2-methoxyethyl)-3-phenylpyrrole-2,4-dicarboxylic acid Chemical compound COCCN1C(CC)=C(C(O)=O)C(C=2C=CC=CC=2)=C1C(O)=O YTRNPLCETQTBPY-UHFFFAOYSA-N 0.000 description 1
- BHKLBPSONOSMKK-UHFFFAOYSA-N 5-ethyl-1-(methoxymethyl)-3-phenylpyrrole-2,4-dicarboxylic acid Chemical compound COCN1C(CC)=C(C(O)=O)C(C=2C=CC=CC=2)=C1C(O)=O BHKLBPSONOSMKK-UHFFFAOYSA-N 0.000 description 1
- PMQQUJQNBXWJCY-UHFFFAOYSA-N 5-ethyl-1-methyl-3-phenylpyrrole-2,4-dicarboxylic acid Chemical compound CN1C(CC)=C(C(O)=O)C(C=2C=CC=CC=2)=C1C(O)=O PMQQUJQNBXWJCY-UHFFFAOYSA-N 0.000 description 1
- OYILLJRBOGMBPN-UHFFFAOYSA-N 5-methyl-1-(2-methylsulfanylethyl)-3-phenylpyrrole-2,4-dicarboxylic acid Chemical compound CSCCN1C(C)=C(C(O)=O)C(C=2C=CC=CC=2)=C1C(O)=O OYILLJRBOGMBPN-UHFFFAOYSA-N 0.000 description 1
- NJBHEVZOJJTVQI-UHFFFAOYSA-N 5-methyl-1-(2-phenoxyethyl)-3-phenylpyrrole-2,4-dicarboxylic acid Chemical compound CC1=C(C(O)=O)C(C=2C=CC=CC=2)=C(C(O)=O)N1CCOC1=CC=CC=C1 NJBHEVZOJJTVQI-UHFFFAOYSA-N 0.000 description 1
- VWQLJSNATAANPR-UHFFFAOYSA-N 5-methyl-1-(methylsulfanylmethyl)-3-phenylpyrrole-2,4-dicarboxylic acid Chemical compound CSCN1C(C)=C(C(O)=O)C(C=2C=CC=CC=2)=C1C(O)=O VWQLJSNATAANPR-UHFFFAOYSA-N 0.000 description 1
- GORJKJXUYPNKKU-UHFFFAOYSA-N 5-methyl-3-phenyl-1-(propoxymethyl)pyrrole-2,4-dicarboxylic acid Chemical compound CCCOCN1C(C)=C(C(O)=O)C(C=2C=CC=CC=2)=C1C(O)=O GORJKJXUYPNKKU-UHFFFAOYSA-N 0.000 description 1
- KNVVITAPHUMAND-UHFFFAOYSA-N 5-methyl-3-phenyl-1-(pyridin-2-ylmethyl)pyrrole-2,4-dicarboxylic acid Chemical compound CC1=C(C(O)=O)C(C=2C=CC=CC=2)=C(C(O)=O)N1CC1=CC=CC=N1 KNVVITAPHUMAND-UHFFFAOYSA-N 0.000 description 1
- UPCNEYRBFUZXPA-UHFFFAOYSA-N 5-methyl-3-phenyl-1-(pyridin-4-ylmethyl)pyrrole-2,4-dicarboxylic acid Chemical compound CC1=C(C(O)=O)C(C=2C=CC=CC=2)=C(C(O)=O)N1CC1=CC=NC=C1 UPCNEYRBFUZXPA-UHFFFAOYSA-N 0.000 description 1
- RBOLWLFRZNOIPS-UHFFFAOYSA-N 5-methyl-3-phenyl-1h-pyrrole-2,4-dicarboxylic acid Chemical compound OC(=O)C1=C(C)NC(C(O)=O)=C1C1=CC=CC=C1 RBOLWLFRZNOIPS-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000012979 RPMI medium Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- IYABWNGZIDDRAK-UHFFFAOYSA-N allene Chemical group C=C=C IYABWNGZIDDRAK-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 125000002618 bicyclic heterocycle group Chemical group 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- SOCHEFQPZSPQJH-UHFFFAOYSA-N dimethyl 1-(3-methoxypropyl)-5-methyl-3-phenylpyrrole-2,4-dicarboxylate Chemical compound COCCCN1C(C)=C(C(=O)OC)C(C=2C=CC=CC=2)=C1C(=O)OC SOCHEFQPZSPQJH-UHFFFAOYSA-N 0.000 description 1
- 125000005879 dioxolanyl group Chemical group 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- FKRNNOWAUWLJFD-UHFFFAOYSA-N ethyl 2-(2-chloro-2-oxoacetyl)-5-methyl-3-phenylpyrrole-1-carboxylate Chemical compound CCOC(=O)N1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O FKRNNOWAUWLJFD-UHFFFAOYSA-N 0.000 description 1
- GWNFQAKCJYEJEW-UHFFFAOYSA-N ethyl 3-[8-[[4-methyl-5-[(3-methyl-4-oxophthalazin-1-yl)methyl]-1,2,4-triazol-3-yl]sulfanyl]octanoylamino]benzoate Chemical compound CCOC(=O)C1=CC(NC(=O)CCCCCCCSC2=NN=C(CC3=NN(C)C(=O)C4=CC=CC=C34)N2C)=CC=C1 GWNFQAKCJYEJEW-UHFFFAOYSA-N 0.000 description 1
- LZIPFRQBFFKOTK-UHFFFAOYSA-N ethyl 4-phenyl-1h-pyrrole-2-carboxylate Chemical compound N1C(C(=O)OCC)=CC(C=2C=CC=CC=2)=C1 LZIPFRQBFFKOTK-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000019256 formaldehyde Nutrition 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- QYZXDKKZGLVLNX-UHFFFAOYSA-N methyl 2-(2-chloro-2-oxoacetyl)-5-methyl-3-phenylpyrrole-1-carboxylate Chemical compound COC(=O)N1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(Cl)=O QYZXDKKZGLVLNX-UHFFFAOYSA-N 0.000 description 1
- BYWFHGCVIKBBEM-UHFFFAOYSA-N n-(3-fluoro-4-piperidin-1-ylphenyl)-2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1F)=CC=C1N1CCCCC1 BYWFHGCVIKBBEM-UHFFFAOYSA-N 0.000 description 1
- ZSYFYSBXSAXAMP-UHFFFAOYSA-N n-[2-fluoro-4-(4-pyridin-2-ylpiperazin-1-yl)phenyl]-2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C(=C1)F)=CC=C1N(CC1)CCN1C1=CC=CC=N1 ZSYFYSBXSAXAMP-UHFFFAOYSA-N 0.000 description 1
- MEEJSANGFKDKBC-UHFFFAOYSA-N n-[2-fluoro-4-[4-(2-methylpropyl)piperazin-1-yl]phenyl]-2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C(=C1)F)=CC=C1N1CCN(CC(C)C)CC1 MEEJSANGFKDKBC-UHFFFAOYSA-N 0.000 description 1
- CKRUIMFCYKVIPQ-UHFFFAOYSA-N n-[3-[2-(dimethylamino)ethoxymethyl]-4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-2-oxoacetamide Chemical compound C=1C=C(N2CCN(CC2)C=2N=C(C)C=C(C)C=2)C(COCCN(C)C)=CC=1NC(=O)C(=O)C(N(C(C)=C1)C)=C1C1=CC=CC=C1 CKRUIMFCYKVIPQ-UHFFFAOYSA-N 0.000 description 1
- AKKMGRQMNIUSMJ-UHFFFAOYSA-N n-[3-chloro-4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-(1,5-dimethyl-3-thiophen-2-ylpyrrol-2-yl)-2-oxoacetamide Chemical compound C=1C=C(N2CCN(CC2)C=2N=C(C)C=C(C)C=2)C(Cl)=CC=1NC(=O)C(=O)C=1N(C)C(C)=CC=1C1=CC=CS1 AKKMGRQMNIUSMJ-UHFFFAOYSA-N 0.000 description 1
- JJULJAXUGJIUFW-UHFFFAOYSA-N n-[3-chloro-4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1Cl)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 JJULJAXUGJIUFW-UHFFFAOYSA-N 0.000 description 1
- WWRUERLCFOEVQA-UHFFFAOYSA-N n-[4-[2-(4,6-dimethylpyridin-2-yl)oxyethoxy]phenyl]-2-(1,5-dimethyl-3-thiophen-2-ylpyrrol-2-yl)-2-oxoacetamide Chemical compound C=1C=C(OCCOC=2N=C(C)C=C(C)C=2)C=CC=1NC(=O)C(=O)C=1N(C)C(C)=CC=1C1=CC=CS1 WWRUERLCFOEVQA-UHFFFAOYSA-N 0.000 description 1
- XRAHNAPOXWPJHB-UHFFFAOYSA-N n-[4-[2-(4,6-dimethylpyridin-2-yl)oxyethylamino]phenyl]-2-(1,5-dimethyl-3-thiophen-2-ylpyrrol-2-yl)-2-oxoacetamide Chemical compound C=1C=C(NCCOC=2N=C(C)C=C(C)C=2)C=CC=1NC(=O)C(=O)C=1N(C)C(C)=CC=1C1=CC=CS1 XRAHNAPOXWPJHB-UHFFFAOYSA-N 0.000 description 1
- YTIZRGSBTRONQP-UHFFFAOYSA-N n-[4-[2-(4,6-dimethylpyridin-2-yl)oxyethylamino]phenyl]-2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1NCCOC1=CC(C)=CC(C)=N1 YTIZRGSBTRONQP-UHFFFAOYSA-N 0.000 description 1
- POAMSBJXGXPOQI-UHFFFAOYSA-N n-[4-[2-[(4,6-dimethylpyridin-2-yl)-methylamino]ethoxy]phenyl]-2-(1,5-dimethyl-3-thiophen-2-ylpyrrol-2-yl)-2-oxoacetamide Chemical compound C=1C(C)=CC(C)=NC=1N(C)CCOC(C=C1)=CC=C1NC(=O)C(=O)C(N(C(C)=C1)C)=C1C1=CC=CS1 POAMSBJXGXPOQI-UHFFFAOYSA-N 0.000 description 1
- QMDAMBSWWNDLGF-UHFFFAOYSA-N n-[4-[2-[(4,6-dimethylpyridin-2-yl)-methylamino]ethyl-methylamino]phenyl]-2-(1,5-dimethyl-3-thiophen-2-ylpyrrol-2-yl)-2-oxoacetamide Chemical compound C=1C=C(NC(=O)C(=O)C=2N(C(C)=CC=2C=2SC=CC=2)C)C=CC=1N(C)CCN(C)C1=CC(C)=CC(C)=N1 QMDAMBSWWNDLGF-UHFFFAOYSA-N 0.000 description 1
- ZWLNYTQQTBUVKL-UHFFFAOYSA-N n-[4-[2-[(4,6-dimethylpyridin-2-yl)-methylamino]ethylamino]phenyl]-2-(1,5-dimethyl-3-thiophen-2-ylpyrrol-2-yl)-2-oxoacetamide Chemical compound C=1C(C)=CC(C)=NC=1N(C)CCNC(C=C1)=CC=C1NC(=O)C(=O)C(N(C(C)=C1)C)=C1C1=CC=CS1 ZWLNYTQQTBUVKL-UHFFFAOYSA-N 0.000 description 1
- BGJOJZWPUOSRGH-UHFFFAOYSA-N n-[4-[2-[(4,6-dimethylpyridin-2-yl)-methylamino]ethylamino]phenyl]-2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1NCCN(C)C1=CC(C)=CC(C)=N1 BGJOJZWPUOSRGH-UHFFFAOYSA-N 0.000 description 1
- IVBYYLYTSSAARM-UHFFFAOYSA-N n-[4-[2-[(4,6-dimethylpyridin-2-yl)amino]ethyl-methylamino]phenyl]-2-(1,5-dimethyl-3-thiophen-2-ylpyrrol-2-yl)-2-oxoacetamide Chemical compound C=1C=C(NC(=O)C(=O)C=2N(C(C)=CC=2C=2SC=CC=2)C)C=CC=1N(C)CCNC1=CC(C)=CC(C)=N1 IVBYYLYTSSAARM-UHFFFAOYSA-N 0.000 description 1
- CONNAHMYKZWQKQ-UHFFFAOYSA-N n-[4-[2-[(4,6-dimethylpyridin-2-yl)amino]ethyl-methylamino]phenyl]-2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(C)CCNC1=CC(C)=CC(C)=N1 CONNAHMYKZWQKQ-UHFFFAOYSA-N 0.000 description 1
- VWKPQMZEUJIKOG-UHFFFAOYSA-N n-[4-[2-[(4,6-dimethylpyridin-2-yl)amino]ethylamino]phenyl]-2-(1,5-dimethyl-3-thiophen-2-ylpyrrol-2-yl)-2-oxoacetamide Chemical compound C=1C=C(NCCNC=2N=C(C)C=C(C)C=2)C=CC=1NC(=O)C(=O)C=1N(C)C(C)=CC=1C1=CC=CS1 VWKPQMZEUJIKOG-UHFFFAOYSA-N 0.000 description 1
- QGCLDACNAASQEI-UHFFFAOYSA-N n-[4-[2-[(4,6-dimethylpyridin-2-yl)amino]ethylamino]phenyl]-2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1NCCNC1=CC(C)=CC(C)=N1 QGCLDACNAASQEI-UHFFFAOYSA-N 0.000 description 1
- SZMKGONHBHTTLP-UHFFFAOYSA-N n-[4-[3-[(4,6-dimethylpyridin-2-yl)-methylamino]propyl]phenyl]-2-[1-(2-methoxyethyl)-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1CCCN(C)C1=CC(C)=CC(C)=N1 SZMKGONHBHTTLP-UHFFFAOYSA-N 0.000 description 1
- BTYFETNOGGIBEG-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)-1,4-diazepan-1-yl]phenyl]-2-(1,5-dimethyl-3-thiophen-2-ylpyrrol-2-yl)-2-oxoacetamide Chemical compound C=1C=C(N2CCN(CCC2)C=2N=C(C)C=C(C)C=2)C=CC=1NC(=O)C(=O)C=1N(C)C(C)=CC=1C1=CC=CS1 BTYFETNOGGIBEG-UHFFFAOYSA-N 0.000 description 1
- OAOQEOHJORPDRC-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)-1,4-diazepan-1-yl]phenyl]-2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCCN1C1=CC(C)=CC(C)=N1 OAOQEOHJORPDRC-UHFFFAOYSA-N 0.000 description 1
- LNXUJNWMTMLNJR-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-(1-ethyl-5-methyl-3-phenylpyrrol-2-yl)-2-oxoacetamide Chemical compound CCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 LNXUJNWMTMLNJR-UHFFFAOYSA-N 0.000 description 1
- NLENMVHHNMZXTL-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-(1-methyl-3-phenylpyrrol-2-yl)-2-oxoacetamide Chemical compound CC1=CC(C)=NC(N2CCN(CC2)C=2C=CC(NC(=O)C(=O)C=3N(C=CC=3C=3C=CC=CC=3)C)=CC=2)=C1 NLENMVHHNMZXTL-UHFFFAOYSA-N 0.000 description 1
- WSTGIBNDDILIBP-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-(1-methyl-4-phenylpyrrol-2-yl)-2-oxoacetamide Chemical compound CC1=CC(C)=NC(N2CCN(CC2)C=2C=CC(NC(=O)C(=O)C=3N(C=C(C=3)C=3C=CC=CC=3)C)=CC=2)=C1 WSTGIBNDDILIBP-UHFFFAOYSA-N 0.000 description 1
- GPNNNCIHVAHNKK-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-(5-ethyl-1-methyl-3-phenylpyrrol-2-yl)-2-oxoacetamide Chemical compound CN1C(CC)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 GPNNNCIHVAHNKK-UHFFFAOYSA-N 0.000 description 1
- IHBGFGZLPHXNHS-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-(5-methyl-1-phenylpyrrol-2-yl)-2-oxoacetamide Chemical compound C=1C=CC=CC=1N1C(C)=CC=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 IHBGFGZLPHXNHS-UHFFFAOYSA-N 0.000 description 1
- JKFZHUPVDCZGDR-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-(5-methyl-3-phenyl-1-propylpyrrol-2-yl)-2-oxoacetamide Chemical compound CCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 JKFZHUPVDCZGDR-UHFFFAOYSA-N 0.000 description 1
- XGIUHXDMAAYMLS-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-(5-methyl-3-phenyl-1h-pyrrol-2-yl)-2-oxoacetamide Chemical compound N1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 XGIUHXDMAAYMLS-UHFFFAOYSA-N 0.000 description 1
- NZTFQXQRSVLNPP-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[1-(2-hydroxyethyl)-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound CC1=CC(C)=NC(N2CCN(CC2)C=2C=CC(NC(=O)C(=O)C=3N(C=CC=3C=3C=CC=CC=3)CCO)=CC=2)=C1 NZTFQXQRSVLNPP-UHFFFAOYSA-N 0.000 description 1
- NMSMZYRMZNJUHW-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[1-(2-methoxyethyl)-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 NMSMZYRMZNJUHW-UHFFFAOYSA-N 0.000 description 1
- XEORCDMMODJATF-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[1-(2-methoxyethyl)-3-thiophen-2-ylpyrrol-2-yl]-2-oxoacetamide Chemical compound C=1C=C(N2CCN(CC2)C=2N=C(C)C=C(C)C=2)C=CC=1NC(=O)C(=O)C=1N(CCOC)C=CC=1C1=CC=CS1 XEORCDMMODJATF-UHFFFAOYSA-N 0.000 description 1
- CZFYAINLKMHXMH-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[1-(methoxymethyl)-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCN1C=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 CZFYAINLKMHXMH-UHFFFAOYSA-N 0.000 description 1
- BMIGHXSSXJORFJ-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[1-[2-(methylamino)-2-oxoethyl]-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound CNC(=O)CN1C=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 BMIGHXSSXJORFJ-UHFFFAOYSA-N 0.000 description 1
- LVLQGPQBZYVZPS-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[3-(furan-2-yl)-1,5-dimethylpyrrol-2-yl]-2-oxoacetamide Chemical compound C=1C=C(N2CCN(CC2)C=2N=C(C)C=C(C)C=2)C=CC=1NC(=O)C(=O)C=1N(C)C(C)=CC=1C1=CC=CO1 LVLQGPQBZYVZPS-UHFFFAOYSA-N 0.000 description 1
- VZKNFGHRPUGOIT-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[5-ethyl-1-(2-methoxyethyl)-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCCN1C(CC)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 VZKNFGHRPUGOIT-UHFFFAOYSA-N 0.000 description 1
- QZAXULOMEPIHKY-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[5-ethyl-1-(methoxymethyl)-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound COCN1C(CC)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 QZAXULOMEPIHKY-UHFFFAOYSA-N 0.000 description 1
- NSYVNTZCXQSSIZ-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[5-methyl-1-(2-methylsulfanylethyl)-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound CSCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 NSYVNTZCXQSSIZ-UHFFFAOYSA-N 0.000 description 1
- QBVOSNYANYMORS-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-[5-methyl-1-(2-phenoxyethyl)-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound C=1C=CC=CC=1OCCN1C(C)=CC(C=2C=CC=CC=2)=C1C(=O)C(=O)NC(C=C1)=CC=C1N(CC1)CCN1C1=CC(C)=CC(C)=N1 QBVOSNYANYMORS-UHFFFAOYSA-N 0.000 description 1
- QVLULKRWVCWYFO-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxo-2-(1-phenyl-6,7,8,9-tetrahydro-5h-pyrrolo[1,2-a]azepin-3-yl)acetamide Chemical compound CC1=CC(C)=NC(N2CCN(CC2)C=2C=CC(NC(=O)C(=O)C=3N4CCCCCC4=C(C=3)C=3C=CC=CC=3)=CC=2)=C1 QVLULKRWVCWYFO-UHFFFAOYSA-N 0.000 description 1
- CISFJSBUWMBVIQ-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxo-2-(1-phenylpyrrol-2-yl)acetamide Chemical compound CC1=CC(C)=NC(N2CCN(CC2)C=2C=CC(NC(=O)C(=O)C=3N(C=CC=3)C=3C=CC=CC=3)=CC=2)=C1 CISFJSBUWMBVIQ-UHFFFAOYSA-N 0.000 description 1
- JGCBSIOZVPEITN-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxo-2-(2-phenyl-6,7,8,9-tetrahydro-5h-pyrrolo[1,2-a]azepin-3-yl)acetamide Chemical compound CC1=CC(C)=NC(N2CCN(CC2)C=2C=CC(NC(=O)C(=O)C=3N4CCCCCC4=CC=3C=3C=CC=CC=3)=CC=2)=C1 JGCBSIOZVPEITN-UHFFFAOYSA-N 0.000 description 1
- ULWZJISJVMQJPA-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxo-2-(2-phenyl-6,7-dihydro-5h-pyrrolizin-3-yl)acetamide Chemical compound CC1=CC(C)=NC(N2CCN(CC2)C=2C=CC(NC(=O)C(=O)C=3N4CCCC4=CC=3C=3C=CC=CC=3)=CC=2)=C1 ULWZJISJVMQJPA-UHFFFAOYSA-N 0.000 description 1
- SFGRRCRLAFOFPP-UHFFFAOYSA-N n-[4-[4-(4,6-dimethylpyridin-2-yl)piperazin-1-yl]phenyl]-2-oxo-2-(7-phenyl-3,4-dihydro-1h-pyrrolo[2,1-c][1,4]oxazin-6-yl)acetamide Chemical compound CC1=CC(C)=NC(N2CCN(CC2)C=2C=CC(NC(=O)C(=O)C=3N4CCOCC4=CC=3C=3C=CC=CC=3)=CC=2)=C1 SFGRRCRLAFOFPP-UHFFFAOYSA-N 0.000 description 1
- XMSDNHSJKVNEKQ-UHFFFAOYSA-N n-isoquinolin-5-yl-2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound C=1C=CC2=CN=CC=C2C=1NC(=O)C(=O)C=1N(CCOC)C(C)=CC=1C1=CC=CC=C1 XMSDNHSJKVNEKQ-UHFFFAOYSA-N 0.000 description 1
- PUSYALHOLQDWLA-UHFFFAOYSA-N n-isoquinolin-8-yl-2-[1-(2-methoxyethyl)-5-methyl-3-phenylpyrrol-2-yl]-2-oxoacetamide Chemical compound C=1C=CC2=CC=NC=C2C=1NC(=O)C(=O)C=1N(CCOC)C(C)=CC=1C1=CC=CC=C1 PUSYALHOLQDWLA-UHFFFAOYSA-N 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
- 125000000160 oxazolidinyl group Chemical group 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000006194 pentinyl group Chemical group 0.000 description 1
- 125000004928 piperidonyl group Chemical group 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000004853 tetrahydropyridinyl group Chemical group N1(CCCC=C1)* 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/36—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
- A01N43/42—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/60—1,4-Diazines; Hydrogenated 1,4-diazines
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/74—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
- A01N43/76—1,3-Oxazoles; Hydrogenated 1,3-oxazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/84—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms six-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,4
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un compuesto que es un derivado de pirrol de formula (I), o una sal farmaceuticamente aceptable del mismo, para su uso en la prevencion o tratamiento de una enfermedad fungica:**Fórmula** donde: R1 representa hidrogeno, alquilo C1-C8, alquenilo C2-C8, 10 alquinilo C2-C8, -COR' o -SO2(alquilo C1-C4) sin sustituir o sustituidos, o un grupo -A2, -L2-A2, -L3-A2, -A2-L3-A3 o -A4; A1 representa un enlace o un grupo fenilo, naftilo, grupo heterociclilo de 5 o 6 miembros o heterociclilo de 8 a miembros sin sustituir o sustituido; A2 y A3 son iguales o diferentes y representan cicloalquilo C3-C6 o un grupo arilo C6-C10 o heterociclilo de 5 a 12 miembros sin sustituir o sustituido; A4 es un grupo heterociclilo de 5 a 12 miembros sin sustituir o sustituido en el que 1 o 2 atomos de carbono del anillo estan sustituidos con un grupo seleccionado de >C(>=O), >S(>=O)2, >C(>=NOR7) en el que R7 es hidrogeno o un grupo alquilo C1-C4, >C>=CH2 o >C(-OCH2CH2O-); L1 representa un enlace, un grupo alquileno C1-C6 en el que ninguno, uno o dos grupos -CH2- estan independientemente sustituidos con -O- o -NR'-, o un grupo heterociclilo de 5 a 7 miembros en el que R' es hidrogeno, alquilo C1-C4 sin sustituir o alquilo C1-C4 sustituido con un grupo alcoxi C1-C4 sin sustituir; L2 representa -NR'-, -O-, -CO-, -OCO-, -OCONR'R"-, -CONR'R"- o -SO2-, en la que R' y R" representan independientemente hidrogeno, alquilo C1-C8, alquenilo C2-C8 o alquinilo C2-C8; L3 representa un enlace o un grupo alquileno C1-C4 en el que ninguno, uno o dos grupos -CH2- estan independientemente sustituidos con -O-, -S- o -NR'-, en la que R' representa hidrogeno, alquilo C1-C8, alquenilo C2-C8 o alquinilo C2-C8; n es 1; R6 representa hidrogeno o alquilo C1-C4; R5 representa un grupo sin sustituir o sustituido seleccionado de arilo C6-C10, un grupo heterociclilo de 5 a 12 miembros, alquilo C1-C8 y cicloalquilo C3-C6, hidrogeno, halogeno o un grupo de formula -B1-B2 o -B3; B1 representa un grupo arilo C6-C10 sin sustituir o sustituido; B2 representa un grupo arilo C6-C10 o heterociclilo de 5 a 12 miembros sin sustituir o sustituido; B3 es un grupo heterociclilo de 5 a 12 miembros sin sustituir o sustituido en el que 1 o 2 atomos de carbono del anillo estan sustituidos con un grupo seleccionado de >C(>=O), >S(>=O)2, >C(>=NOR11) en la que R11 es hidrogeno o un grupo alquilo C1-C4, >C>=CH2 o >C(-OCH2CH2O-); R2 representa arilo C6-C10, un grupo heterociclilo de 5 a 12 miembros, cicloalquilo C3-C6, hidrogeno, halogeno, alquilo C1-C8, alquenilo C2-C8, alquinilo C2-C8, cicloalquilo C3-C6, -OR', -SR', -SOR', -SO2R', - SO2NR'R", -SO3H, -NR'R", -NR'COR',-CO2R', -CONR'R", -COR', -OCOR', -CF3, -NSO2R' u -OCONR'R", un grupo alquil (C1-4) -A5, en el que ninguno, uno o dos grupos -CH2- estan reemplazados independientemente por -O-,-S- o -NR'- y en el que A5 representa arilo C6-10 o un grupo heterociclilo de 5 a 12 miembros, en el que R' y R" representan independientemente hidrogeno, alquilo C1-C8, alquenilo C2-C8 o alquinilo C2-C8, o un grupo de formula -Alk1-X-R', en el que Alk1 es un grupo alquileno C1-C6 sin sustituir o sustituido, X es un grupo -O-, -S-, -NR"-, -CO2-, -CONR"-, -OCO-, -OCONR"- o -SO2-, y R' y R" se seleccionan independientemente entre hidrogeno y alquilo C1-C4 sin sustituir o sustituido; R3 representa arilo C6-C10, un grupo heterociclilo de 5 a 12 miembros, cicloalquilo C3-C6, hidrogeno, halogeno, alquilo C1-C8, alquenilo C2-C8, alquinilo C2-C8, cicloalquilo C3-C6, -OR', -SR', -SOR', -SO2R', - SO2NR'R", -SO3H, -NR'R", -NR'COR', -CO2R', -CONR'R", -COR', -OCOR', -CF3, -NSO2R' u -OCONR'R", o un grupo alquil (C1-4)-A5, en el que ninguno, uno o dos grupos -CH2- estan reemplazados independientemente por -O-,-S- o -NR'- y en el que A5 representa arilo C6-10 o un grupo heterociclilo de 5 a 12 miembros, en el que R' y R" representan independientemente hidrogeno, alquilo C1-C8, alquenilo C2-C8 o alquinilo C2-C8; R4 representa hidrogeno, halogeno, fenilo, alquilo C1-C4, alquenilo C2-C4, alquinilo C2-C4, -OR', -CO2R', - CONR'R", -COR', -CN, -NO2, -NR'R" o CF3 en las que R' y R" son independientemente hidrogeno o alquilo C1- C4; Y representa alquileno C1-C8, alquenileno C2-C8 o alquinileno C2-C8;
Description
E09734928
24-04-2015
pentenilo, hexenilo, heptenilo y octenilo e isómeros de los mismos.
Como se usa en el presente documento, un grupo o resto alquinilo C2-C8 puede ser lineal o ramificado, pero es preferentemente lineal. Contiene uno o más triples enlaces carbono-carbono. Es preferentemente un grupo alquinilo
5 C2-C6, más preferentemente un grupo alquinilo C2-C4, lo más preferentemente un grupo alquinilo C2-C3. Tales grupos y restos alquinilo adecuados incluyen etinilo, propinilo, butinilo, pentinilo, hexinilo, heptinilo y octinilo e isómeros de los mismos.
Un grupo o resto alquilo, alquenilo o alquinilo puede estar sustituido o sin sustituir. Normalmente, lleva hasta tres sustituyentes, por ejemplo, uno o dos sustituyentes. Sustituyentes adecuados están preferentemente ellos mismos sin sustituir e incluyen halógeno tal como flúor, hidroxi, amino, (alquilo C1-C4)amino, di(alquilo C1-C4)amino, alcoxi C1-C4 tal como metoxi, etoxi y propoxi, -S(alquilo C1-C4) tal como -SMe,-CO2H, -CO2(alquilo C1-C4), fenilo, heterociclilo de 5 o 6 miembros tal como piridinilo, -CONR'R" y -NR'CO(alquilo C1-C4) en las que R' y R" son iguales
o diferentes y representan hidrógeno o alquilo C1-C4 sin sustituir. Preferentemente, R' y R" son iguales o diferentes y
15 representan hidrógeno o metilo. Más preferentemente, R' representa hidrógeno y R" representa metilo. Ejemplos de estos sustituyentes incluyen sustituyentes sin sustituir tales como halógeno (por ejemplo, flúor), hidroxi, amino, S(alquilo C1-C4) (por ejemplo, -SMe), fenilo, piridinilo, -COO(alquilo C1-C4) (por ejemplo, -COOMe, -COOEt y -COOPr), -CONR'R" (por ejemplo, -CONHMe), -NR'CO(alquilo C1-C4) (por ejemplo, -NHCOMe), (alquilo C1-C4)amino y di(alquilo C1-C4)amino, y alcoxi C1-C4 tal como metoxi, etoxi o propoxi que están ellos mismos sin sustituir o adicionalmente sustituidos con metoxi o etoxi sin sustituir. Se prefieren alcoxi C1-C4, tal como metoxi o etoxi, halógeno, tal como flúor, e hidroxi. Otros grupos preferidos incluyen fenilo sin sustituir o piridinilo, -NMe2, -COOR' en la que R' es alquilo C1-C3, -CONHMe y -NHCOMe.
En una realización preferida, sustituyentes adecuados en un grupo o resto alquilo, alquenilo o alquinilo están
25 preferentemente ellos mismos sin sustituir e incluyen halógeno tal como flúor, hidroxi, amino, (alquilo C1-C4)amino, di(alquilo C1-C4)amino, alcoxi C1-C4 tal como metoxi o etoxi, -CO2H y -CO2(alquilo C1-C4). Ejemplos preferidos de estos sustituyentes incluyen sustituyentes sin sustituir tales como halógeno (por ejemplo, flúor), hidroxi, amino, (alquilo C1-C4)amino y di(alquilo C1-C4)amino, y alcoxi C1-C4 tal como metoxi o etoxi que están ellos mismos sin sustituir o adicionalmente sustituidos con metoxi o etoxi sin sustituir. Los preferidos son alcoxi C1-C4, tal como metoxi
o etoxi, halógeno, tal como flúor, e hidroxi.
Como se usa en el presente documento, un grupo cicloalquilo C3-C6 normalmente es un grupo cicloalquilo C4, C5 o C6, más preferentemente un grupo cicloalquilo C5 o C6. Normalmente, un grupo cicloalquilo está sin sustituir o sustituido con hasta tres sustituyentes, por ejemplo, uno o dos sustituyentes. Sustituyentes adecuados incluyen
35 alquilo C1-C8, alquenilo C2-C8, alquinilo C2-C8, Z e -Y-Z en las que Y y Z son como se han definido anteriormente en este documento. Si están presentes, preferentemente los sustituyentes están ellos mismos sin sustituir. Normalmente, un grupo cicloalquilo está sin sustituir.
Si Y es alquileno C1-C8, es preferentemente alquileno C1-C4, más preferentemente metileno o etileno.
Si Y es alquenileno C2-C8, es preferentemente alquenileno C2-C4, más preferentemente etenileno.
Si Y es alquinileno C2-C8, es preferentemente alquinileno C2-C4, más preferentemente etinileno.
45 Si R' o R" es alquilo C1-C8, es preferentemente alquilo C1-C4, más preferentemente metilo o etilo.
Si R' o R" es alquenilo C2-C8, es preferentemente alquenilo C2-C4, más preferentemente etenilo.
Si R' o R" es alquinilo C2-C8, es preferentemente alquinilo C2-C4, más preferentemente etinilo.
Como se usa en el presente documento, un grupo o resto arilo normalmente es fenilo o naftilo, más preferentemente fenilo.
Como se usa en el presente documento y a menos que se establezca de otro modo, un grupo o resto heterociclilo es
55 un sistema de anillos de 5 a 12 miembros saturado o insaturado en el que el anillo contiene al menos un heteroátomo. Normalmente, el anillo contiene hasta tres o cuatro heteroátomos, por ejemplo, uno o dos heteroátomos, seleccionados de O, S y N. Así, un grupo o resto heterociclilo es normalmente un anillo de 5 a 12 miembros que contiene uno, dos o tres heteroátomos seleccionados de O, S y N. Tales grupos y restos heterociclilo adecuados incluyen, por ejemplo, anillos de 5 a 8 miembros saturados monocíclicos, más preferentemente anillos de 5 a 7 miembros, tales como tetrahidrofuranilo, piperidinilo, oxazolidinilo, morfolinilo, tiomorfolinilo, pirrolidinilo, dioxolanilo, piperidonilo, azepanilo, piperazinilo, tetrahidropiranilo y 1,4-diazepanilo, más preferentemente pirrolidinilo, morfolinilo, piperazinilo, tetrahidropiranilo, piperidinilo, azepanilo y 1,4-diazepanilo, más preferentemente todavía más preferentemente pirrolidinilo, morfolinilo, piperazinilo, tetrahidropiranilo, piperidinilo, azepanilo y 1,4diazepanilo; anillos de 5 a 8 miembros al menos parcialmente insaturados monocíclicos, más preferentemente
65 anillos de 5 a 6 miembros, tales como furanilo, pirrolilo, tiofenilo, oxazolilo, isoxazolilo, tiazolilo, pirazolilo, imidazolilo, triazolilo, tetrazolilo, piridinilo, pirimidinilo, pirazinilo, piridazinilo y di-y tetrahidropiridinilo, por ejemplo, oxazolilo,
8
E09734928
24-04-2015
halógeno. En una realización, A1 está sin sustituir.
Si L1 representa un grupo heterociclilo de 5 a 7 miembros, puede ligarse a A1 y R1 mediante un átomo de carbono o un heteroátomo. Grupos heterociclilo de 5 a 7 miembros preferidos son grupos saturados que contienen al menos un
5 átomo de nitrógeno, por ejemplo, uno o dos átomos de nitrógeno, en los que el grupo heterociclilo está ligado a al menos uno de A1 y R1, preferentemente ambos de A1 y R1, mediante un átomo de nitrógeno. Ejemplos de heterociclos adecuados para L1 incluyen piperazinilo, pirrolidinilo, oxazolilo, morfolinilo, piperidinilo y 1,4-diazepanilo. Ejemplos preferidos de heterociclos adecuados para L1 incluyen piperazinilo y 1,4-diazepanilo, especialmente piperacinilo. Si L1 representa un grupo heterociclilo de 5 a 7 miembros, normalmente está sin sustituir o sustituido con un grupo sin sustituir seleccionado de alquilo C1-C4, alcoxi C1-C4, hidroxi y halógeno. Se prefieren sustituyentes hidroxilo. Preferentemente, si L1 representa un grupo heterociclilo de 5 a 7 miembros, está sin sustituir.
L1 es lo más preferentemente un grupo heterociclilo de 5 a 7 miembros saturado que contiene uno o dos átomos de nitrógeno, o un grupo alquileno C1-C6 sin sustituir en el que ninguno, uno o dos grupos -CH2-están
15 independientemente sustituidos con -O-o -NR'-en la que R' es hidrógeno, alquilo C1-C4 sin sustituir o alquilo C1-C4 sustituido con un grupo alcoxi C1-C4 sin sustituir. En una realización, L1 es un grupo heterociclilo de 5 a 7 miembros saturado, preferentemente un grupo piperazinilo o 1,4-diazepanilo.
Si L1 es un grupo alquileno C1-C6 sin sustituir en el que ninguno, uno o dos grupos -CH2-están independientemente sustituidos con -O-o -NR'-, grupos adecuados incluyen grupos alquileno C4 o C5 en los que dos restos -CH2(preferentemente uno o lo dos restos -CH2-terminales) están sustituidos con -O-o -NR'-en la que R' es hidrógeno o alquilo C1-C2 sin sustituir. Por ejemplo, grupos L1 preferidos en esta categoría incluyen -NMe-CH2-CH2-NMe-, -NHCH2-CH2-O-, -O-CH2-CH2-NMe-, -O-CH2-CH2-O-, -NMe-CH2-CH2-NH-, -NH-CH2-CH2-NH-, -NH-CH2-CH2-NMe-, CH2-CH2-CH2-NMe-y -NMe-CH2-CH2-CH2-NMe-. Lo más preferentemente, L1 es piperazinilo.
25 R1 representa preferentemente hidrógeno, alquilo C1-C8, alquenilo C2-C8, alquinilo C2-C8, -COR' o -SO2(alquilo C1-C4) sin sustituir o sustituidos, o un grupo -A2, -L2-A2, -L3-A2, -A2-L3-A3 o -A4. Más preferentemente, R1 representa hidrógeno, un grupo sin sustituir seleccionado de alquilo C1-C6, alquenilo C2-C6, alquinilo C2-C6, -CO(alquilo C1-C4)y -SO2(alquilo C1-C4), o un grupo -A2, -L2-A2, -L3-A2, -A2-L3-A3 o -A4. Si L1 es un enlace, R1 representa preferentemente hidrógeno o un grupo -A2, L2-A2, A2-L3-A3 o A4. Si L1 es distinto de un enlace, R1 es preferentemente hidrógeno, un grupo alquilo C1-C6, un grupo alquenilo C2-C6, un grupo alquinilo C2-C6, -CO-(alquilo C1-C4) sin sustituir, -SO2(alquilo C1-C4) sin sustituir o un grupo -A2, L2-A2, -L3-A2 o -A2-L3-A3. En una realización, R1 es preferentemente un grupo -A2, -L2-A2, -L3-A2 o -A2-L3-A3, más preferentemente un grupo -A2.
35 En una realización preferida, R1 representa alquilo C1-C8, alquenilo C2-C8, alquinilo C2-C8, -COR' o -SO2(alquilo C1-C4) sin sustituir o sustituidos, o un grupo -A2, -L2-A2, -L3-A2, -A2-L3-A3 o -A4. Más preferentemente, R1 representa un grupo sin sustituir seleccionado de alquilo C1-C6, alquenilo C2-C6, alquinilo C2-C6 y -SO2(alquilo C1-C4), o un grupo -A2, -L2-A2, -L3-A2, -A2-L3-A3 o -A4. Si L1 es un enlace, R1 representa preferentemente A2, L2-A2, A2-L3-A3 o A4. Si L1 es distinto de un enlace, R1 es preferentemente un grupo alquilo C1-C6, un grupo alquenilo C2-C6, un grupo alquinilo C2-C6, -SO2(alquilo C1-C4) sin sustituir o un grupo -A2, L2-A2, -L3-A2 o -A2-L3-A3.
Si R1 representa un grupo alquilo, alquenilo o alquinilo es preferentemente alquilo C1-C6, alquenilo C2-C6 o alquinilo C3-C6, más preferentemente alquilo C1-C6 (por ejemplo, alquilo C3 o C4), alquenilo C3-C6 o alquinilo C3-C6. Los grupos alquilo, alquenilo y alquinilo están sin sustituir o sustituidos con 1, 2 o 3 sustituyentes seleccionados de
45 halógeno (por ejemplo, flúor), hidroxilo, amino, alcoxi C1-C4, CO2H y CO2(alquilo C1-C4). Se prefiere halógeno, por ejemplo, flúor. Los sustituyentes están ellos mismos sin sustituir. Preferentemente, si R1 representa un grupo alquilo, alquenilo o alquinilo, está sin sustituir.
A2 representa preferentemente cicloalquilo C3-C6, fenilo o un grupo heterociclilo de 5 a 12 miembros. Preferentemente, A2 representa fenilo o un grupo heterociclilo de 5 o 6 miembros. Grupos heterociclilo preferidos incluyen anillos de 5 a 6 miembros saturados o insaturados monocíclicos, pudiendo cada uno contener uno, dos o tres, por ejemplo, uno o dos, heteroátomos seleccionados de N, O y S. Anillos 5 o 6 miembros insaturados incluyen oxazolilo, isoxazolilo, imidazolilo, furanilo, tiofenilo, pirimidinilo y piridinilo, preferentemente piridinilo. Los anillos saturados son preferentemente anillos de 6 miembros, por ejemplo, piperidinilo, morfolinilo y tetrahidropiranilo, por
55 ejemplo, morfolinilo o tetrahidropiranilo. En una realización, A2 representa fenilo o piridinilo, especialmente piridinilo.
A2 puede estar sin sustituir o sustituido con uno, dos o tres sustituyentes. Ejemplos de sustituyentes adecuados son sustituyentes sin sustituir seleccionados de halógeno, -CO2R', -CONR'R", OCOR', hidroxilo, ciano, -NR'R", -COR', -NSO2R', -O(alquinilo C2-C4), alquenilo C2-C4, -SO2R', -OCONR'R" y -CR'=NOR", o grupos alquilo C1-C6 o alcoxi C1-C6 que están sin sustituir o sustituidos con uno, dos, tres o cuatro, por ejemplo, uno, dos o tres, por ejemplo, un grupo sin sustituir seleccionado de halógeno, hidroxilo, amino, (alquilo C1-C4)amino, di(alquilo C1-C4)amino, alcoxi C1-C4 y -O-(alquilo C1-C4)-O-(alquilo C1-C4), preferentemente hidroxilo, alcoxi C1-C4 y -O-(alquilo C1-C4)-O-(alquilo C1-C2).
65 Sustituyentes preferidos en A2 son sustituyentes sin sustituir seleccionados de halógeno, -NR'R", -CO2R', -CONR'R", -OCONR'R", -OCOR', -COCF3, hidroxilo y ciano, o alquilo C1-C6 o alcoxi C1-C4 que están sin sustituir o sustituidos
10
E09734928
24-04-2015
En otra realización, R5 es un grupo -B1-B2 o -B3. Si R2 es -B1-B2, B1 es normalmente un grupo fenilo sin sustituir o sustituido. Más preferentemente, B1 es un grupo fenilo sin sustituir. Si R5 es -B1-B2, B2 es normalmente un grupo fenilo sin sustituir o sustituido o heterociclilo de 5 a 6 miembros, más preferentemente un grupo fenilo, piperazinilo o morfolinilo sin sustituir o sustituido, por ejemplo, un grupo fenilo o piperazinilo sin sustituir o sustituido. Si está
5 sustituido, sustituyentes preferidos son 1 o 2 grupos seleccionados de átomos de halógeno y grupos alquilo C1-C4 y alcoxi C1-C4, más preferentemente átomos de halógeno o grupos alquilo C1-C2 o alcoxi C1-C2, más preferentemente grupos alquilo C1-C2 tales como metilo.
Si R5 es B3, normalmente B3 es un grupo heterociclilo de 5 a 6 miembros en el que 1 o 2 átomos de carbono del anillo están sustituidos con >C(=O)-, >S(=O)2-, >C(=NOR11), >C(NR11), >C(=CH2) o >C(-OCH2=CH2O-)-en las que R11 es hidrógeno o alquilo C1-C4. Preferentemente, R11 es hidrógeno o alquilo C1-C2, más preferentemente hidrógeno o metilo. Si R5 es B3, más preferentemente B3 es un grupo heterociclilo de 5 a 6 miembros en el que 1 átomo de carbono del anillo está sustituido con >C(=O)-, >S(=O)2-, >C(=NOR11), >C(NR11), >C(=CH2) o >C(-OCH2CH2O-) en las que R11 es hidrógeno o alquilo C1-C2, más preferentemente 1 átomo de carbono del anillo está
15 sustituido con >C(=O). Un grupo B3 preferido es oxo-dihidropiridinilo. Si R5 es B3, B3 puede estar sin sustituir o sustituido. Preferentemente, está sin sustituir.
Si R2 y R3 representan o contienen arilo C6-C10 o un grupo heterociclilo de 5 a 12 miembros, el arilo o el grupo heterociclilo es típicamente fenilo o un grupo heterociclilo saturado o insaturado de 5 a 6 miembros. Típicamente ninguno o uno de R2 y R3 representa o contiene un arilo o un grupo heterociclilo. Ejemplos de grupos heterociclilos adecuados incluyen, anillos saturados, tales como, pirrolidinilo, morfolinilo, piperazinilo, tetrahidropiranilo y piperidinilo, y anillos insaturados, tales como, oxazolilo, furanilo, tiofenilo, piridinilo y pirimidinilo, por ejemplo furanilo, tifenilo, piridinilo y pirimidinilo. Anillos bicíclicos de 8 a 10 miembros, también pueden presentarse en R2 y R3, por ejemplo anillos indolilo, benzofuranilo y benzotiofenilo.
25 Un arilo o un grupo o resto heterociclilo en R2 o R3 puede estar sin sustituir o sustituido en cualquier átomo del anillo. Típicamente, está sin sustituir o sustituido con uno, dos o tres sustituyentes. Ejemplos de sustituyentes adecuados, son sustituyentes sin sustituir seleccionados de halógeno, -CO2R', -CONR'R", OCOR', hidroxilo, ciano, NR'R", -COR', -NSO2R', -O(alquenilo C2-C4), alquenilo C2-C4, -SO2R', -OCONR'R" y -CR'=NOR" o grupos alquilo C1-C6 o alcoxi C1-C6 que están sin sustituir o sustituidos con uno, dos, tres o cuatro, por ejemplo, uno, dos o tres, por ejemplo, un grupo sin sustituir seleccionado de halógeno, hidroxilo, amino, (alquilo C1-C4)amino, di(alquilo C1C4)amino, alcoxi C1-C4 y -O-(alquilo C1-C4)-O-(alquilo C1-C4), preferentemente hidroxilo, alcoxi C1-C4 y -O-(alquilo C1C4)-O-(alquilo C1-C2).
35 Sustituyentes preferidos son sustituyentes sin sustituir seleccionados de halógeno, -NR'R", -CO2R', -CONR'R", -OCONR'R", -OCOR', -COCF3 e hidroxilo, o alquilo C1-C6 o alcoxi C1-C4 que están sin sustituir o sustituidos con un hidroxilo o grupo alcoxi C1-C4 sin sustituir; en las que R' y R" están seleccionados independientemente de hidrógeno, alquilo C1-C4 sin sustituir y alquilo C1-C4 sustituido con un hidroxilo o grupo alcoxi C1-C4 sin sustituir. Sustituyentes más preferidos son halógeno, alquilo C1-C4 sin sustituir (por ejemplo, metilo) y grupos alcoxi C1-C4 sin sustituir, en particular metilo.
En esta realización, R2 preferentemente representa fenilo, hidrógeno, -COO(alquilo C1-C4), halógeno, cicloalquilo C3-C6 sin sustituir, o un alquilo C1-C4, alquenilo C2-C4 o un grupo alcoxi C1-C4 que está sin sustituir o sustituido con -SMe, -SEt, hidroxilo, di(alquilo C1-C4)amino, -COO(alquilo C1-C4), -CONR'R", -NR'CO(alquilo C1-C4), alcoxi 45 C1-C4 sin sustituir o alcoxi C1-C4 sustituido con -OMe u -OEt, en los que R' y R" son iguales o diferentes y representan hidrógeno o alquilo C1-C4 sin sustituir; o R2 representa un grupo alquil (C1-C4) -A5, en el que ninguno
o uno de los grupos -CH2-están reemplazados independientemente por -O-, -S-o -NR'-y en el que A5 representa fenilo, piridinilo o oxazolilo.
Más preferentemente, R2 representa fenilo sin sustituir, hidrógeno, halógeno, alcoxi C1-C4 sin sustituir, alquenilo C2-C4 sin sustituir, alquilo C1-C4 sin sustituir, o alquilo C1-C4 o alquenilo C2-C4 sustituido con -OMe, -OEt, -OPr, -OBu,-OCH2CH2OMe, -SMe, hidroxi, di(alquilo C1-C4)amino, -COO(alquilo C1-C4), -CONR'R" o -NR'CO(alquilo C1-C4) en los que R' y R" son iguales o diferentes y representan hidrógeno de alquilo C1-C4 sin sustituir; o R2 representa un grupo alquil (C1-C4) -A5, en el que ninguno o uno de los grupos -CH2-, están reemplazados por -O-y
55 en el que A5 representa fenilo, piridinilo o oxazolilo, cada uno de los cuales está sin sustituir o sustituido con uno o dos sustituyentes seleccionados entre halógeno, alquilo C1-C4 y alcoxi C1-C4.
En esta realización, más preferentemente R2 representa fenilo, hidrógeno, halógeno, alquenilo C2-C4 sin sustituir, cicloalquilo C3-C6 sin sustituir, o un grupo alcoxi C1-C4 o alquilo C1-C4 que está sin sustituir o sustituido con -OMe u -OEt. Más preferentemente, R2 representa fenilo sin sustituir, hidrógeno, halógeno, alcoxi C1-C4 sin sustituir, alquilo C1-C4 sin sustituir, o alquilo C1-C4 sustituido con -OMe u -OEt. Más preferentemente, R2 representa alquilo C1-C4 sin sustituir, por ejemplo metilo.
En esta realización, R3 preferiblemente representa hidrógeno, halógeno, fenilo sin sustituir, alquenilo C2-C4 sin
65 sustituir, o un grupo alcoxi C1-C4 o alquilo C1-C4 que está sin sustituir o sustituido con -OMe u -OEt. Más preferentemente, R3 representa hidrógeno, halógeno, fenilo sin sustituir, alcoxi C1-C4 sin sustituir, alquilo C1-C4 sin
12
E09734928
24-04-2015
sustituir, o alquilo C1-C4 sustituido con -OMe u -OEt. En esta realización, todavía más preferentemente R3 representa hidrógeno, halógeno, alquenilo C2-C4 sin sustituir, o un grupo alcoxi C1-C4 o alquilo C1-C4 que está sin sustituir o sustituido con -OMe u -OEt. Más preferentemente, R3 representa hidrógeno, halógeno, alcoxi C1-C4 sin sustituir, alquilo C1-C4 sin sustituir, o alquilo C1-C4 sustituido con -OMe u -OEt. Más preferentemente R3 representa
5 hidrógeno o alquilo C1-C4 sin sustituir, por ejemplo metilo.
Si R4 es fenilo, el grupo fenilo puede estar sin sustituir o sustituido en cualquier átomo del anillo, por ejemplo, con uno, dos o tres sustituyentes. Sustituyentes preferidos son sustituyentes sin sustituir seleccionados de halógeno, NR'R", -CO2R', -CONR'R", -OCONR'R", -OCOR', -COCF3 e hidroxilo, o alquilo C1-C6 o alcoxi C1-C4 que están sin sustituir o sustituidos con un hidroxilo o grupo alcoxi C1-C4 sin sustituir; en las que R' y R" están seleccionados independientemente de hidrógeno, alquilo C1-C4 sin sustituir y alquilo C1-C4 sustituido con un hidroxilo o grupo alcoxi C1-C4 sin sustituir. Sustituyentes más preferidos son halógeno, alquilo C1-C4 sin sustituir (por ejemplo, metilo) y grupos alcoxi C1-C4 sin sustituir, en particular metilo o metoxi. Más preferentemente, el anillo de fenilo está sin sustituir.
15 En una realización, R4 representa hidrógeno, halógeno o alquilo C1-C4, preferentemente hidrógeno. Si R4 puede estar sustituido, normalmente está sin sustituir o sustituido con un átomo de halógeno, más preferentemente está sin sustituir.
En una realización, si R5 es fenilo o tienilo, entonces preferentemente R4 es hidrógeno. En otra realización, si R4 es preferentemente fenilo, R5 es hidrógeno.
Normalmente, Z es halógeno, OR', SR', -NR'R', -CO2R', -CONR'R", -COR', -OCOR' o CN, en las que R' y R" son independientemente hidrógeno o alquilo C1-C4.
25 En una realización preferida de la invención, R1 representa hidrógeno, alquilo C1-C8 sin sustituir, alquenilo C2-C8, alquinilo C2-C8, -COR' o -SO2(alquilo C1-C4), o un grupo -A2, -L2-A2, -L3-A2, -A2-L3-A3 o -A4; A1 representa un enlace, fenilo, naftilo, un grupo heterociclilo monocíclico de 5 o 6 miembros, o un grupo heterociclilo bicíclico 8 a 10 miembros; A2 y A3 son iguales o diferentes y representan fenilo o un grupo heterociclilo de 5 a 12 miembros; A4 representa un grupo heterociclilo de 5 a 6 miembros en el que 1 átomo de carbono del anillo se ha sustituido con un grupo seleccionado de >C(=O), >S(=O)2, >C(=NOR7) en la que R7 es hidrógeno o un grupo alquilo C1-C4, >C=CH2 o >C(-OCH2CH2O-); L1 representa un enlace, un grupo heterociclilo de 5 a 7 miembros que está sin sustituir o sustituido con un grupo sin
35 sustituir seleccionado de alquilo C1-C4, alcoxi C1-C4, hidroxi y halógeno, o un grupo alquileno C1-C6 en el que ninguno, uno o dos grupos -CH2-están independientemente sustituidos con -O-o -NR'-, en la que R' es hidrógeno, alquilo C1-C4 sin sustituir o alquilo C1-C4 sustituido con un grupo alcoxi C1-C4 sin sustituir; L2 es como se ha definido anteriormente; L3 representa un enlace o un grupo alquileno C1-C4 en el que ninguno, uno o dos restos -CH2-están independientemente sustituidos con -O-o -NR'-, en la que R' representa hidrógeno o alquilo C1-C4 sin sustituir; n es como se ha definido anteriormente; R6 representa hidrógeno o alquilo C1-C4 sin sustituir; R5 representa hidrógeno, fenilo, un anillo de heterociclilo de 5 a 8 miembros monocíclico, un grupo cicloalquilo C3-C6 sin sustituir, un alquilo C1-C8 sin sustituir o un alquilo C1-C8 sustituido con un alcoxi C1-C4;
45 R2 representa fenilo, hidrógeno, -COO(alquilo C1-C4), halógeno, cicloalquilo C3-C6 sin sustituir, o un grupo alcoxi C1-C4, alquenilo C2-C4 o alquilo C1-C4 que está sin sustituir o sustituido con -SMe, -SEt, hidroxilo, di(alquilo C1C4)amino, -COO(alquilo C1-C4), -CONR'R", -NR'CO(alquilo C1-C4), alcoxi C1-C4 sin sustituir o alcoxi C1-C4 sustituido con -OMe u -OEt, en los que R' y R" son iguales o diferentes y representan hidrógeno o alquilo C1-C4 sin sustituir; o R2 representa un grupo alquil (C1-C4)-A5, en el que ninguno o uno de los grupos -CH2-son reemplazados independientemente por -O-, -S-o NR'-y en el que A5 representa fenilo, piridinilo o oxazolilo; y R3 representa hidrógeno, halógeno, alquenilo C2-C4 sin sustituir, o un grupo alcoxi C1-C4 o alquilo C1-C4 que está sin sustituir o sustituido con -OMe u -OEt; y R4 representa hidrógeno, halógeno, fenilo, o un grupo sin sustituir seleccionado de alquilo C1-C4, alquenilo C2-C4, alquenilo C2-C4, -OR', -CO2R', CONR'R", -COR', -CN, -NO2, -NR'R" o -CF3, en las que R' y R" son independientemente hidrógeno o alquilo C1-C4;
55 en la que los anillos de arilo y heterociclilo formados por A1, A2, A3, A4, R5, R2 o R2 y R3 están sin sustituir o sustituidos con uno, dos o tres sustituyentes seleccionados de los grupos halógeno sin sustituir, -CO2R', -CONR'R", OCOR', hidroxilo, ciano, -NR'R", -COR', -NSO2R', -O(alquenilo C2-C4), alquenilo C2-C4, -SO2R', -OCONR'R" y -CR'=NOR", y de grupos alquilo C1-C6 y alcoxi C1-C6 que están sin sustituir o sustituidos con uno, dos, tres o cuatro grupos sin sustituir seleccionados de hidroxilo, alcoxi C1-C4 y -O-(alquilo C1-C4)-O-(alquilo C1-C2), y en la que el grupo A1 puede estar sustituido adicionalmente o alternativamente con un grupo de fórmula -(alquilo C1-C2)-O(alquilo C1-C4)-NR'R" en la que R' y R" son iguales o diferentes y representan hidrógeno o alquilo C1-C4, o R' y R", junto con el átomo de nitrógeno al que están unidos, forman un grupo piperazinilo o morfolinilo que está sin sustituir
o sustituido con 1 o 2 grupos alquilo C1-C4.
65 En esta realización preferida, R1 representa más preferentemente alquilo C1-C8 sin sustituir, alquenilo C2-C8, alquinilo C2-C8, -COR' o -SO2(alquilo C1-C4), o un grupo -A2, -L2-A2, -L3-A2, -A2-L3-A3 o -A4. Preferentemente,
13
E09734928
24-04-2015
A1 representa fenilo o un grupo heterociclilo de 5 o 6 miembros. Preferentemente, R5 representa hidrógeno, fenilo, un anillo de heterociclilo de 5 a 8 miembros monocíclico, un grupo cicloalquilo C3-C6 sin sustituir o alquilo C1-C8 sin sustituir. Preferentemente, R4 representa hidrógeno, halógeno, o un grupo sin sustituir seleccionado de alquilo C1-C4, alquenilo C2-C4, alquinilo C2-C4, -OR', -CO2R', CONR'R", -COR', -CN, -NO2, -NR'R" o -CF3, en las que R' y R" 5 son independientemente hidrógeno o alquilo C1-C4. En esta realización preferida, preferentemente los anillos de arilo y heterociclilo formados por A1, A2, A3, A4, R5, R2 o R2 y R3 están sin sustituir o sustituidos con uno, dos o tres sustituyentes seleccionados de los grupos halógeno sin sustituir, -CO2R', -CONR'R", OCOR', hidroxilo, ciano, NR'R", -COR', -NSO2R', -O(alquenilo C2-C4), alquenilo C2-C4, -SO2R', -OCONR'R" y -CR'=NOR", y de grupos alquilo C1-C6 y alcoxi C1-C6 que están sin sustituir o sustituidos con uno, dos, tres o cuatro grupos sin sustituir
10 seleccionados de hidroxilo, alcoxi C1-C4 y -O-(alquilo C1-C4)-O-(alquilo C1-C2).
Compuestos particularmente preferidos para su uso en la invención son derivados de pirrol de fórmula (Ia) y sales farmacéutica o agrícolamente aceptables de los mismos:
15
en la que:
A1 representa un enlace, fenilo, naftilo, piridilo, piperidinilo, benzofuranilo, indolilo, isoquinolinilo o quinolinilo,
20 pudiendo cada uno estar sin sustituir o sustituido con uno o más sustituyentes seleccionados de alquilo C1-C4 sin sustituir, alquilo C1-C4 sustituido con un grupo alcoxi C1-C4 sin sustituir, alcoxi C1-C4 sin sustituir, -CO2H y halógeno, o de un grupo de fórmula -(alquilo C1-C2)-O-(alquilo C1-C4)-NR'R" en la que R' y R" son iguales o diferentes y representan hidrógeno o alquilo C1-C4, o R' y R", junto con el átomo de nitrógeno al que están unidos, forman un grupo piperazinilo o morfolinilo que está sin sustituir o sustituido con 1 o 2 grupos alquilo C1
25 C4; n representa uno; L1 representa un enlace, un grupo heterociclilo de 5 a 7 miembros saturado que contiene uno o dos átomos de nitrógeno, o un grupo alquileno C1-C6 sin sustituir en el que ninguno, uno o dos grupos -CH2-están independientemente sustituidos con -O-o -NR'-en la que R' es hidrógeno, alquilo C1-C4 sin sustituir o alquilo
30 C1-C4 sustituido con un grupo alcoxi C1-C4 sin sustituir, y en el que el grupo heterociclilo está sin sustituir o sustituido con un grupo sin sustituir seleccionado de alquilo C1-C4, alcoxi C1-C4, hidroxi y halógeno; si L1 es un enlace, R1 representa hidrógeno, -A2, -SO2-A2, A2-L3-A3 o A4; y si L1 es distinto de un enlace, R1 representa hidrógeno o un grupo sin sustituir seleccionado de alquilo C1-C6, alquenilo C2-C6, alquinilo C2-C6, -CO(alquilo C1-C4) y -SO2(alquilo C1-C4), o un grupo -A2, -SO2-A2, -L3-A2 o -A2-L3-A3;
35 A2 y A3 representan independientemente fenilo o un grupo heterociclilo de 5 o 6 miembros, en la que A2 y A3 están sin sustituir o sustituidos con uno, dos o tres sustituyentes seleccionados de los sustituyentes sin sustituir halógeno, -COCF3, -OCONR'R" y -NR'R", y de grupos alquilo C1-C4 y alcoxi C1-C4 que están sin sustituir o sustituidos con -OH, -OMe, -OEt u -O(alquilo C1-C4)-O(alquilo C1-C2), en las que R' y R" están seleccionados independientemente de hidrógeno, alquilo C1-C4 sin sustituir y alquilo C1-C4 sustituido con un hidroxilo o
40 grupo alcoxi C1-C4 sin sustituir; L3 representa un enlace o metileno, etileno o propileno sin sustituir; A4 representa dioxotiomorfolinilo, metoxiiminopiperidinilo, metoxiiminopirrolidinilo, metilenpiperidinilo, dioxoazaespirodecilo u oxadihidropirazolilo sin sustituir; R5 representa hidrógeno, fenilo sin sustituir o sustituido, cicloalquilo C3-C6 sin sustituir, piridinilo o piperidinilo
45 sin sustituir o sustituido, o tiofenilo, furanilo o tetrahidropiranilo sin sustituir, estando los sustituyentes seleccionados de halógeno, alquilo C1-C4 sin sustituir, alcoxi C1-C4 sin sustituir o R5 es un grupo alquilo C1-C8 que está sin sustituir o sustituido con un grupo alcoxi C1-C4; y R2 representa fenilo sin sustituir, hidrógeno, halógeno, alcoxi C1-C4 sin sustituir, alquenilo C2-C4 sin sustituir, alquilo C1-C4 sin sustituir, o alquilo C1-C4 o alquenilo C2-C4 sustituido con -OMe, -OEt, -OPr, -OBu,
50 OCH2CH2OMe, -SMe, hidroxi, di(alquilo C1-C4)amino, -COO(alquilo C1-C4), -CONR'R" o -NR'CO(alquilo C1-C4) en los que R' y R" son iguales o diferentes y representan hidrógeno o alquilo C1-C4 sin sustituir; o R2 representa un grupo alquil (C1-C4)-A5, en el que ninguno o uno de los grupos -CH2-están reemplazados independientemente por -O-y en el que A5 representa fenilo, piridinilo o oxazolilo, cada uno de los cuales está sin sustituir o sustituido con uno o dos sustituyentes seleccionados entre halógeno, alquilo C1-C4 y alcoxi C1
55 C4; y R3 representa hidrógeno, halógeno, fenilo sin sustituir, alcoxi C1-C4 sin sustituir, alquilo C1-C4 sin sustituir o alquilo C1-C4 sustituido con -OMe u -OEt.
14
E09734928
24-04-2015
Alternativamente, si L1 es distinto de un enlace, R1 representa un grupo sin sustituir seleccionado de alquilo C1-C6, alquenilo C2-C6, alquinilo C2-C6 y -SO2(alquilo C1-C4), o un grupo -A2, -L2-A2, -L3-A2, -A2-L3-A3 o -A4. Lo más preferentemente, si L1 es distinto de un enlace, R1 representa un grupo alquilo C1-C6, un grupo alquenilo C2-C6, un grupo alquinilo C2-C6, -SO2(alquilo C1-C4) sin sustituir o un grupo -A2, L2-A2, -L3-A2 o -A2-L3-A3.
5 En otro aspecto preferido de esta realización, L1 representa preferentemente un enlace, -CH2-, -NR'-, un grupo heterociclilo de 5 a 7 miembros o un grupo alquileno C2-C6 en el que ninguno, uno o dos grupos -CH2-están independientemente sustituidos con -O-o -NR'-, en la que R' es hidrógeno, alquilo C1-C4 sin sustituir o alquilo C1-C4 sustituido con un grupo alcoxi C1-C4 sin sustituir. Si L1 representa un grupo heterociclilo de 5 a 7 miembros, es preferentemente como se ha definido anteriormente.
En esta realización, L1 es lo más preferentemente -CH2-, -NR'-, un grupo heterociclilo de 5 a 7 miembros saturado que contiene uno o dos átomos de nitrógeno, o un grupo alquileno C2-C6 sin sustituir en el que ninguno, uno o dos grupos -CH2-están independientemente sustituidos con -O-o -NR'-, en la que R' es hidrógeno, alquilo C1-C4 sin
15 sustituir o alquilo C1-C4 sustituido con un grupo alcoxi C1-C4 sin sustituir.
Compuestos preferidos de esta realización son compuestos de fórmula (IA) como se han definido anteriormente, o sales farmacéutica o agrícolamente aceptables de los mismos, en la que si A1 es un enlace, (i) -L1-R1 no es hidrógeno, (ii) si R2 es fenilo sin sustituir o sustituido y R3 a R5 son todos hidrógeno, -L1-R1 no es bencilo sin sustituir o fenetilo sustituido, y (iii) si R6 es hidrógeno y R3 a R5 son todos hidrógeno o cloro, entonces ninguno de L1, L3 y L1-R1 representan un grupo alquilo C1-C4 sin sustituir o sustituido, y (iv) si L1 es un enlace, R1 representa un grupo sin sustituir seleccionado de alquilo C1-C6, alquenilo C2-C6, alquinilo C2-C6, -CO(alquilo C1-C4) y SO2(alquilo C1-C4) o un grupo -A2, -L2-A2, -L3-A2 o -A2-L3-A3.
25 Normalmente en esta realización, L1 representa un enlace, -CH2-, -NR'-, un grupo heterociclilo de 5 a 7 miembros saturado que contiene uno o dos átomos de nitrógeno, o un grupo alquileno C2-C6 sin sustituir en el que ninguno, uno o dos grupos -CH2-están independientemente sustituidos con -O-o -NR'-, en la que R' es hidrógeno, alquilo C1-C4 sin sustituir o alquilo C1-C4 sustituido con un grupo alcoxi C1-C4 sin sustituir, y en la que el grupo heterociclilo está sin sustituir o sustituido con un grupo sin sustituir seleccionado de alquilo C1-C4, alcoxi C1-C4, hidroxi y halógeno. Si L1 representa un grupo alquileno C2-C6 sin sustituir en el que ninguno, uno o dos grupos -CH2-están independientemente sustituidos con -O-o -NR'-, preferentemente es un grupo alquileno C4 o C5 en el que ninguno, uno o dos, más preferentemente uno o dos, grupos -CH2-están independientemente sustituidos con -O-o -NR'-en la que R' es hidrógeno o alquilo C1-C4 sin sustituir.
35 Ejemplos específicos de compuestos de fórmula (I) incluyen:
2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxo-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxi-2-(1-fenil-1H-pirrol-2-il)-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-metil-1-fenil-1H-pirrol-2-il)-2-oxo-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-metil-1H-pirrol-2-il)-2-oxo-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(1-isopropil-5-metil-3-fenil-1H-pirrol-2-il)-2-oxo-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxoacetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-[4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-3-(3-morfolin-4-il-propoximetil)
45 fenil]-2-oxo-acetamida, N-{3-Cloro-4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(1,5-dimetil-3-fenil-1H-pirrol-2-il)-2-oxo-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il)-fenil}-2-(3-furan-2-il-1,5-dimetil-1H-pirrol-2-il)-2-oxo-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(1,5-dimetil-3-tiofen-2-il-1H-pirrol-2-il)-2-oxo-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il)-fenil}-2-(3-isopropil-1,5-dimetil-1H-pirrol-2-il)-2-oxo-aceta-mide, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1,5-dimetil-3-(tetrahidro-piran-4-il)-1H-pirrol-2-il]-2-oxoacetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-naftalen-1-il-2-oxo-acetamida, N-{3-(2-Dimetilamino-etoximetil)-4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(1,5-dimetil-3-fenil-1H-pirrol-2il)-2-oxo-acetamida,
55 2-((1,4-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-3-[3-(4-metil-piperazin-1-il)propoximetil]-fenil}-2-oxo-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-isopropil-1-metil-3-fenil-1H-pirrol-2-il)-2-oxo-acetamida, N-{2-Cloro-4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(1,5-dimetil-3-fenil-1H-pirrol-2-il)-2-oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-3-hidroxi-fenil}-2-oxo-acetamida, N-(2,3-Dihidro-benzofuran-4-il)-2-(1,5-dimetil-3-fenil-1H-pirrol-2-il)-2-oxo-acetamida, N-{3-Cloro-4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxoacetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[3-isopropil-1-(2-metoxi-etil)-5-metil-1H-pirrol-2-il]-2-oxo
65 acetamida, N-{2-Cloro-4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(2-metoxi-etil}-5-metil-3-fenil
17 5
15
25
35
45
55
65
E09734928
24-04-2015
1H-pirrol-2-il]-2-oxo-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(2-etoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxoacetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-2-oxo-N-[4-(4-piridin-2-il-piperazin-1-il)-fenil]-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(4-metil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(6-metil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(5-metil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxo-acetamida, 2-[1-(2-Metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxo-N-[4-(4-piridin-2-ilpiperazin-1-il)-fenil]-acetamida, 2-[1-(2-Metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-N-{4-[4-(4-metil-piridin-2-il)-piperazin-1-il]-fenil}-2oxo-acetamida, 2-[1-(2-Metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-N-{4-[4-(6-metil-piridin-2-il)-piperazin-1-il]-fenil}-2oxo-acetamida, 2-[1-(2-Metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-N-{4-[4-(5-metil-piridin-2-il)-piperazin-1-il]-fenil}-2oxo-acetamida, 2-((1,5-Dimetil-3-tiofen-2-il-1H-pirrol-2-il)-2-oxo-N-[4-(4-piridin-2-il-piperazin-1-il)-fenil]-acetamida, 2-((1,5-Dimetil-3-tiofen-2-il-1H-pirrol-2-il)-N-{4-[4-(4-metil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxoacetamida, 2-((1,5-Dimetil-3-tiofen-2-il-1H-pirrol-2-il)-N-{4-[4-(5-metil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxo-acetamida, 2-((1,5-Dimetil-3-tiofen-2-il-1H-pirrol-2-il)-N-{4-[4-(6-metil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxo-acetamida, N-{3-Cloro-4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(1,5-dimetil-3-tiofen-2-il-1H-pirrol-2-il)-2-oxoacetamida, N-{2-Cloro-4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il)-fenil}-2-(1,5-dimetil-3-tiofen-2-il-1H-pirrol-2-il)-2-oxoacetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-[4-({2-[(4,6-dimetil-piridin-2-il)-metil-amino]-etil}-metil-amino)-fenil]-2-oxoacetamida, N-[4-({2-[(4,6-Dimetil-piridin-2-il)-metil-amino]-etil}-metil-amino)-fenil]-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol2-il]-2-oxo-acetamida, N-[4-({2-[(4,6-Dimetil-piridin-2-il)-metil-amino]-etil}-metil-amino)-fenil]-2-(1,5-dimetil-3-tiofen-2-il-1H-pirrol-2-il)-2oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[2-(4,6-dimetil-piridin-2-iloxi)-etilamino]-fenil}-2-oxo-acetamida, N-{4-[2-(4,6-Dimetil-piridin-2-iloxi)-etilamino]-fenil}-2-[-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxoacetamida, N-{4-[2-(4,6-Dimetil-piridin-2-iloxi)-etilamino]-fenil}-2-(1,5-dimetil-3-tiofen-2-il-1H-pirrol-2-il)-2-oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-(4-{2-[(4,6-dimetil-piridin-2-il)-metil-amino]-etoxi}-fenil)-2-oxo-acetamida, N-(4-{2-[(4,6-Dimetil-piridin-2-il)-metil-amino]-etoxi}-fenil)-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxoacetamida, N-(4-{2-[(4,6-Dimetil-piridin-2-il)-metil-amino]-etoxi}-fenil)-2-(1,5-dimetil-3-tiofen-2-il-1H-pirrol-2-il)-2-oxoacetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[2-(4,6-dimetil-piridin-2-iloxi)-etoxi]-fenil}-2-oxo-acetamida, N-{4-[2-(4,6-Dimetil-piridin-2-iloxi)-etoxi]-fenil}-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxo-acetamida, N-{4-[2-(4,6-Dimetil-piridin-2-iloxi)-etoxi]-fenil}-2-(1,5-dimetil-3-tiofen-2-il-1H-pirrol-2-il)-2-oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-(4-{[2-(4,6-dimetil-piridin-2-ilamino)-etil]-metil-amino}-fenil)-2-oxoacetamida, N-(4-{[2-(4,6-Dimetil-piridin-2-ilamino)-etil]-metil-amino}-fenil)-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2oxo-acetamida, N-(4-{[2-(4,6-Dimetil-piridin-2-ilamino)-etil]-metil-amino}-fenil)-2-(1,5-dimetil-3-tiofen-2-il-1H-pirrol-2-il)-2-oxoacetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[2-(4,6-dimetil-piridin-2-ilamino)-etilamino]-fenil}-2-oxo-acetamida, N-{4-[2-(4,6-Dimetil-piridin-2-ilamino)-etilamino]-fenil}-2-[1-(2-metoxietil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxoacetamida, N-{4-[2-(4,6-Dimetil-piridin-2-ilamino)-etilamino]-fenil}-2-(1,5-dimetil-3-tiofen-2-il-1H-pirrol-2-il)-2-oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-(4-{2-[(4,6-dimetil-piridin-2-il)-metil-amino]-etilamino}-fenil)-2-oxoacetamida, N-(4-{2-[(4,6-Dimetil-piridin-2-il)-metil-amino]-etilamino}-fenil)-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2oxo-acetamida, N-(4-{2-[(4,6-Dimetil-piridin-2-il)-metil-amino]-etilamino}-fenil)-2-(1,5-dimetil-3-tiofen-2-il-1H-pirrol-2-il)-2-oxoacetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-(4-{3-[(4,6-dimetil-piridin-2-il)-metil-amino]-propil}-fenil)-2-oxo-acetamida, N-(4-{3-[(4,6-Dimetil-piridin-2-il)-metil-amino]-propil}-fenil)-2-[1-(2-metoxietil)-3-fenil-1H-pirrol-2-il]-2-oxoacetamida, N-(4-{3-[(4,6-Dimetil-piridin-2-il)-metil-amino]-propil}-fenil)-2-(1,5-dimetil-3-tiofen-2-il-1H-pirrol-2-il)-2-oxoacetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(4,6-dimetil-piridin-2-il)-[1,4]diazepan-1-il]-fenil}-2-oxo-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-[1,4]diazepan-1-il]-fenil}-2-[1-(2-metoxietil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxoacetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-[1,4]diazepan-1-il]-fenil}-2-(1,5-dimetil-3-tiofen-2-il-1H-pirrol-2-il)-2-oxo-acetamida,
18
E09734928
24-04-2015
- Ejemplo de referencia
- Compuesto
- 116
- Ácido 1-butil-5-metil-3-fenil-pirrol-2,4-dicarboxílico
- 117
- Ácido 1-metil-4-fenil-pirrol-2-carboxílico
- 118
- Ácido 1-bencil-5-metil-3-fenil-pirrol-2,4-dicarboxílico
- 119
- Ácido 5-metil-3-fenil-1H-pirrol-2,4-dicarboxílico
- 120
- Ácido 5-etil-1-metil-3-fenil-pirrol-2,4-dicarboxílico
- 121
- Ácido 5-etil-1-(2-metoxietil)-3-fenil-pirrol-2,4-dicarboxílico
- 122
- Ácido 4-(2-clorofenil)-1-(2-metoxietil)pirrol-2-carboxílico
- 123
- Ácido 4-isobutil-1-(2-metoxietil)pirrol-3-carboxílico
- 124
- Ácido 4-(3-clorofenil)-1-(2-metoxietil)pirrol-2-carboxílico
- 125
- Ácido 5-isopropil-1-(2-metoxietil)-3-fenil-pirrol-2,4-dicarboxílico
- 126
- Ácido 3-(2-metoxietil)-5-metil-1-fenil-pirrol-2,4-dicarboxílico
- 127
- Ácido 4-isopropil-1H-pirrol-3-carboxílico
- 128
- Ácido 4-isobutil-1H-pirrol-3-carboxílico
- 129
- Ácido 5-metil-3-fenil-1-(2-piridilmetil)pirrol-2,4-dicarboxílico
- 130
- Ácido 5-metil-3-fenil-1-(4-piridilmetil)pirrol-2,4-dicarboxílico
- 131
- Ácido 4-ciclobutil-1H-pirrol-3-carboxílico
- 132
- Ácido 1-metil-3-fenil-5-propil-pirrol-2,4-dicarboxílico
- 133
- Ácido 5-etil-1-(metoximetil)-3-fenil-pirrol-2,4-dicarboxílico
- 134
- Ácido 5-(2-metoxietil)-1-metil-3-fenil-pirrol-2,4-dicarboxílico
- 135
- Ácido 1-(etoximetil)-5-metil-3-fenil-pirrol-2,4-dicarboxílico
- 136
- Ácido 5-metil-1-(2-metilsulfaniletil)-3-fenil-pirrol-2,4-dicarboxílico
- 137
- Ácido 1-(3-hidroxipropil)-5-metil-3-fenil-pirrol-2,4-dicarboxílico
- 138
- Ácido 5-metil-1-(metilsulfanilmetil)-3-fenil-pirrol-2,4-dicarboxílico
- 139
- Ácido 1-(2-metoxietoximetil)-5-metil-3-fenil-pirrol-2,4-dicarboxílico
- 140
- Ácido 5-metil-3-fenil-1-(propoximetil)pirrol-2,4-dicarboxílico
- 141
- Ácido 1-(2-metoxietil)-5-metil-3-fenil-pirrol-2,4-dicarboxílico
- 142
- Ácido 5-metil-1-(2-fenoxietil)-3-fenil-pirrol-2,4-dicarboxílico
- 143
- Ácido 1-(4-metoxibut-2-enil)-5-metil-3-fenil-pirrol-2,4-dicarboxílico
- 144
- Ácido 5-metil-1-[(2-metiloxazol-4-il)metil]-3-fenil-pirrol-2,4-dicarboxílico
- 145
- Ácido 1-(butoximetil)-5-metil-3-fenil-pirrol-2,4-dicarboxílico
Se agitaron una mezcla de 4-fenil-1H-pirrol-2-carboxilato de etilo (700 mg, 3,25 mmoles), hidróxido sódico acuoso
5 (10 % en peso/volumen, 10 ml) y etanol (10 ml) a temperatura ambiente durante la noche. El etanol se evaporó a vacío, a continuación se añadió agua (20 ml) y los extractos orgánicos se extrajeron con acetato de etilo (3 x 20 ml). La fase acuosa se acidificó con HCl 2 N (to pH 3) y se extrajo con acetato de etilo (3 x 20 ml). La fase orgánica combinada se lavó con agua, salmuera (20 ml), se secó sobre sulfato de sodio anhidro y se concentró a presión reducida proporcionando ácido 4-fenil-1H-pirrol-2-carboxílico (400 mg, 66 %) como un sólido.
10
Los compuestos expuestos a continuación se prepararon de un modo análogo al Ejemplo de referencia 146:
- Ejemplo de referencia
- Compuesto
- 147
- Ácido 1-(2-metoxietil)-4-fenil-pirrol-2-carboxílico
- 148
- Ácido 1-(metoximetil)-4-fenil-pirrol-2-carboxílico
- 149
- Ácido 4-(2-tienil)-1H-pirrol-3-carboxílico
- 150
- Ácido 4-(3-tienil)-1H-pirrol-3-carboxílico
Se añadió metóxido de sodio (190 mg, 3,50 mmoles) a una disolución de 1-(3-cloropropil)-5-metil-3-fenil-pirrol-2,4
20 dicarboxilato de dietilo (1,1 g, 2,91 mmoles) en metanol (10 ml) y se agitó a reflujo durante 28 h. La mezcla de reacción se enfrió a temperatura ambiente y se concentró a sequedad. El residuo se disolvió en agua y la fase acuosa se extrajo con diclorometano. La fase orgánica se lavó con agua, salmuera, se secó sobre sulfato de sodio anhidro y se concentró a vacío proporcionando 1-(3-metoxipropil)-5-metil-3-fenil-pirrol-2,4-dicarboxilato de dimetilo (330 mg, 33 %) como un aceite amarillo. La fase acuosa se acidificó con ácido clorhídrico 2 N a pH 2 y se extrajo
25 con acetato de etilo. La fase orgánica combinada se lavó con agua, salmuera, se secó sobre sulfato de sodio anhidro y se concentró proporcionando ácido 4-metoxicarbonil-1-(3-metoxipropil)-5-metil-3-fenil-pirrol-2-carboxílico (170 mg, 18 %) como un aceite rosa.
41
E09734928
24-04-2015
- Ejemplo de referencia
- Compuesto
- 166
- 1-(2-Etoxietil)-2-metil-4-fenil-pirrol
- 167
- 1-(3-Metoxipropil)-2-metil-4-fenil-pirrol
- 168
- 1-Etil-2-metil-4-fenil-pirrol
- 169
- 2-Metil-4-fenil-1-propil-pirrol
- 170
- 1-Butil-2-metil-4-fenil-pirrol
- 171
- 3-Fenil-1H-pirrol
- 172
- 1-Metil-3-fenil-pirrol
- 173
- 1-(2-Metoxietil)-3-fenil-pirrol
- 174
- 1-Bencil-2-metil-4-fenil-pirrol
- 175
- 2-Metil-4-fenil-1H-pirrol
- 176
- 2-Etil-1-metil-4-fenil-pirrol
- 177
- 2-Etil-1-(2-metoxietil)-4-fenil-pirrol
- 178
- 3-(2-Clorofenil)-1-(2-metoxietil)pirrol
- 179
- 3-(4-Clorofenil)-1-(2-metoxietil)pirrol
- 180
- 1-(Metoximetil)-3-fenil-pirrol
- 181
- 3-(2-Tienil)-1H-pirrol
- 182
- 3-Isobutil-1-(2-metoxietil)pirrol
- 183
- 3-(3-Clorofenil)-1-(2-metoxietil)pirrol
- 184
- 3-(3-Tienil)-1H-pirrol
- 185
- 2-Isopropil-1-(2-metoxietil)-4-fenil-pirrol
- 186
- 4-(2-Metoxietil)-2-metil-1-fenil-pirrol
- 187
- 3-Isopropil-1H-pirrol
- 188
- 3-Isobutil-1H-pirrol
- 189
- 3-Bromo-1,2-dimetil-4-fenil-pirrol
- 190
- 2-[(2-Metil-4-fenil-pirrol-1-il)metil]piridina
- 191
- 3-Bromo-2-metil-4-fenil-1H-pirrol
- 192
- 4-[(2-Metil-4-fenil-pirrol-1-il)metil]piridina
- 193
- 3-Ciclobutil-1H-pirrol
- 194
- 1-Metil-4-fenil-2-propil-pirrol
- 195
- 2-Etil-1-(metoximetil)-4-fenil-pirrol
- 196
- 2-(2-Metoxietil)-1-metil-4-fenil-pirrol
- 197
- 1-(Etoximetil)-2-metil-4-fenil-pirrol
- 198
- 2-Metil-1-(2-metilsulfaniletil)-4-fenil-pirrol
- 199
- 3-(2-Metil-4-fenil-pirrol-1-il)-propan-1-ol
- 200
- 2-Metil-1-(metilsulfanilmetil)-4-fenil-pirrol
- 201
- 1-(2-Metoxietoximetil)-2-Metil)-4-fenil-pirrol
- 202
- 2-Metil-4-fenil-1-(propoximetil)pirrol
- 203
- 1-(2-Metoxietil)-2-metil-4-fenil-pirrol
- 204
- 2-Metil-1-(2-fenoxietil)-4-fenil-pirrol
- 205
- 1-(4-Metoxibut-2-enil)-2-metil-4-fenil-pirrol
- 206
- 2-Metil-4-[(2-metil-4-fenil-pirrol-1-il)metil]oxazol
- 207
- 1-(Butoximetil)-2-metil-4-fenil-pirrol
5 Se burbujeó gas cloruro de hidrógeno seco en una disolución con agitación de 5-(3-fenil-pirrol-1-il)pentanonitrilo (1,45 g, 6,47 mmoles) en éter dietílico seco (50 ml) y eterato de trifluoruro de boro (2 ml) a -5 a 0 ºC. Si la mezcla se saturó con el gas cloruro de hidrógeno, se dejó reposar durante 24 h. Se eliminó a vacío el exceso de éter dietílico y el residuo se hidrolizó añadiendo hidróxido de amonio diluido (20 ml) y cloroformo (30 ml). La mezcla de reacción se sometió a reflujo durante 12 h y se separó la fase de cloroformo. La fase de cloroformo se secó sobre sulfato de
10 sodio anhidro y se concentró a presión reducida proporcionando una mezcla de 2-fenil-5,6,7,8-tetrahidro-pirrolo[1,2a]azepin-9-ona y 1-fenil-5,6,7,8-tetrahidropirrolo[1,2-a]azepin-9-ona (1,50 g, 99 %) como un sólido gomoso.
15 Se añadió 80 % de hidracina hidratada (0,56 ml, 9,0 mmoles) en una porción a una disolución con agitación de 2fenil-5,6,7,8-tetrahidro-pirrolo[1,2-a]azepin-9-ona y 1-fenil-5,6,7,8-tetrahidro-pirrolo[1,2-a]azepin-9-ona (50 mg, 2,22 mmoles) e hidróxido potásico (500 mg, 8,90 mmoles) en dietilenglicol (6 ml) y se calentó a 160-165 ºC durante 16 h. La mezcla de reacción se enfrió, se vertió en agua con hielo (20 ml) y se extrajo con éter dietílico (3 x 20 ml). La fase
20 orgánica combinada se lavó con salmuera (20 ml), se secó sobre sulfato de sodio anhidro, se concentró a presión reducida dando el compuesto en bruto que se purificó por cromatografía en columna sobre alúmina neutra usando
43
E09734928
24-04-2015
- Ejemplo de referencia
- Compuesto
- 287
- Cloruro de 2-(5-metil-1H-pirrol-2-il)-2-oxo-acetilo
- 288
- Cloruro de 2-(2-metil-7-fenil-3,4-dihidro-1H-pirrolo[1,2-a]pirazin-6-il)-2-oxo-acetilo
- 289
- Cloruro de 2-oxo-2-(2-fenil-6,7-dihidro-5H-pirrolizin-3-il)acetilo
- 290
- Cloruro de 2-oxo-2-(7-fenil-3,4-dihidro-1H-pirrolo[2,1-c][1,4]oxazin-6-il)acetilo
- 291
- Cloruro de 2-(1-isopropil-5-metil-3-fenil-pirrol-2-il)-2-oxo-acetilo
- 292
- Cloruro de 2-[1-(2-metoxietil)-5-metil-3-fenil-pirrol-2-il]-2-oxo-acetilo
- 293
- Cloruro de 2-[3-(2-furil)-1,5-dimetil-pirrol-2-il]-2-oxo-acetilo
- 294
- Cloruro de 2-[1,5-dimetil-3-(2-tienil)pirrol-2-il]-2-oxo-acetilo
- 295
- Cloruro de 2-(3-isopropil-1,5-dimetil-pirrol-2-il)-2-oxo-acetilo
- 296
- Cloruro de 2-(1,5-dimetil-3-tetrahidropiran-4-il-pirrol-2-il)-2-oxo-acetilo
- 297
- Cloruro de 2-(1,4-dimetil-3-fenil-pirrol-2-il)-2-oxo-acetilo (obtenido como una mezcla con el regioisómero cloruro de 2-(1,3-dimetil-4-fenil-1H-pirrol-2-il)-2-oxo-acetilo)
- 298
- Cloruro de 2-(5-isopropil-1-metil-3-fenil-pirrol-2-il)-oxo-acetilo
- 299
- Cloruro de 2-[3-isopropil-1-(2-metoxietil)-5-metil-pirrol-2-il]-2-oxo-acetilo
- 300
- Cloruro de 2-[1-(2-etoxietil)-5-metil-3-fenil-pirrol-2-il]-2-oxo-acetilo
- 301
- Cloruro de 2-[1-(3-metoxipropil)-5-metil-3-fenil-pirrol-2-il]-2-oxo-acetilo
- 302
- Cloruro de 2-(5-etil-1-metil-3-fenil-pirrol-2-il)-2-oxo-acetilo
- 303
- Cloruro de 2-[5-etil-1-(2-metoxietil)-3-fenil-pirrol-2-il]-2-oxo-acetilo
- 304
- 2-(2-Cloro-2-oxo-acetil)-5-metil-3-fenil-pirrol-1-carboxilato de etilo
- 305
- 2-(2-Cloro-2-oxo-acetil)-5-metil-3-fenil-pirrol-1-carboxilato de metilo
- 306
- Cloruro de 2-[3-(2-clorofenil)-1-(2-metoxietil)pirrol-2-il]-2-oxo-acetilo
- 307
- Cloruro de 2-[4-(2-clorofenil)-1-(2-metoxietil)pirrol-2-il]-2-oxo-acetilo
- 308
- Cloruro de 2-[3-(4-clorofenil)-1-(2-metoxietil)pirrol-2-il]-2-oxo-acetilo
- 309
- 2-[2-(2-Cloro-2-oxo-acetil)pirrol-1-il]acetato de metilo
- 310
- Cloruro de 2-[1-(metoximetil)-3-fenil-pirrol-2-il]-2-oxo-acetilo y cloruro de 2-[1(metoximetil)-4-fenil-1H-pirrol-2-il)-2-oxo-acetilo
- 311
- 2-[2-(2-Cloro-2-oxo-acetil)-5-metil-3-fenil-pirrol-1-il]acetato
- 312
- Cloruro de 2-[1-(2-acetamidoetil)-5-metil-3-fenil-pirrol-2-il]-2-oxo-acetilo
- 313
- Cloruro de 2-[1-(2-metoxietil)-3-(2-fenil)pirrol-2-il]-2-oxo-acetilo
- 314
- Cloruro de 2-[3-isobutil-1-(2-metoxietil)pirrol-2-il]-2-oxo-acetilo
- 315
- Cloruro de 2-[3-(3-clorofenil)-1-(2-metoxietil)pirrol-2-il]-2-oxo-acetilo y cloruro de 2[4-(3-clorofenil)-1-(2-metoxietil)pirrol-2-il]-2-oxo-acetilo
- 316
- 2-[2-(2-Cloro-2-oxo-acetil)-3-fenil-pirrol-1-il]acetato de etilo
- 317
- 2-[2-(2-Cloro-2-oxo-acetil)-3-fenil-pirrol-1-il]acetato de metilo y 2-[2-(2-cloro-2-oxoacetil)-4-fenil-pirrol-1-il]acetato de metilo
- 318
- 2-[2-(2-Cloro-2-oxo-acetil)-5-metil-3-fenil-pirrol-1-il]acetato de isopropilo
- 319
- Cloruro de 2-[5-isopropil-1-(2-metoxietil)-3-fenil-pirrol-2-il]-2-oxo-acetilo
- 320
- Cloruro de 2-[3-(2-metoxietil)-5-metil-1-fenil-pirrol-2-il]-2-oxo-acetilo
- 321
- Cloruro de 2-[1-(2-metoxietil)-3-fenil-pirrol-2-il]-2-oxo-acetilo
- 322
- Cloruro de 2-[3-isopropil-1-(2-metoxietil)pirrol-2-il]-2-oxo-acetilo
- 323
- Cloruro de 2-[1-(2-dimetilaminoetil)-3-fenil-pirrol-2-il]-2-oxo-acetilo
- 324
- Cloruro de 2-[1-(2-dimetilaminoetil)-4-fenil-pirrol-2-il]-2-oxo-acetilo
- 325
- Cloruro de 2-[1-(2-dimetilaminoetil)-5-metil-3-fenil-pirrol-2-il]-2-oxo-acetilo
- 326
- 2-[2-(2-Cloro-2-oxo-acetil)-3-(2-tienil)pirrol-1-il]acetato de metilo
- 327
- 2-[2-(2-Cloro-2-oxo-acetil)-3-isopropil-pirrol-1-il]acetato de metilo
- 328
- 2-[2-(2-Cloro-2-oxo-acetil)-3-isobutil-pirrol-1-il]acetato de metilo
- 329
- Cloruro de 2-(4-fluoro-1,5-dimetil-3-fenil-pirrol-2-il)-2-oxo-acetilo
- 330
- Cloruro de 2-[5-metil-3-fenil-1-(2-piridilmetil)pirrol-2-il]-2-oxo-acetilo
- 331
- Cloruro de 2-[5-metil-3-fenil-1-(3-piridilmetil)pirrol-2-il]-2-oxo-acetilo
- 332
- Cloruro de 2-[4-fluoro-1-(2-metoxietil)-5-metil-3-fenil-pirrol-2-il]-2-oxo-acetilo
- 333
- Cloruro de 2-[1-(2-isopropoxietil)-5-metil-3-fenil-pirrol-2-il]-2-oxo-acetilo
- 334
- Cloruro de 2-[5-metil-3-fenil-1-(4-piridilmetil)pirrol-2-il]-2-oxo-acetilo
- 335
- Cloruro de 2-[3-ciclobutil-1-(2-metoxietil)pirrol-2-il]-2-oxo-acetilo
- 336
- 2-[2-(2-Cloro-2-oxo-acetil)-3-ciclobutil-pirrol-1-il]acetato de metilo
- 337
- Cloruro de 2-(1-metil-3-fenil-5-propil-pirrol-2-il)-2-oxo-acetilo
- 338
- Cloruro de 2-[5-etil-1-(metoximetil)-3-fenil-pirrol-2-il]-2-oxo-acetilo
- 339
- Cloruro de 2-[1-(etoximetil)-5-metil-3-fenil-pirrol-2-il]-2-oxo-acetilo
- 340
- Cloruro de 2-[5-metil-1-(2-metilsulfaniletil)-3-fenil-pirrol-2-il]-2-oxo-acetilo
- 341
- Cloruro de 2-[1-(3-etoxipropil)-5-metil-3-fenil-pirrol-2-il]-2-oxo-acetilo
- 342
- Cloruro de 2-[1-(2-metoxietoximetil)-5-metil-3-fenil-pirrol-2-il]-2-oxo-acetilo
- 343
- Cloruro de 2-[5-metil-3-fenil-1-(propoximetil)pirrol-2-il]-2-oxo-acetilo
- 344
- Cloruro de 2-[5-metil-1-(2-fenoxietil)-3-fenil-pirrol-2-il]-2-oxo-acetilo
52
Se añadió una disolución de cloruro de (1,5-dimetil-3-fenil-1H-pirrol-2-il)-oxo-acetilo (46 g, 0,176 moles) en
5 diclorometano seco (300 ml) a una disolución de 4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilamina (40 g, 0,140 moles) y trietilamina (14,2 g, 0,140 moles) en diclorometano seco (300 ml) durante 15 min. Después de agitar durante 1 h, la mezcla de reacción se inactivó en agua (200 ml) y se separó la fase orgánica. La fase acuosa se extrajo con diclorometano (2 × 50 ml) y las fases orgánicas combinadas se lavaron sucesivamente con agua (2 × 200 ml), salmuera (2 × 100 ml), se secaron sobre sulfato de sodio anhidro y se concentraron dando un sólido. Éste
10 se disolvió en acetona (580 ml) y se añadió gel de sílice (72,5 g, 100-200 de malla). La mezcla se agitó a temperatura ambiente durante 1 h, se filtró y los sólidos se lavaron con acetona (75 ml). Se repitió el tratamiento con sílice una segunda vez. El filtrado se concentró a ~ 300 ml (~ 4 vol), se añadió carbono activo (8 g) y se calentó a reflujo durante 15 min. La mezcla se enfrió a 45-50 ºC y se filtró sobre Celite, lavando con acetona (75 ml). La disolución se concentró de nuevo a ~300 ml y se añadió éter de petróleo (725 ml, 10 vol), lentamente, a reflujo. La
15 suspensión resultante se enfrió a temperatura ambiente, se agitó durante 15 min, a continuación se enfrió a 0 ºC y se agitó durante 1 h. El sólido se separó por filtración, se lavó con éter de petróleo (150 ml) y se secó a vacío proporcionando 2-(1,5-dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxoacetamida (53,5 g, 74 %) como un sólido amarillo.
20 Los compuestos expuestos a continuación se prepararon de un modo análogo al Ejemplo 1:
- Ejemplo
- Compuesto
- 2
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxo-2-(1-fenil-1H-pirrol-2-il)-acetamida
- 3 4
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-metil-1-fenil-1H-pirrrol-2-il)-2-oxo-acetamida N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-metil-1H-pirrol-2-il)-2-oxo-acetamida
- 5
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(2-metil-7-fenil-1,2,3,4-tetrahidro-pirrolo[1,2a]pirazin-6-il)-2-oxo-acetamida
- 6
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxo-2-(2-fenil-6,7-dihidro-5H-pirrolizin-3-il)acetamida
- 7
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxo-2-(7-fenil-3,4-dihidro-1H-pirrolo[2,1c][1,4]oxazin-6-il)-acetamida
- 8
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(1-isopropil-5-metil-3-fenil-1H-pirrol-2-il)-2-oxoacetamida
- 9
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2oxo-acetamida
- 10
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-[4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-3-(3-morfolin-4-ilpropoximetil)-fenil]-2-oxo-acetamida
- 11
- N-{3-Cloro-4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(1,5-dimetil-3-fenil-1H-pirrol-2-il)-2-oxoacetamida
- 12
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(3-furano-2-il-1,5-dimetil-1H-pirrol-2-il)-2-oxoacetamida
- 13
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(1,5-dimetil-3-tiofen-2-il-1H-pirrol-2-il)-2-oxoacetamida
- 14
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(3-isopropil-1,5-dimetil-1H-pirrol-2-il)-2-oxoacetamida
- 15
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1,5-dimetil-3-(tetrahidro-piran-4-il)-1H-pirrol-2il]-2-oxo-acetamida
- 16
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-naftalen-1-il-2-oxo-acetamida
- 17
- N-{3-(2-Dimetilamino-etoximetil)-4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(1,5-dimetil-3-fenil1H-pirrol-2-il)-2-oxo-acetamida
- 18
- 2-(1,4-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxoacetamida
- 19
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-3-[3-(4-metilpiperazin-1-il)-propoximetil]-fenil}-2-oxo-acetamida
- 20
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-isopropil-1-metil-3-fenil-1H-pirrol-2-il)-2-oxoacetamida
- 21
- N-{2-Cloro-4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(1,5-dimetil-3-fenil-1H-pirrol-2-il)-2-oxoacetamida
- 22
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-3-hidroxi-fenil}-2oxo-acetamida
- 23
- N-(2,3-Dihidro-benzofuran-4-il)-2-(1,5-dimetil-3-fenil-1H-pirrol-2-il)-2-oxo-acetamida
- 24
- N-{3-Cloro-4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1Hpirrol-2-il]-2-oxo-acetamida
- 25
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[3-isopropil-1-(2-metoxi-etil)-5-metil-1H-pirrol-2il]-2-oxo-acetamida
64 65 66
- Ejemplo
- Compuesto
- 26
- N-{2-Cloro-4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1Hpirrol-2-il]-2-oxo-acetamida
- 27
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(2-etoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2oxo-acetamida
- 28
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(3-metoxi-propil)-5-metil-3-fenil-1H-pirrol-2-il]2-oxo-acetamida
- 29
- 2-[1-(2-Metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxo-N-quinolin-5-il-acetamida
- 30
- N-Isoquinolin-5-il-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxo-acetamida
- 31
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-2-oxo-N-quinolin-8-il-acetamida
- 32
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-2-oxo-N-quinolin-5-il-acetamida
- 33
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-2-oxo-N-piridin-4-il-acetamida
- 34
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(1-etil-5-metil-3-fenil-1H-pirrol-2-il)-2-oxoacetamida
- 35
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-metil-3-fenil-1-propil-1H-pirrol-2-il)-2-oxoacetamida
- 36
- 2-(1-Butil-5-metil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxoacetamida
- 37
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-2-oxo-N-quinolin-3-il-acetamida
- 38
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-2-oxo-N-[4-(4-piridin-2-il-piperazin-1-il)-fenil]-acetamida
- 39 40 41a
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(6-metil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxo-acetamida 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(4-metil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxo-acetamida N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxo-2-(2-fenil-6,7,8,9-tetrahidro-5H-pirrolo[1,2a]azepin-3-il)-acetamida
- 41b
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxo-2-(1-fenil-6,7,8,9-tetrahidro-5H-pirrolo[1,2a]azepin-3-il)-acetamida
- 42
- N-Isoquinolin-8-il-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxo-acetamida
- 43
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-isoquinolin-8-il-2-oxo-acetamida
- 44
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-naftalen-2-il-2-oxo-acetamida
- 45 46 47
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(1-metil-3-fenil-1H-pirrol-2-il)-2-oxo-acetamida N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(1-metil-4-fenil-1H-pirrol-2-il)-2-oxo-acetamida N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(2-metoxi-etil)-3-fenil-1H-pirrol-2-il]-2-oxoacetamida
- 48
- 2-(1-Bencil-5-metil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxoacetamida
- 49
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-[5-(4-metil-piperazin-1-il)-naftalen-1-il]-2-oxo-acetamida
- 50 51
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-metil-3-fenil-1H-pirrol-2-il)-2-oxo-acetamida 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-3-metil-fenil}-2-oxoacetamida
- 52
- Éster metílico del ácido (2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilaminooxalil}-5-metil-3-fenilpirrol-1-il)-acético
- 53
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-etil-1-metil-3-fenil-1H-pirrol-2-il)-2-oxoacetamida
- 54
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[5-etil-1-(2-metoxi-etil)-3-fenil-1H-pirrol-2-il]-2oxo-acetamida
- 55
- Éster etílico del ácido 2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilaminooxalil}-5-metil-3-fenilpirrol-1-carboxílico
- 56
- Éster metílico del ácido 2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilaminooxalil}-5-metil-3-fenilpirrol-1-carboxílico
- 57
- 2-[3-(2-Cloro-fenil)-1-(2-metoxi-etil)-1H-pirrol-2-il]-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}2-oxo-acetamida
- 58
- 2-[4-(2-Cloro-fenil)-1-(2-metoxi-etil)-1H-pirrol-2-il]-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}2-oxo-acetamida
- 59
- 2-[3-(4-Cloro-fenil)-1-(2-metoxi-etil)-1H-pirrol-2-il]-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}2-oxo-acetamida
- 60
- 2-[1-(2-Metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxo-N-fenil-1-acetamida
- 61
- Éster metílico del ácido (2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilaminooxalil}-pirrol-1-il)acético
- 62
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(1-metoximetil-5-metil-3-fenil-1H-pirrol-2-il)-2oxo-acetamida
- 63
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(1-metoximetil-3-fenil-1H-pirrol-2-il)-2-oxoacetamida
- 65
- 2-[1-(2-Acetilamino-etil)-5-metil-3-fenil-1H-pirrol-2-il]-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]fenil}-2-oxo-acetamida
- Ejemplo
- Compuesto
- 66
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(2-hidroxi-etil)-3-fenil-1H-pirrol-2-il]-2-oxoacetamida
- 67
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(2-metoxi-etil)-3-tiofen-2-il-1H-pirrol-2-il]-2oxo-acetamida
- 68
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[3-isobutil-1-(2-metoxi-etil)-1H-pirrol-2-il]-2-oxoacetamida
- 69
- Éster etílico del ácido (2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilaminooxalil}-5-metil-3-fenilpirrol-1-il)-acético
- 70
- 2-[3-(3-Cloro-fenil)-1-(2-metoxi-etil)-1H pirrol-2-il]-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}2-oxo-acetamida
- 71
- 2-[4-(3-Cloro-fenil)-1-(2-metoxi-etil)-1H-pirrol-2-il]-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}2-oxo-acetamida
- 73
- Éster etílico del ácido (2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilaminooxalil}-3-fenil-pirrol-1il)-acético
- 74
- Éster metílico del ácido (2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilaminooxalil}-3-fenilpirrol-1il)-acético
- 77
- Éster isopropílico del ácido (2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilaminooxalil}-5-metil-3fenil-pirrol-1-il)-acético
- 78
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperizin-1-il]-fenil}-2-[5-isopropil-1-(2-metoxi-etil)-3-fenil-1H-pirrol-2il]-2-oxo-acetamida
- 79
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-2-oxo-N-quinolin-5-il-acetamida
- 80
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[3-(2-metoxi-etil)-5-metil-1-fenil-1H-pirrol-2-il]-2oxo-acetamida
- 81
- 2-[1-(2-Metoxi-etil)-3-fenil-1H-pirrol-2-il]-2-oxo-N-fenil-acetamida
- 82
- 2-[1-(2-Metoxi-etil)-3-fenil-1H-pirrol-2-il]-2-oxo-N-propil-acetamida
- 83
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[3-isopropil-1-(2-metoxi-etil)-1H-pirrol-2-il]-2oxo-acetamida
- 84
- 2-[1-(2-Dimetilamino-etil)-3-fenil-1H-pirrol-2-il]-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2oxo-acetamida
- 85
- 2-[1-(2-Dimetilamino-etil)-4-fenil-1H-pirrol-2-il]-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2oxo-acetamida
- 86
- 2-[1-(2-Dimetilamino-etil)-5-metil-3-fenil-1H-pirrol-2-il]-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]fenil}-2-oxo-acetamida
- 87
- Éster metílico del ácido (2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilaminooxalil}-3-tiofen-2-ilpirrol-1-il)-acético
- 88
- Éster metílico del ácido (2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilaminooxalil}-[3-isopropilpirrol-1-il)-acético
- 89
- Éster metílico del ácido (2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilaminooxalil}-3-isobutilpirrol-1-il)-acético
- 90
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(4-fluoro-1,5-dimetil-3-fenil-1H-pirrol-2-il)-2-oxoacetamida
- 91
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-metil-3-fenil-1-piridin-2-ilmetil-1H-pirrol-2-il)2-oxo-acetamida
- 92
- N-{2-Cloro-4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1Hpirrol-2-il]-2-oxo-acetamida
- 93
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-metil-3-fenil-1-piridin-3-ilmetil-1H-pirrol-2-il)2-oxo-acetamida
- 94
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[4-fluoro-1-(2-metoxi-etil)-5-metil-3-fenil-1Hpirrol-2-il]-2-oxo-acetamida
- 95
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-[2-fluoro-4-(4-piridin-2-il-piperazin-1-il)-fenil]-2-oxo-acetamida
- 96
- N-[2-Fluoro-4-(4-piridin-2-il-piperazin-1-il)-fenil]-2-[1-(2-metoxietil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxoacetamida
- 97
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(2-isopropoxi-etil)-5-metil-3-fenil-1H-pirrol-2il]-2-oxo-acetamida
- 98
- Éster metílico del ácido (2-{2-cloro-4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilaminooxalil}-5metil-3-fenil-pirrol-1-il)-acético
- 99
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-2-oxo-N-(6-pirrolidin-1-il-piridin-3-il)-acetamida
- 100
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-[2-fluoro-4-oxazol-2-il-fenil)-2-oxo-acetamida
- 101
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-(2-fluoro-4-morfolin-4-il-fenil)-2-oxo-acetamida
- 102
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-metil-3-fenil-1-piridin-4-ilmetil-1H-pirrol-2-il)2-oxo-acetamida
- 103
- 2-[1-(2-Metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-N-{4-[4-(5-morfolin-4-ilmetil-piridin-2-il)-piperazin-1-il]fenil}-2-oxo-acetamida
- Ejemplo
- Compuesto
- 104
- 2-[3-Ciclobutil-1-(2-metoxi-etil)-1H-pirrol-2-il]-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperizin-1-il]-fenil}-2oxo-acetamida
- 105
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-[2-fluoro-4-(4-isobutil-piperazin-1-il)-fenil]-2-oxo-acetamida
- 106
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-(2-fluoro-4-piperidin-1-il-fenil)-2-oxo-acetamida
- 107
- Éster metílico del ácido (3-ciclobutil-2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilaminooxalil}pirrol-1-il)-acético
- 108 109
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{2-fluoro-4-[4-(2-metil-alil)-piperazin-1-il]-fenil}-2-oxo-acetamida N-{2-Fluoro-4-[4-(2-metil-alil)-piperazin-1-il]-fenil}-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2oxo-acetamida
- 110
- N-[2-Fluoro-4-(4-isobutil-piperazin-1-il)-fenil]-2-[1-(2-metoxietil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxoacetamida
- 111
- Éster metílico del ácido (2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-2-fluoro-fenilaminooxalil}-5metil-3-fenil-pirrol-1-il)-acético
- 112
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(2,2-dimetil-propyl)-piperazin-1-il]-2-fluoro-fenil}-2-oxoacetamida
- 113
- N-{4-[4-(2,2-Dimetil-propil)-piperazin-1-il]-2-fluoro-fenil}-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol-2il]-2-oxo-acetamida
- 114
- N-(2-Fluoro-4-piperidin-1-il-fenil)-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxo-acetamida
- 115
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-(3-fluoro-4-piperidin-1-il-fenil)-2-oxo-acetamida
- 116 117
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-[3 -fluoro-4-(4-piridin-2-il-piperazin-1-il)-fenil]-2-oxo-acetamida N-(2-Fluoro-4-morfolin-4-il-fenil)-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxo-acetamida
- 118
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-[3-fluoro-4-(4-isobutil-piperazin-1-il)-fenil]-2-oxo-acetamida
- 119
- N-(3-Fluoro-4-piperidin-1-il-fenil)-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxo-acetamida
- 120
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(5-morfolin-4-ilmetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxoacetamida
- 121
- 2-[1-(2-Metoxi-etil)-4-fenil-1H-pirrol-2-il]-2-oxo-N-propil-acetamida
- 122
- Éster metílico del ácido (2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilaminooxalil}-4-fenil-pirrol-1il)-acético
- 123
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-2-fluoro-fenil}-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1Hpirrol-2-il)-2-oxo-acetamida
- 124
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperizin-1-il]-fenil}-2-(1-metil-3-fenil-5-propil-1H-pirrol-2-il)-2-oxoacetamida
- 125
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-etil-1-metoximetil-3-fenil-1H-pirrol-2-il)-2-oxoacetamida
- 127
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-(5-fluoro-naftalen-1-il)-2-oxo-acetamida
- 132
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(1-etoximetil-5-metil-3-fenil-1H-pirrol-2-il)-2-oxoacetamida
- 133
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[5-metil-1-(2-metilsulfanil-etil)-3-fenil-1H-pirrol2-il]-2-oxo-acetamida
- 134
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[5-metil-1-(2-fenoxi-etil)-3-fenil-1H-pirrol-2-il]-2oxo-acetamida
- 135
- 2-(1-Butoximetil-5-metil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2oxo-acetamida
- 136
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(3-etoxi-propil)-5-metil-3-fenil-1H-pirrol-2-il]2-oxo-acetamida
- 138
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(2-metoxi-etoximetil)-5-metil-3-fenil-1H-pirrol2-il]-2-oxo-acetamida
- 139
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-metil-3-fenil-1-propoximetil-1H-pirrol-2-il)-2oxo-acetamida
- 140
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[5-metil-3-fenil-1-(2-propoxi-etil)-1H-pirrol-2-il]2-oxo-acetamida
- 141
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(4-metoxi-but-2-enil)-5-metil-3-fenil-1H-pirrol2-il]-2-oxo-acetamida
- 142
- N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(4-metoxi-butil)-5-metil-3-fenil-1H-pirrol-2-il]2-oxo-acetamida
- 143
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-2-oxo-N-(4-piperidin-1-il-fenil)-acetamida
- 148
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-[3-fluoro-4-oxazol-2-il-fenil)-2-oxo-acetamida
- 154
- 2-(1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-(4-morfolin-4-il-fenil)-2-oxo-acetamida
Se añadió cloruro de oxalilo (0,19 g, 1,53 mmoles) a una disolución de 1-(2-metoxi-etil)-2-metil-4-fenil-1H-pirrol (0,30 67
Se calentaron éster etílico de ácido (2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilaminooxalil}-3-fenil-pirrol-1
5 il)acético (100 mg, 0,17 mmoles) y amoniaco metanólico (5 ml) a 60 ºC en un tubo cerrado durante 2 h. Al completarse la reacción, los volátiles se eliminaron a vacío dando el compuesto en bruto, que se purificó por HPLC preparativa proporcionando 2-(1-carbamoilmetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]fenil}-2-oxo-acetamida (70 mg, 74 %) como un polvo amarillo.
10 El compuesto expuesto a continuación se preparó de un modo análogo al Ejemplo 75:
Ejemplo
N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(1-metilcarbamoilmetil-3-fenil1H-pirrol-2-il)-2-oxo-acetamida
- Ejemplo
- Datos de RMN Espectro de EM
- 1
- RMN 1H (400 MHz, CDCl3) δ 8,20 (s, 1H), 7,31-7,28 (m, 2H), 7,27-7,21 (m, 4H), 7,09 (d, 2H), 6,84 (d, 2H), 6,38 (s, 1H), 6,31 (s, 1H), 6,13 (s, 1H), 3,81 (s, 3H), 3,65 (t, 4H), 3,22 (t, 4H), 2,37 (s, 3H), 2,32 (s, 3H), 2,23 (s, 3H) 508 (M+H)
- 2
- RMN 1H (400 MHz, CDCl3) δ 9,00 (s, 1H), 8,23 (dd, 1H), 7,53 (d, 2H), 7,47-7,45 (m, 3H), 7,31-7,29 (dd, 2H), 7,16 (t, 1H), 6,95 (d, 2H), 6,44 (s, 1H), 6,40 (s, 1H), 6,30 (s, 1H), 3,65 (t, 4H), 3,24 (t, 4H), 2,38 (s, 3H), 2,24 (s, 3H) 480 (M+H)
- 3
- RMN 1H (400 MHz, CDCl3) δ 9,01 (s, 1H), 8,21 (d, 1H), 7,53-7,50 (m, 5H), 7,23-7,21 (m, 2H), 6,94 (d, 2H), 6,38 (s, 1H), 6,31 (s, 1H), 6,23 (d, 1H), 3,69 (s, 4H), 3,26 (s, 4H), 2,38 (s, 3H), 2,23 (s, 3H), 2,09 (s, 3H) 494 (M+H)
- 4
- RMN 1H (400 MHz, CDCl3): δ 11,4 (s ancho, 1H), 9,35 (s ancho, 1H), 7,60 (d, 2H), 7,33 (s ancho, 1H), 6,98 (d, 2H), 6,39 (s, 1H), 6,32 (s, 1H), 6,13 (m, 1H), 3,68 (t, 4H), 3,28 (t, 4H), 2,38 (s, 6H), 2,24 (s, 3H) 418 (M+H)
- Referencia 5
- RMN 1H (400 MHz, CDCl3) δ 8,11 (s, 1H), 7,33-7,32 (m, 2H), 7,26-7,22 (m, 3H), 7,09 (d, 2H), 6,84 (d, 2H), 6,38 (s, 1H), 6,31 (s, 1H), 6,08 (s, 1H), 4,39 (t, 2H), 3,69 (s, 2H), 3,35 (t, 4H), 3,22 (t, 4H), 2,83 (t, 2H), 2,49 (s, 3H), 2,37 (s, 3H), 2,23 (s, 3H) 549 (M+H)
- Referencia 6
- RMN 1H (400 MHz, CDCl3) δ 8,16 (s, 1H), 7,37 (d, 2H), 7,35-7,25 (m, ~3H, solapamiento del disolvente), 7,18 (d, 2H), 6,85 (d, 2H), 6,38 (s, 1H), 6,31 (s, 1H), 6,10 (s, 1H), 4,37 (qn, 2H), 3,66 (t, 4H), 3,23 (t, 4H), 2,92 (t, 2H), 2,59-2,52 (m, 2H), 2,38 (s, 3H), 2,23 (s, 3H) 520 (M+H)
- Referencia 7
- RMN 1H (400 MHz, CDCl3) δ 8,13 (s, 1H), 7,33-7,24 (m, ~5H solapamiento del disolvente), 7,11 (d, 2H), 6,84 (d, 2H), 6,39 (s, 1H), 6,31 (s, 1H), 6,10 (s, 1H), 4,91 (s, 2H), 4,37 (t, 2H), 4,06 (t, 2H), 3,66 (t, 4H), 3,23 (t, 4H), 2,37 (s, 3H), 2,23 (s, 3H) 536 (M+H)
- 8
- RMN 1H (400 MHz, CDCl3) δ 8,26 (s, 1H), 7,31-7,29 (m, 2H), 7,26-7,21 (m, 3H), 7,09 (d, 2H), 6,85 (d, 2H), 6,41 (s, 1H), 6,33 (s, 1H), 6,10 (s, 1H), 3,68 (t, 4H), 3,24 (t, 4H), 2,47 (s, 3H), 2,40 (m, 1H), 2,39 (s, 3H), 2,25 (s, 3H), 1,60 (d, 6H) 536 (M+H)
- 9
- RMN 1H (400 MHz, CDCl3) δ 8,06 (s, 1H), 7,32 (d, 2H), 7,24-7,21 (m, 3H), 7,06 (d, 2H), 6,82 (d, 2H), 6,38 (s, 1H), 6,31 (s, 1H), 6,13 (s, 1H), 4,38 (t, 2H), 3,73 (t, 2H), 3,65 (t, 4H), 3,32 (s, 3H), 3,22 (t, 4H), 2,38 (s, 3H), 2,37 (s, 3H), 2,23 (s, 3H) 552 (M+H)
- 10
- RMN 1H (400 MHz, CDCl3): δ 8,19 (s, 1H), 7,30 (d, 2H), 7,24-7,20 (m, 3H), 7,14-7,10 (m, 2H), 6,71 (d, 1H), 6,35 (s, 1H), 6,25 (s, 1H), 6,13 (s, 1H), 3,97 (t, 2H), 3,82 (s, 3H), 3,71 (t, 4H), 3,53-3,50 (m, 6H), 2,56 (m, 4H), 2,51 (t, 2H), 2,45 (m, 4H), 2,35 (s, 3H), 2,33 (s, 3H), 2,21 (s, 3H), 1,95 (qn, 2H) 665 (M+H)
- 11
- RMN 1H (400 MHz, CDCl3) δ 8,18 (s, 1H), 7,29-7,22 (m, ~5H, solapamiento del disolvente), 7,20 (d, 1H), 7,04 (dd, 1H), 6,92 (d, 1H), 6,38 (s, 1H), 6,31 (s, 1H), 6,14 (s, 1H), 3,82 (s, 3H), 3,67 (t, 4H), 3,09 (t, 4H), 2,37 (s, 3H), 2,33 (s, 3H), 2,23 (s, 3H) 541 (M-H)
- 12
- RMN 1H (400 MHz, CDCl3) δ 8,40 (s, 1H), 7,45 (d, 2H), 7,20 (s, 1H), 6,93 (d, 2H), 6,48 (d, 1H), 6,39-6,37 (m, 2H), 6,32 (s, 1H), 6,20 (s, 1H), 3,77 (s, 3H), 3,67 (t, 4H), 3,26 (t, 4H), 2,38 (s, 3H), 2,30 (s, 3H), 2,23 (s, 3H) 498 (M+H)
69 70 71 72 73 74 75 76 77
- Ejemplo
- Datos de RMN Espectro de EM
- 13
- RMN 1H (400 MHz, CDCl3) δ 8,25 (s, 1H), 7,29-7,26 (m, ~2H, solapamiento del disolvente), 7,22 (d, 1H), 6,98 (d, 1H), 6,93-6,88 (m, 3H), 6,39 (s, 1H), 6,32 (s, 1H), 6,17 (s, 1H), 3,78 (s, 3H), 3,66 (t, 4H), 3,24 (t, 4H), 2,38 (s, 3H), 2,31 (s, 3H), 2,23 (s, 3H) 514 (M+H)
- 14
- RMN 1H (400 MHz, CD3OD) δ 7,53 (d, 2H), 7,03 (d, 2H), 6,48 (s, 1H), 6,44 (s, 1H), 6,04 (s, 1H), 3,80 (s, 3H), 3,63 (t, 4H), 3,26 (m, 4H), 3,15 (m, 1H), 2,33 (s, 3H), 2,27 (s, 3H), 2,24 (s, 3H), 1,15 (d, 6H) 472 (M-H)
- 15
- RMN 1H (400 MHz, CDCl3) δ 8,43 (s, 1H), 7,57 (d, 2H), 6,99 (d, 2H), 6,40 (s, 1H), 6,33 (s, 1H), 6,00 (s, 1H), 3,98 (dd, 2H), 3,69-3,67 (m, 7H), 3,42 (t, 2H), 3,29 (m, 4H), 3,13 (m, 1H), 2,38 (s, 3H), 2,26 (s, 3H), 2,24 (s, 3H), 1,79-1,69 (m, 4H) 516 (M+H)
- 16
- RMN 1H (400 MHz, CDCl3) δ 8,88 (s ancho, 1H), 7,90 (d, 1H), 7,84 (d, 1H), 7,63 (d, 1H), 7,62-7,49 (m, 2H), 7,40-7,34 (m, 4H), 7,27-7,23 (m, ~3H, solapamiento del disolvente), 6,16 (s, 1H), 3,87 (s, 3H), 2,35 (s, 3H) 369 (M+H)
- 17
- RMN 1H (400 MHz, CDCl3) δ 8,21 (s, 1H), 7,29 (m, 2H), 7,26-7,22 (m, 3H), 7,14-7,09 (m, 2H), 6,71 (d, 1H), 6,34 (s, 1H), 6,25 (s, 1H), 6,13 (s, 1H), 4,03 (t, 2H), 3,81 (s, 3H), 3,53 (m, 6H), 2,72 (t, 2H), 2,56 (t, 4H), 2,36 (s, 3H), 2,33 (s, 6H), 2,32 (s, 3H), 2,21 (s, 3H) 609 (M+H)
- 18
- RMN 1H (400 MHz, CDCl3) δ 7,98 (s, 1H), 7,29-7,23 (m, 5H), 7,01 (d, 2H), 6,83 (d, 2H), 6,79 (s, 1H), 6,39 (s, 1H), 6,31 (s, 1H), 3,89 (s, 3H), 3,66 (t, 4H), 3,22 (t, 4H), 2,38 (s, 3H), 2,23 (s, 3H), 2,01 (s, 3H) 508 (M+H)
- 19
- RMN 1H (400 MHz, CDCl3) δ 8,18 (s, 1H), 7,30 (d, 2H), 7,24-7,20 (m, 3H), 7,13-7,10 (m, 2H), 6,71 (d, 1H), 6,34 (s, 1H), 6,25 (s, 1H), 6,13 (s, 1H), 3,96 (t, 2H), 3,81 (s, 3H), 3,53 (m, 6H), 2,57-2,40 (m ancho, ~14H), 2,36 (s, 3H), 2,33 (s, 3H), 2,29 (s, 3H), 2,21 (s, 3H), 1,95 (qn, 2H) 678 (M+H)
- 20
- RMN 1H (400 MHz, CDCl3) δ 8,21 (s, 1H), 7,32-7,30 (m, 2H), 7,26-7,21 (m, 3H), 7,09 (d, 2H), 6,84 (d, 2H), 6,38 (s, 1H), 6,32 (s, 1H), 6,16 (s, 1H), 3,85 (s, 3H), 3,66 (t, 4H), 3,22 (t, 4H), 3,02 (m, 1H), 2,37 (s, 3H), 2,23 (s, 3H), 1,32 (d,6H) 536 (M+H)
- 21
- RMN 1H (400 MHz, CDCl3) δ 8,64 (s, 1H), 7,49 (d, 1H), 7,30 (d, 2H), 7,217,19 (m, 3H), 6,92 (d, 1H), 6,70 (dd, 1H), 6,39 (s, 1H), 6,31 (s, 1H), 6,13 (s, 1H), 3,83 (s, 3H), 3,65 (t, 4H), 3,22 (t, 4H), 2,37 (s, 3H), 2,33 (s, 3H), 2,23 (s, 3H) 540 (M-H)
- 22
- RMN 1H (400 MHz, CDCl3): δ 8,26 (s, 1H), 7,30-7,22 (m, ~5H, solapamiento del disolvente), 7,05 (d, 1H), 6,84 (s, 1H), 6,72 (d, 1H), 6,38 (s, 1H), 6,32 (s, 1H), 6,14 (s, 1H), 3,81 (s, 3H), 3,65 (m, 4H), 3,60 (s, 1H), 2,94 (m, 4H), 2,37 (s, 3H), 2,33 (s, 3H), 2,21 (s, 3H) 524 (M+H)
- 23
- RMN 1H (400 MHz, CDCl3) δ 8,17 (s,1H), 7,31-7,26 (m, 5H), 6,98 (t, 1H), 6,81 (d, 1H), 6,55 (d, 1H), 6,13 (s, 1H), 4,55 (d, 2H), 3,81 (s, 3H), 3,03 (t, 2H), 2,34 (s, 3H) 361 (M+H)
- 24
- RMN 1H (400 MHz, CDCl3) δ 8,08 (s, 1H), 7,30-7,09 (m, ~5H, solapamiento del disolvente), 7,16 (d, 1H), 7,01 (d, 1H), 6,91 (d, 1H), 6,38 (s, 1H), 6,31 (s, 1H), 6,14 (s, 1H), 4,40 (t, 2H), 3,73 (t, 2H), 3,69 (m, 4H), 3,33 (s, 3H), 3,09 (m, 4H), 2,39 (s, 3H), 2,37 (s, 3H), 2,23 (s, 3H) 586 (M+H)
- 25
- RMN 1H (400 MHz, CDCl3) δ 8,25 (s, 1H), 7,55 (d, 2H), 6,98 (d, 2H), 6,39 (s, 1H), 6,32 (s, 1H), 5,98 (s, 1H), 4,31 (t, 2H), 3,69-3,64 (m, 6H), 3,293,24 (m, 8H), 2,38 (s, 3H), 2,30 (s, 3H), 2,24 (s, 3H), 1,18 (d, 6H) 518 (M+H)
- 26
- RMN 1H (400 MHz, CDCl3) δ 8,54 (s, 1H), 7,46 (d, 1H), 7,31 (d, 2H), 7,257,18 (m, 3H), 6,91 (d, 1H), 6,70 (dd, 1H), 6,39 (s, 1H), 6,31 (s, 1H), 6,13 (s, 1H), 4,41 (t, 2H), 3,75 (t, 2H), 3,65 (m, 4H), 3,33 (s, 3H), 3,22 (m, 4H), 2,39 (s, 3H), 2,37 (s, 3H), 2,23 (s, 3H) 586 (M+H)
- 27
- RMN 1H (400 MHz, CDCl3) δ 8,13 (s, 1H), 7,32 (d, 2H), 7,25-7,21 (m, 3H), 7,06 (d, 2H), 6,82 (d, 2H), 6,38 (s, 1H), 6,31 (s, 1H), 6,13 (s, 1H), 4,39 (t, 2H), 3,77 (t, 2H), 3,65 (t, 4H), 3,47 (q, 2H), 3,22 (t, 4H), 2,39 (s, 3H), 2,37 (s, 3H), 2,23 (s, 3H), 1,14 (t, 3H) 564 (M-H)
- 28
- RMN 1H (400 MHz, CDCl3) δ 8,15 (s, 1H), 7,31 (d, 2H), 7,24-7,21 (m, 3H), 7,07 (d, 2H), 6,83 (d, 2H), 6,38 (s, 1H), 6,31 (s, 1H), 6,12 (s, 1H), 4,32 (t, 2H), 3,65 (t, 4H), 3,41 (t, 2H), 3,35 (s, 3H), 3,22 (t, 4H), 2,37-2,36 (m, 6H), 2,36 (s, 3H), 2,04 (m, 2H) 564 (M-H)
- 29
- RMN 1H (400 MHz, CDCl3) δ 8,92 (m, 1H), 8,74 (s ancho, 1H), 8,12 (d, 1H), 7,91 (d, 1H), 7,57 (t, 1H), 7,42-7,34 (m, 4H), 7,29-7,26 (m, 3H), 6,17 (s, 1H), 4,44 (t, 2H), 3,78 (t, 2H), 3,35 (s, 3H), 2,50 (s, 3H) 412 (M-H)
- Ejemplo
- Datos de RMN Espectro de EM
- 30
- RMN 1H (400 MHz, CDCl3) δ 9,24 (s, 1H), 8,78 (s ancho, 1H), 8,56 (d, 1H), 7,75 (d, 1H), 7,62 (m, 2H), 7,46 (t, 1H), 7,36-7,34 (m, 2H), 7,26-7,23 (m, 3H), 6,17 (s, 1H), 4,44 (t, 2H), 3,79 (t, 2H), 3,35 (s, 3H), 2,24 (s, 3H) 412 (M-H)
- 31
- RMN 1H (400 MHz, CDCl3) δ 8,86 (d, 1H), 8,15-8,09 (dd, 2H), 7,49-7,44 (m, 2H), 7,38 (t, 1H), 7,31-7,26 (m, 3H), 7,05-7,03 (m, 3H), 6,13 (s, 1H), 3,90 (s, 3H), 2,35 (S, 3H) 368 (M-H)
- 32
- RMN 1H (400 MHz, CDCl3) δ 8,93 (d, 1H), 8,81 (s ancho, 1H), 8,14 (d, 1H), 7,92 (d, 1H), 7,58 (t, 1H), 7,43-7,34 (m, 4H), 7,29-7,28 (m, 3H), 6,16 (s, 1H), 3,87 (s, 3H), 2,36 (s, 3H) 370 (M+H)
- 33
- RMN 1H (400 MHz, CDCl3) δ 8,42 (d, 1H), 7,26-7,22 (m, 3H), 7,21-7,19 (m, 4H), 7,12 (d, 2H), 6,15 (s, 1H), 3,83 (s, 3H), 2,34 (s, 3H) 320 (M+H)
- 34
- RMN 1H (400 MHz, CDCl3) δ 8,14 (s, 1H), 7,32-7,21 (m, 5H), 7,07 (d, 2H), 6,83 (d, 2H), 6,38 (s, 1H), 6,31 (s, 1H), 6,12 (s, 1H), 4,26 (q, 2H), 3,65 (t, 4H), 3,22 (t, 4H), 2,37 (s, 3H), 2,36 (s, 3H), 2,33 (s, 3H), 1,41 (t, 3H) 520 (M-H)
- 35
- RMN 1H (400 MHz, CDCl3) δ 10,17 (s, 1H), 7,22 (d, 2H), 7,10-7,03 (m, 5H), 6,79 (d, 2H), 6,47 (s, 1H), 6,37 (s, 1H), 6,08 (s, 1H), 4,18 (t, 2H), 3,55 (m, 4H), 3,11 (m, 4H), 2,33 (s, 3H), 2,25 (s, 3H), 2,17 (s, 3H), 1,70 (q, 2H), 0,91 (t, 3H) 534 (M-H)
- 36
- RMN 1H (400 MHz, CDCl3) δ 8,14 (s, 1H), 7,30 (d, 2H), 7,26-7,20 (m, 3H), 7,07 (d, 2H), 6,83 (d, 2H), 6,38 (s, 1H), 6,31 (s, 1H), 6,12 (s, 1H), 4,19 (t, 2H), 3,65 (t, 4H), 3,22 (t, 4H), 2,37 (s, 3H), 2,35 (s, 3H), 2,23 (s, 3H), 1,17 (m, 2H), 1,43 (m, 2H), 0,98 (t, 3H) 550 (M+H)
- 37
- RMN 1H (400 MHz, CDCl3) δ 8,60 (s, 1H), 8,49 (s, 1H), 8,15 (s, 1H), 8,02 (d, 1H), 7,69 (d, 1H), 7,62 (t, 1H), 7,51 (t, 1H), 7,31 (d, 2H), 7,21-7,16 (m, 3H), 6,17 (s, 1H), 3,86 (s, 3H), 2,36 (s, 3H) 370 (M+H)
- 38
- RMN 1H (400 MHz, CDCl3) δ 8,20 (m, 2H), 7,50 (t, 1H), 7,31 (d, 2H), 7,23 (m, 3H), 7,10 (d, 2H), 6,84 (d, 2H), 6,70-6,64 (m, 2H), 6,13 (s, 1H), 3,82 (s, 3H), 3,68 (t, 4H), 3,23 (t, 4H), 2,33 (s, 3H) 480
- 39
- RMN 1H (400 MHz, CDCl3) δ 8,19 (s, 1H), 7,39 (t, 1H), 7,31 (d, 2H), 7,217,31 (m, 3H), 7,10 (d, 2H), 6,84 (d, 2H), 6,52-6,47 (dd, 2H), 6,13 (s, 1H), 3,82 (s, 3H), 3,67 (t, 4H), 3,23 (t, 4H), 2,41 (s, 3H), 2,33 (s, 3H) 494 (M+H)
- 40
- RMN 1H (400 MHz, CDCl3) δ 8,19 (s, 1H), 8,07 (d, 1H), 7,31 (d, 2H), 7,257,21 (m, 3H), 7,10 (d, 2H), 6,85 (d, 2H), 6,50 (d, 2H), 6,13 (s, 1H), 3,82 (s, 3H), 3,67 (t, 4H), 3,23 (t, 4H), 2,33 (s, 3H), 2,28 (s, 3H) 494 (M+H)
- Referencia 41a
- RMN 1H (400 MHz, CDCl3) δ 8,26 (s, 1H), 7,31-7,29 (d, 2H), 7,24-7,21 (m, 2H), 7,11 (d, 2H), 6,84 (d, 2H), 6,38 (s, 1H), 6,31 (s, 1H), 6,09 (s, 1H), 4,39 (s, 3H), 3,65 (t, 4H), 3,22 (t, 4H), 2,81 (m, 2H), 2,37 (s, 3H), 2,31 (s, 3H), 1,85 (s ancho, 4H), 1,74 (s ancho, 2H) 548 (M+H)
- Referencia 41b
- RMN 1H (400 MHz, CDCl3) δ 9,10 (s, 1H), 8,09 (s, 1H), 7,60 (d, 3H), 7,417,26 (m, H), 6,98 (d, 2H), 6,39 (s, 1H), 6,32 (s, 3H), 4,78 (s ancho, 2H), 3,68 (t, 4H), 3,27 (t, 4H), 2,93 (m, 2H), 2,38 (s, 3H), 2,23 (s, 3H), 1,891,83 (m, 4H), 1,73 (m, 2H) 548 (M+H)
- 42
- RMN 1H (400 MHz, CDCl3) δ 9,38 (s ancho, 1H), 8,98 (s ancho, 1H), 8,57 (s ancho, 1H), 7,64-7,51 (m, 4H), 7,35 (d, 2H), 7,24-7,19 (m, 3H), 6,17 (s, 1H), 4,45 (t, 2H), 3,78 (t, 2H), 3,35 (s, 3H), 3,41 (s, 3H) 414 (M+H)
- 43
- RMN 1H (400 MHz, CDCl3) δ 9,41 (s, 1H), 9,06 (s, 1H), 8,57 (d, 1H), 7,647,53 (m, 4H), 7,34-7,33 (m, 2H), 7,31-7,18 (m, 3H), 6,17 (s, 1H), 3,88 (s, 3H), 2,36 (s, 3H) 368 (M-H)
- 44
- RMN 1H (400 MHz, CDCl3) δ 8,45 (s, 1H), 7,56-7,68 (m, 4H), 7,44-7,34 (m, 2H), 7,32 (d, 2H), 7,24-7,15 (m, 4H), 6,15 (s, 114), 3,84 (s, 3H), 2,34 (s, 3H) 367 (M-H)
- 45
- RMN 1H (400 MHz, CDCl3) δ 9,11 (s, 1H), 8,18 (s, 1H), 7,32 (d, 2H), 7,267,23 (mezclado con disolvente, ∼3H), 7,12 (d, 2H), 6,94 (d, 1H), 6,84 (d, 2H), 6,38 (s, 1H), 6,31 (s, 1H), 3,91 (s, 3H), 3,66 (t, 4H), 3,23 (t, 4H), 2,37 (s, 3H), 2,23 (s, 3H) 494
- 46
- RMN 1H (400 MHz, CDCl3) δ 9,10 (s, 1H), 8,38 (d, 1H), 7,62 (d, 2H), 7,55 (d, 2H), 7,36 (t, 2H), 7,31 (s, 1H), 7,25-7,22 (mezclado con disolvente, ∼ 1H), 7,00 (d, 2H), 6,40 (s, 1H), 6,32 (s, 1H), 4,05 (s, 3H), 3,69 (t, 4H), 3,29 (t, 4H), 2,38 (s, 3H), 2,24 (s, 3H) 494 (M+H)
- 47
- RMN 1H (400 MHz, CDCl3) δ 8,14 (s, 1H), 7,32 (d, 2H), 7,28-7,22 (m, 3H), 7,11-7,09 (m, 3H), 6,84 (d, 2H), 6,38 (s, 1H), 6,33-6,31 (m, 2H), 4,43 (t, 2H), 3,72 (t, 2H), 3,65 (t, 4H), 3,34 (s, 3H), 3,22 (t, 4H), 2,37 (s, 3H), 2,23 (s, 3H) 538 (M+H)
- Ejemplo
- Datos de RMN Espectro de EM
- 48
- RMN 1H (400 MHz, CDCl3) δ 8,15 (s, 1H), 7,36-7,29 (m, 6H), 7,27-7,23 (m, 3H), 7,06 (d, 4H), 6,82 (d, 2H), 6,38 (s, 1H), 6,30 (s, 1H), 6,20 (s, 1H), 5,51 (s, 1H), 3,64 (t, 4H), 3,21 (t, 4H), 2,37 (s, 3H), 2,26 (s, 3H), 2,23 (s, 3H) 583 (M-H)
- 49
- RMN 1H (400 MHz, CDCl3) δ 8,85 (s, 1H), 8,01 (d, 1H), 7,61 (d, 1H), 7,46 (t, 1H), 7,35-7,32 (m, 4H), 7,25-7,23 (m, 3H), 7,12 (d, 1H), 6,15 (s, 1H), 3,86 (s, 3H), 3,13 (s ancho, 4H), 2,70 (s ancho, 4H), 2,41 (s, 3H), 2,35 (s, 3H) 468 (M+H)
- 50
- RMN 1H (400 MHz, CDCl3) δ 11,93 (s ancho, 1H), 9,42 (s, 1H), 7,61 (d, 2H), 7,55 (d, 2H), 7,42-7,32 (m, 3H), 6,98 (d, 2H), 6,39 (s, 1H), 6,32 (s, 1H), 6,21 (d, 1H), 3,68 (t, 4H), 3,29 (t, 4H), 2,41 (s, 3H), 2,38 (s, 3H), 2,24 (s, 3H) 494 (M+H)
- 51
- RMN 1H (400 MHz, CDCl3) δ 8,17 (s, 1H), 7,32-7,23 (m, 4H), 6,97 (d, 2H), 6,89 (d, 2H), 6,38 (s, 1H), 6,31 (s, 1H), 6,13 (s, 1H), 3,82 (s, 3H), 3,63 (t, 4H), 2,95 (t, 4H), 2,37 (s, 3H), 2,33 (s, 3H), 2,26 (s, 3H), 2,23 (s, 3H) 522 (M+H)
- 52
- RMN 1H (400 MHz, CDCl3) δ 8,05 (s, 1H), 7,34-7,32 (m, 2H), 7,25-7,24 (m, 3H), 7,06 (d, 2H), 6,82 (d, 2H), 6,38 (s, 1H), 6,31 (s, 1H), 6,20 (s, 1H), 4,93 (s, 2H, 3,84 (s, 3H), 3,65 (t, 4H), 3,21 (t, 4H), 2,37 (s, 3H), 2,31 (s, 3H), 2,23 (s, 3H) 566 (M+H)
- 53
- RMN 1H (400 MHz, CDCl3) δ 8,23 (s, 1H), 7,31 (d, 2H), 7,27-7,24 (m, 3H), 7,10 (d, 2H), 6,84 (d, 2H), 6,39 (s, 1H), 6,31 (s, 1H), 6,16 (s, 1H), 3,82 (s, 3H), 3,65 (t, 4H), 3,23 (t, 4H), 2,67 (q, 2H), 237 (s, 3H), 2,23 (s, 3H), 1,32 (t, 3H) 522 (M+H)
- 54
- RMN 1H (400 MHz, CDCl3) δ 8,13 (s, 1H), 7,36-7,33 (m, 3H), 7,27-7,25 (m, 2H), 7,08 (d, 2H), 6,84 (d, 2H), 6,40 (s, 1H), 6,32 (s, 1H), 6,19 (s, 1H), 4,42 (t, 2H), 3,74 (t, 2H), 3,67 (t, 4H), 3,34 (s, 3H), 3,23 (t, 4H), 2,27 (m, 2H), 2,39 (s, 3H), 2,25 (s, 3H), 1,34 (t, 3H) 566 (M+H)
- 55
- RMN 1H (400 MHz, CDCl3) δ 9,21 (s, 1H), 7,40 (m, 5H), 6,85 (d, 2H), 6,59 (d, 2H), 6,39 (s, 1H), 6,30 (s, 1H), 6,05 (d, 1H), 4,16 (q, 2H), 3,63 (m, 4H), 3,30 (m, 4H), 2,37 (s, 6H), 2,23 (s, 3H), 1,15 (t, 3H) 566 (M+H)
- 56
- RMN 1H (400 MHz, CDCl3) δ 9,21 (s, 1H), 7,39 (s, 5H), 6,85 (d, 2H), 6,61 (d, 2H), 6,39 (s, 1H), 6,33 (s, 1H), 6,05 (s, 1H), 3,71 (s, 3H), 3,65 (t, 4H), 3,30 (t, 4H), 2,38 (s, 6H), 2,23 (s, 3H) 552 (M+H)
- 57
- RMN 1H (400 MHz, CDCl3) δ 8,01 (s, 1H), 7,33-7,28 (m, 2H), 7,19-7,09 (m, 5H), 6,84 (d, 2H), 6,39 (s, 1H), 6,32 (s, 1H), 6,28 (d, 1H), 4,48 (t, 2H), 3,75 (t, 2H), 3,66 (t, 4H), 3,35 (s, 3H), 3,23 (t, 4H), 2,38 (s, 3H), 2,23 (s, 3H) 572 (M+H)
- 58
- RMN 1H (400 MHz, CDCl3) δ 9,10 (s, 1H), 8,46 (d, 1H), 7,62 (d, 2H), 7,557,52 (m, 1H), 7,44 (dd, 1H), 7,30-7,27 (m, 1H), 7,21 (t, 1H), 7,09 (d, 2H), 6,41 (s, 1H), 6,34 (s, 1H), 4,64 (t, 2H), 3,74 (t, 2H), 3,70 (t, 4H), 3,34 (s, 3H), 3,30 (t, 4H), 2,39 (s, 3H), 2,25 (s, 3H) 572 (M+H)
- 59
- RMN 1H (400 MHz, CDCl3) δ 8,20 (s, 1H), 7,26-7,23 (m, 4H), 7,15-7,12 (d, 2H), 7,08 (d, 1H), 6,88 (d, 2H), 6,39 (s, 1H), 6,31 (s, 1H), 6,29 (d, 1H), 4,42 (t, 2H), 3,71-7,65 (m, 6H), 3,33 (s, 3H), 3,26 (m, 4H), 2,37 (s, 3H), 2,24 (s, 3H) 572 (M+H)
- 60
- RMN 1H (400 MHz, CDCl3) δ 8,22 (s, 1H), 7,32-7,30 (dd, 2H), 7,24-7,16 (m, 7H), 7,07-7,04 (m, 1H), 6,14 (s, 1H), 4,41-4,39 (t, 2H), 3,75-3,72 (t, 2H), 3,27 (s, 3H), 2,39 (s, 3H) 363 (M+H)
- 61
- RMN 1H (400 MHz, CDCl3) δ 9,01(s, 1H), 8,21 (dd, 1H), 7,57 (d, 2H), 7,03 (s, 1H), 6,97 (d, 2H), 6,39 (s, 1H), 6,35-6,32 (m, 2H), 5,04 (s, 2H), 3,80 (s, 3H), 3,68 (t, 4H), 3,27 (t, 4H), 2,38 (s, 3H), 2,23 (s, 3H) 476 (M+H)
- 62
- RMN 1H (400 MHz, CDCl3) δ 8,18 (s, 1H), 7,32-7,30 (m, 3H), 7,28-7,26 (m, 2H), 7,09 (d, 2H), 6,84 (d, 2H), 6,38 (s, 1H), 6,31 (S, 1H), 6,20 (s, 1H), 5,60 (s, 2H), 3,65 (t, 4H), 3,40 (s, 3H), 3,22 (t, 4H), 2,42 (s, 3H), 2,37 (s, 3H), 2,23 (s, 3H) 538 (M+H)
- 63
- RMN 1H (400 MHz, CDCl3) δ 8,27 (s, 1H), 7,36-7,34 (m, 2H), 7,30-7,26 (m, 3H), 7,17-7,14 (m, 3H), 6,86 (d, 2H), 6,41-6,39 (m, 2H), 6,32 (s, 1H), 5,57 (s, 2H), 3,66 (t, 4H), 3,34 (s, 3H), 3,23 (t, 4H), 2,38 (s, 3H), 2,24 (s, 3H) 522 (M-H)
- 64
- RMN 1H (400 MHz, CDCl3) δ 8,14 (s, 1H), 7,30 (m, 2H), 7,26-7,24 (m, 3H), 7,02 (d, 2H), 6,83 (d, 2H), 6,74 (s, 1H), 6,39 (s, 1H), 6,30 (d, 1H), 6,17 (d, 1H), 4,37 (t, 2H), 4,00 (d, 2H), 3,64 (m, 4H), 3,22 (m, 4H), 2,39 (s, 3H), 2,37 (s, 3H), 2,23 (s, 3H) 538 (M+H)
- Ejemplo
- Datos de RMN Espectro de EM
- 65
- RMN 1H (400 MHz, CDCl3) δ 8,21 (s, 1H), 7,30-7,28 (m, 2H), 7,26-7,22 (m, 3H), 7,05 (d, 2H), 6,82 (d, 2H), 6,39 (s, 1H), 6,31 (s, 1H), 6,24 (s ancho, 1H), 6,16 (s, 1H), 4,37 (t, 2H), 3,66-3,58 (m, 6H), 3,23 (m 4H), 2,37 (s, 6H), 2,23 (s, 3H), 1,94 (s, 3H) 579 (M+H)
- 66
- RMN 1H (400 MHz, CDCl3) δ 8,16 (s, 1H), 7,50 (d, 1H), 7,33-7,31 (m, 3H), 7,27-7,25 (m, 2H), 7,10-7,07 (m, 2H), 6,84 (d, 2H), 6,75 (s, 1H), 6,39-6,36 (m, 2H), 6,30 (m, 1H), 4,41 (t, 2H), 3,97 (t, 2H), 3,64 (m, 4H), 3,34-3,17 (m, 4H), 2,37 (s, 3H), 2,23 (s, 3H) 524 (M+H)
- 67
- RMN 1H (400 MHz, CDCl3) δ 8,20 (s, 1H), 7,26-7,21 (m, 3H), 7,06 (d, 1H), 6,99 (d, 1H), 6,93-6,87 (m, 3H), 6,38(s, 1H), 6,35 (d, 1H), 6,31 (s, 1H), 4,40 (t, 2H), 3,70-3,65 (m, 6H), 3,32 (s, 3H), 3,24 (t, 4H), 2,37 (s, 3H), 2,23 (s, 3H) 544 (M+H)
- 68
- RMN 1H (400 MHz, CDCl3) δ 8,29 (s, 1H), 7,56 (d, 2H), 6,98 (t, 3H), 6,39 (s, 1H), 6,32 (s, 1H), 6,05 (d, 1H), 4,37 (t, 2H), 3,68 (m, 4H), 3,62 (t, 2H), 3,29 (s, 3H), 3,27 (m, 4H), 2,63 (d, 2H), 2,38 (s, 3H), 2,24 (s, 3H), 1,80 (m, 1H), 0,84 (d, 6H) 518 (M+H)
- 69
- RMN 1H (400 MHz, CDCl3) δ 8,03 (s ancho, 1H), 7,34-7,31 (m, 2H), 7,257,23 (m, 3H), 7,06 (d, 2H), 6,83 (d, 2H), 6,38 (s, 1H), 6,31 (s, 1H), 6,19 (s, 1H), 4,92 (s, 2H), 4,30 (q, 2H), 3,65 (t, 4H), 3,21 (t, 4H), 2,37 (s, 3H), 2,31 (s, 3H), 2,23 (s, 3H), 1,33 (t, 3H) 580 (M+H)
- 70
- RMN 1H (400 MHz, CDCl3) δ 8,22 (s ancho, 1H), 7,33 (s, 1H), 7,20-7,16 (m, 5H, 7,07 (d, 1H), 6,87 (d, 2H), 6,38 (s, 1H), 6,31 (d, 2H), 4,42 (t, 2H), 3,72-3,65 (m, 6H), 3,33 (s, 3H), 3,24 (t, 4H), 2,37 (s, 3H), 2,23 (s, 3H) 572 (M+H)
- 71
- RMN 1H (400 MHz, CDCl3) δ 9,07 (s, 1H), 8,44 (d, 1H), 7,61 (d, 2H), 7,55 (s, 1H), 7,44 (d, 2H), 7,29 (d, 1H), 7,19 (d, 1H), 6,99 (d, 2H), 6,39 (s, 1H), 6,32 (s, 1H), 4,59 (t, 2H), 3,72-3,67 (m, 6H), 3,33 (s, 3H), 3,29 (t, 4H), 2,38 (s, 3H), 2,24 (s, 3H) 572 (M+H)
- 72
- RMN 1H (400 MHz, CDCl3) δ 8,19 (s, 1H), 7,26 (q, 3H), 7,17 (d, 1H), 7,12 (d, 1H), 7,08 (d, 1H), 6,90 (s, 1H), 6,88 (s, 1H), 6,39 (s, 1H), 6,31 (t, 2H), 4,42 (t, 2H), 3,69 (m, 6H), 3,33 (s, 3H), 3,24 (t, 4H), 2,38 (s, 3H), 2,24 (s, 3H) 544 (M+H)
- 73
- RMN 1H (400 MHz, CDCl3) δ 8,05 (s, 1H), 7,35 (d, 2H), 7,29 (m, 3H), 7,07 (d, 2H), 6,99 (d,1H), 6,83 (d, 2H), 6,39 (d, 2H), 6,31 (s, 1H), 4,94 (s, 2H), 4,28 (q, 2H), 3,65 (t, 4H), 3,22 (t, 4H), 2,37 (s, 3H), 2,23 (s, 3H), 1,32 (t, 3H) 566 (M+H)
- 74
- RMN 1H (400 MHz, CDCl3) δ 8,02 (s, 1H), 7,34 (m, 3H), 7,25 (m, 2H), 7,07 (d, 2H), 6,99 (s, 1H), 6,83 (d, 2H), 6,38 (d, 2H), 6,30 (s, 1H), 4,95 (s, 2H), 3,83 (s, 3H), 3,65 (m, 4H), 3,22 (m, 4H), 2,37 (s, 3H), 2,32 (s, 3H) 552 (M+H)
- 75
- RMN 1H (400 MHz, CDCl3) δ 8,24 (s, 1H), 7,33-7,25 (m, 5H), 7,07 (m, 3H), 6,83 (d, 2H), 6,43 (d, 1H), 6,39 (s, 1H), 6,31 (s, 1H), 6,03 (s, 1H), 5,63 (s, 1H), 4,88 (s, 2H), 3,65 (t, 4H), 3,22 (t, 4H), 2,38 (s, 3H), 2,23 (s, 3H) 537 (M+H)
- 76
- RMN 1H (400 MHz, CDCl3) δ 8,16 (s, 1H), 7,34-7,27 (m, 4H), 7,08 (m, 3H), 6,84 (d, 2H), 6,43 (d, 1H), 6,39 (s, 1H), 6,31 (s, 1H), 6,01 (s, 1H), 5,63 (s, 1H), 4,86 (s, 2H), 3,65 (t, 4H), 3,23 (t, 4H), 2,83 (d, 3H), 2,38 (s, 3H), 2,23 (s, 3H) 549 (M-H)
- 77
- RMN 1H (400 MHz, CDCl3) δ 8,06 (s, 1H), 7,23-7,32 (q, 2H), 7,23 (d, 2H), 7,05 (d, 2H), 6,83 (d, 2H), 6,39 (s, 1H), 6,31 (s, 1H), 6,19 (s, 1H), 5,15 (q, 1H), 4,89 (s, 2H), 3,65 (t, 4H), 3,21 (t, 4H), 2,37 (s, 3H), 2,31 (s, 3H), 2,23 (s, 3H), 1,30 (m, 7H) 594 (M+H)
- 78
- RMN 1H (400 MHz, CDCl3) δ 8,12 (s ancho, 1H), 7,32 (d, 2H), 7,23 (m, 3H), 7,06 (d, 2H), 6,83 (d, 2H), 6,38 (s, 1H), 6,30 (s, 1H), 6,18 (s, 1H), 4,43 (m, 2H), 3,71 (m, 2H), 3,65 (m, 4H), 3,32 (s, 3H), 3,21 (m, 5H), 2,37 (s, 3H), 2,23 (s, 3H), 1,30 (d, 6H) 578 (M-H)
- 79
- RMN 1H (400 MHz, CDCl3) δ 8,86 (s, 1H), 7,76 (d, 1H), 7,70 (s ancho, 1H), 7,64 (d, 1H), 7,48 (t, 1H), 7,60-7,40 (m, mezclado con disolvente, 3H), 7,34-7,33 (m, 2H), 7,26-7,23 (m, 2H), 6,17 (s, 1H), 3,87 (s, 3H), 2,36 (s, 3H) 368 (M-H)
- 80
- RMN 1H (400 MHz, CDCl3) δ 8,27 (s, 1H), 7,40-7,35 (m, 3H), 7,31 (d, 2H), 7,22 (d, 2H), 6,89 (d, 2H), 6,39 (s, 1H), 6,31 (s, 1H), 6,14 (s, 1H), 3,673,63 (m, 6H), 3,35 (s, 3H), 3,24 (t, 4H), 3,11 (t, 2H), 2,37 (s, 3H), 2,23 (s, 3H), 2,08 (s, 3H) 552 (M+H)
- Ejemplo
- Datos de RMN Espectro de EM
- 81
- RMN 1H (400 MHz, CDCl3) δ 8,25 (s ancho, 1H), 7,33-7,31 (m, 2H), 7,257,10 (m, 7H), 7,10-7,07 (m, 2H), 6,33-6,32 (d, 1H), 4,46-4,42 (t, 2H), 3,743,70 (t, 2H), 3,34 (s, 3H) 347 (M-H)
- 82
- RMN 1H (400 MHz, CDCl3) δ 7,33-7,25 (m, 5H), 7,05 (d, 1H), 6,32 (s ancho, 1H), 6,27-6,26 (d, 1H), 4,41-4,39 (t, 2H), 3,71-3,69 (t, 2H), 3,33 (s, 3H), 2,90-2,85 (q, 2H), 1,36-1,30 (q, 2H), 0,85-0,81 (t, 3H) 315 (M+H)
- 83
- RMN 1H (400 MHz, CDCl3) δ 8,34 (s, 1H), 7,56 (d, 2H), 6,98 (d, 3H), 6,396,32 (d, 2H, 6,16 (d, 1H), 4,34 (t, 2H), 3,69-3,62 (m, 6H), 3,33-3,27 (m, 8H), 2,38 (s, 3H), 2,24 (s, 3H), 1,20 (d, 6H) 504 (M+H)
- 84
- RMN 1H (400 MHz, CDCl3) δ 8,28 (s, 1H), 7,33 (d, 2H), 7,28-7,22 (m, 3H), 7,14 (d, 2H), 7,04 (d, 1H), 6,85 (d, 2H), 6,39 (s, 1H), 6,33-6,31 (m, 2H), 4,35 (t, 2H), 3,65 (t, 4H), 3,23 (t, 4H), 2,66 (t, 2H), 2,38 (s, 3H), 2,26 (s, 6H), 2,23 (s, 3H) 551 (M+H)
- 85
- RMN 1H (400 MHz, CDCl3) δ 9,13 (s, 1H), 8,43 (d, 1H), 7,63 (d, 2H), 7,56 (d, 2H), 7,43-7,35 (m, 3H), 7,23 (m, 1H), 7,00 (d, 2H), 6,40 (s, 1H), 6,33 (s, 1H), 4,52 (t, 2H), 3,69 (t, 4H), 3,29 (t, 4H), 2,69 (t, 2H), 2,38 (s, 3H), 2,33 (s, 6H), 2,24 (s, 3H) 551 (M+H)
- 86
- RMN 1H (400 MHz, CDCl3) δ 8,17 (s, 1H), 7,31-7,29 (m, 2H), 7,26-7,21 (m, mezclado con disolvente, ∼3H), 7,08 (d, 2H), 6,83 (d, 2H), 6,38 (s, 1H), 6,31 (s, 1H), 6,13 (s, 1H), 4,32 (t, 2H), 3,65 (t, 4H), 3,22 (t, 4H), 2,65 (t, 2H), 2,37 (s, 6H), 2,31 (s, 6H), 2,23 (s, 3H) 565 (M+H)
- 87
- RMN 1H (400 MHz, CDCl3) δ 8,08 (s, 1H), 7,23-7,21 (m, 3H), 7,02-6,93 (m, 3H), 6,87 (d, 2H), 6,40 (d, 2H), 6,31 (s, 1H), 4,94 (s, 2H), 3,82 (s 3H), 3,66 (t, 4H), 3,24 (t, 4H), 2,37 (s, H), 2,23 (s, 3H) 558 (M+H)
- 88
- RMN 1H (400 MHz, CDCl3) δ 8,30 (s, 1H), 7,54 (d, 2H), 6,99-6,91 (m, 3H), 6,40-6,33 (d, 2H), 6,25 (d, 1H), 4,85 (s, 2H), 3,80 (s, 3H), 3,68 (t, 4H), 3,36 (m, 1H), 3,28 (t, 4H), 2,38 (s, 3H), 2,24 (s, 3H), 1,21 (d, 6H) 518 (M+H)
- 89
- RMN 1H (400 MHz, CDCl3) δ 9,05 (s, 1H), 8,01 (d, 1H), 7,58 (d, 2H), 6,97 (d, 2H), 6,83 (d, 1H), 6,39 (s, 1H), 6,32 (s, 1H), 4,99 (s, 2H), 3,80 (s, 3H), 3,68 (t, 4H), 3,27 (t, 4H), 2,67 (d, 2H), 2,41 (s, 3H), 2,35 (s, 3H), 1,81 (t, 1H), 0,92 (d, 6H) 532 (M+H)
- 90
- RMN 1H (400 MHz, CDCl3) δ 8,18 (s, 1H), 7,33-7,26 (m, 5H), 7,07 (d, 2H), 6,83 (d, 2H), 6,38 (s, 1H), 6,31 (s, 1H), 3,80 (s, 3H), 3,65 (t, 4H), 3,23 (t, 4H), 2,37 (s, 3H), 2,30 (s, 3H), 2,23 (s, 3H) 526 (M+H)
- 91
- RMN 1H (400 MHz, CDCl3) δ 8,58 (s, 1H), 8,17 (s, 1H), 7,63 (t, 1H), 7,36 (d, 2H), 7,32-7,22 (m, 3H), 7,18 (t, 1H), 7,05 (d, 2H), 6,92 (d, 1H), 6,82 (d, 2H), 6,39 (s, 1H), 6,24 (d, 2H), 5,61 (s, 2H), 3,62 (s, 4H), 3,21 (s, 4H), 2,38 (s, 3H), 2,36 (s, 3H), 2,22 (s, 3H) 585 (M+H)
- 92
- RMN 1H (400 MHz, CDCl3) δ 8,54 (s, 1H), 7,46 (d, 1H), 7,31 (d, 2H), 7,257,19 (m, 3H), 6,91-6,90 (d, 1H), 6,71-6,68 (dd, 1H), 6,39 (s, 1H), 6,30 (s, 1H), 6,13 (s, 1H), 4,40 (t, 2H), 3,75 (t, 2H), 3,65 (t, 4H), 3,32 (s, 3H), 3,22 (t, 4H), 2,38 (d, 6H), 2,23 (s, 3H) 586 (M+H)
- 93
- RMN 1H (400 MHz, CDCl3) δ 8,54 (d, 1H), 8,50 (s, 1H), 8,16 (s, 1H), 7,407,34 (m, 3H), 7,32-7,26 (m, 4H), 7,08 (d, 2H), 6,84 (d, 2H), 6,40 (s, 1H), 6,33 (s, 1H), 6,26 (s, 1H), 5,56 (s, 2H), 3,64 (m, 4H), 3,22 (m, 4H), 2,40 (s, 3H), 2,30 (s, 3H), 2,24 (s, 3H) 585 (M+H)
- 94
- RMN 1H (400 MHz, CDCl3) δ 8,08 (s, 1H), 7,35-7,24 (m, 5H), 7,05 (d, 2H), 6,82 (d, 2H), 6,39 (s, 1H), 6,31 (s, 1H), 4,36 (t, 2H), 3,73 (t, 2H), 3,65 (t, 4H), 3,33 (s, 3H), 3,22 (t, 4H), 2,36 (d, 6H), 2,23 (s, 3H) 570 (M+H)
- 95
- RMN 1H (400 MHz, CDCl3) δ 8,31 (s, 1H), 8,21 (s, 1H), 7,50-7,45 (m, 2H), 7,28-7,20 (m, 5H), 6,70-6,64 (m, 3H), 6,54 (d, 1H), 6,12 (s, 1H), 3,82 (s, 3H), 3,68 (t, 4H), 3,24 (t, 4H), 2,33 (s, 3H) 496 (M-H)
- 96
- RMN 1H (400 MHz, CDCl3) δ 8,21 (s, 2H), 7,52-7,42 (m, 2H), 7,30 (d, 2H), 7,25-7,20 (m, 3H), 6,70-6,67 (m, 3H), 6,64 (d, 1H), 6,13 (s, 1H), 4,40 (t, 2H), 3,74 (t, 2H), 3,67 (t, 4H), 3,33 (s, 3H), 3,23 (t, 4H), 2,38 (s, 3H) 540 (M-H)
- 97
- RMN 1H (400 MHz, CDCl3) δ 8,10 (s, 1H), 7,32-7,21 (m, 5H), 7,06 (d, 2H), 6,82 (d, 2H), 6,38 (s, 1H), 6,31 (s, 1H), 6,12 (s, 1H), 4,37 (t, 2H), 3,76 (t, 2H), 3,65 (t, 4H), 3,56-3,47 (m, 1H), 3,22 (t, 4H), 2,38 (d, 6H), 2,23 (s, 3H), 1,10 (d, 6H) 580 (M+H)
- 98
- RMN 1H (400 MHz, CDCl3) δ 8,50 (s, 1H), 7,48-7,46 (d, 1H), 7,34-7,32 (m, 2H), 7,25-7,19 (m, 3H), 6,90 (d, 1H), 6,71-6,68 (dd, 1H), 6,39 (s, 1H), 6,30 (s, 1H), 6,20 (s, 1H), 4,95 (s, 2H), 3,84 (s, 3H), 3,64 (t, 4H), 3,22 (t, 4H), 2,37 (s, 3H), 2,31 (s, 3H), 2,23 (s, 3H) 600 (M+H)
- Ejemplo
- Datos de RMN Espectro de EM
- 99
- RMN 1H (400 MHz CDCl3) δ 8,03 (s, 1H), 7,90 (d, 1H), 7,35-7,21 (m, 6H), 6,20 (d, 1H), 6,12 (s, 1H), 3,82 (s, 3H), 3,40 (t, 4H), 2,33 (s, 3H), 2,001,97 (m, 4H) 387 (M-H)
- 100
- RMN 1H (400 MHz, CDCl3) δ 8,57 (s ancho, 1H), 7,80-7,65 (m, 4H), 7,27 (t, 2H), 7,22-7,14 (m, 4H), 6,15 (s, 1H), 3,85 (s, 3H), 2,35 (s, 3H) 403 (M+H)
- 101
- RMN 1H (400 MHz, CDCl3) δ 8,32 (s, 1H), 7,46 (t, 1H), 7,29 (d, 2H), 7,257,16 (m, 3H, 6,60 (d, 1H), 6,49 (d, 1H), 6,13 (s, 1H), 3,83 (t, 4H), 3,82 (s, 3H), 3,08 (t, 4H), 2,33 (s, 3H) 422 (M+H)
- 102
- RMN 1H (400 MHz, CDCl3) δ 8,56 (d, 2H), 8,12 (s, 1H), 7,36-7,34 (m, 2H), 7,29-7,25 (m, 3H), 7,05 (d, 2H), 6,96 (d, 2H), 6,82 (d, 2H), 6,38 (s, 1H), 6,30 (s, 1H), 6,27 (s, 1H), 5,50 (s, 2H), 3,64 (t, 4H), 3,21 (t, 4H), 2,37 (s, 3H), 2,25 (s, 3H), 2,22 (s, 3H) 585 (M+H)
- 103
- RMN 1H (400 MHz, CDCl3) δ 8,09 (s, 1H), 7,51 (s, 1H), 7,32 (q, 2H), 7,22 (t, 3H), 7,06 (d, 2H), 6,84 (d, 2H), 6,68 (d, 2H), 6,13 (s, 1H), 4,39 (t, 2H), 3,75-3,66 (m, 10H), 3,40 (s ancho, 3H), 3,32 (s, 3H), 3,22 (t, 4H), 2,38 (s, 6H) 623 (M+H)
- 104
- RMN 1H (400 MHz, CDCl3) δ 8,27 (s, 1H), 7,58 (d, 2H), 7,01 (m, 3H), 6,10 (s, 1H), 6,33 (s, 1H), 6,22 (d, 1H), 4,35 (t, 2H), 3,84 (t, 1H), 3,70-3,63 (m, 6H), 3,30-3,27 (m, 6H), 2,38 (s, 3H), 2,31-2,26 (m, 2H), 2,24 (s, 3H), 2,112,02 (m, 2H), 1,94-1,76 (m, 3H) 514 (M-H)
- 105
- RMN 1H (400 MHz, CDCl3) δ 8,30 (s, 1H), 7,43 (t, 1H), 7,29 (d, 2H), 7,247,16 (m, 3H), 6,62-6,58 (d, 1H), 6,49 (d, 1H), 6,12 (s, 1H), 3,82 (s, 3H), 3,12 (t, 4H), 2,57 (t, 4H), 2,33 (s, 3H), 2,13 (s, 2H), 1,84-1,77 (m, 1H), 0,91 (d, 6H) 477 (M+H)
- 106
- RMN 1H (400 MHz, CDCl3) δ 8,28 (s, 1H), 7,41 (t, 1H), 7,29-7,18 (m, 5H), 6,62-6,58 (dd, 1H), 6,51-6,48 (d, 1H), 6,12 (s, 1H), 3,82 (s, 3H), 3,09 (t, 4H), 2,33 (s, 3H), 1,67-1,55 (m, 6H) 420 (M+H)
- 107
- RMN 1H (400 MHz, CDCl3) δ 8,22 (s, 1H), 7,55 (d, 2H), 6,98 (d, 2H), 6,39 (s, 1H), 6,32 (s, 2H), 4,95 (dd, 2H), 4,84 (s, 2H), 3,80 (s, 3H), 3,69-3,67 (m, 4H), 3,29-3,27 (m, 4H), 2,38 (s, 3H), 2,34-2,26 (m, 2H), 2,24 (s, 3H), 2,11-2,01 (m, 2H), 1,95-1,78 (m, 2H) 530 (M+H)
- 108
- RMN 1H (400 MHz, CDCl3) δ 8,28 (s, 1H), 7,44 (t, 1H), 7,29-7,26 (m, 5H), 6,62-6,58 (d, 1H), 6,50-6,48 (d, 1H), 6,12 (s, 1H), 4,89-4,87 (d, 2H), 3,82 (s, 3H), 3,12 (t, 4H), 2,90 (s, 2H), 2,50 (t, 4H), 2,32 (s, 3H), 1,75 (s, 3H) 473 (M-H)
- 109
- RMN 1H (400 MHz, CDCl3) δ 8,19 (s, 1H), 7,41 (t, 1H), 7,30 (d, 2H), 7,237,17 (m, 3H), 6,61-6,57 (dd, 1H), 6,49 (d, 1H), 6,12 (s, 1H), 4,88 (d, 2H), 4,40 (t, 2H), 3,74 (t, 2H), 3,32 (s, 3H), 3,12 (t, 4H), 2,90 (s, 2H), 2,50 (t, 4H), 2,38 (s, 3H), 1,76 (s, 3H) 517 (M-H)
- 110
- RMN 1H (400 MHz, CDCl3) δ 8. 02 (s ancho, 1H), 7,40 (t, 1H), 7,30 (d, 3H), 7,21 (d, 2H), 6,59 (d, 1H), 6,49 (d, 1H), 6,13 (s, 1H), 4,39 (s, 2H), 3,74 (s, 2H), 3,33 (s, 3H), 3,12 (s, 4H), 2,52 (s, 4H), 2,38 (s, 3H), 2,12 (s, 2H), 1,80 (m, 1H), 0,91 (d, 6H) 521 (M+H)
- 111
- RMN 1H (400 MHz, CDCl3) δ 8,19 (s, 1H), 7,46 (t, 1H), 7,32 (m, 2H), 7,237,20 (m, 3H), 6,64 (d, 1H), 6,54 (d, 1H), 6,39 (s, 1H), 6,30 (s, 1H), 6,20 (s, 1H), 4,94(s, 2H), 3,84 (s, 3H), 3,64 (t, 4H), 3,22 (t, 4H), 2,37 (s, 3H), 2,31 (s, 3H), 2,23 (s, 3H) 584 (M+H)
- 112
- RMN 1H (400 MHz, CDCl3) δ 8,28 (s, 1H), 7,43 (t, 1H), 7,28 (d, 2H), 7,237,15 (m, 3H), 6,61-6,57 (dd, 1H), 6,48 (d, 1H), 6,12 (s, 1H), 3,82 (s, 3H), 3,09 (t, 4H), 2,64 (t, 4H), 2,32 (s, 3H), 2,10 (s, 2H), 0,88 (s, 9H) 491 (M+H)
- 113
- RMN 1H (400 MHz, CDCl3) δ 8,18 (s, 1H), 7,04 (t, 1H), 7,30 (d, 2H), 7,237,17 (m, 3H), 6,60-6,56 (q, 1H), 6,47 (d, 1H), 6,12 (s, 1H), 4,39 (t, 2H), 3,74 (t, 2H), 3,32 (s, 3H), 3,08 (t, 4H), 2,64 (t, 4H), 2,38 (s, 3H), 2,10 (s, 2H), 0,88 (s, 9H) 535 (M+H)
- 114
- RMN 1H (400 MHz, CDCl3) δ 8,18 (s, 1H), 7,38 (t, 3H), 7,30 (d, 2H), 7,227,15 (m, 3H), 6,59 (dd, 1H), 6,49 (d, 1H), 6,12 (s, 1H), 4,39 (t, 2H), 3,74 (t, 2H), 3,32 (s, 1H), 3,01-3,07 (m, 4H), 2,38 (s, 3H), 1,66-1,65 (m, 5H), 1,57 (m, 1H) 464 (M+H)
- 115
- RMN 1H (400 MHz, CDCl3) δ 8,20 (s, 1H), 7,27-7,20 (m, 5H), 6,95 (d, 1H), 6,83-6,78 (m, 2H), 6,13 (s, 1H), 3,81 (s, 3H), 2,95 (t, 4H), 2,33 (s, 3H), 1,73-1,69 (m, 4H), 1,56-1,55 (m, 2H) 420 (M+H)
- 116
- RMN 1H (400 MHz, CDCl3) δ 8,23-8,20 (m, 2H), 7,50 (t, 1H), 7,28-7,23 (m, 5H), 7,00 (d, 1H), 6,86-6,81 (m, 1H), 6,70-6,63 (m, 2H), 6,13 (s, 1H), 3,81 (s, 3H), 3,69 (t, 4H), 3,13 (t, 4H), 2,33 (s, 3H) 496 (M-H)
- Ejemplo
- Datos de RMN Espectro de EM
- 117
- RMN 1H (400 MHz, CDCl3) δ 8,21 (s, 1H), 7,44 (t, 1H), 7,30 (d, 2H), 7,237,17 (m, 3H), 6,59 (dd, 1H), 6,48 (d, 1H), 6,13 (s, 1H), 4,40 (t, 2H), 3,833,81 (m, 4H), 3,74 (t, 2H), 3,32 (s, 3H), 3,09-3,07 (m, 4H), 2,38 (s, 3H) 466 (M+H)
- 118
- RMN 1H (400 MHz, CDCl3) δ 8,19 (s ancho, 1H), 7,28-7,22 (m, 5H), 6,96 (d, 1H), 6,81 (t, 2H), 6,13 (s, 1H), 3,81 (s, 3H), 3,04 (t, 4H), 2,55 (s, 4H), 2,33 (s, 3H), 2,13 (d, 2H), 1,83-1,77 (m, 1H), 0,91 (d, 6H) 477 (M+H)
- 119
- RMN 1H (400 MHz, CDCl3) δ 8,08 (s, 1H), 7,29-7,28 (d, 2H), 7,23 (d, 3H), 6,93-6,90 (d, 1H), 6,80-6,78 (d, 2H), 6,13 (s, 1H), 4,39 (t, 2H), 3,72 (t, 2H), 3,32 (s, 3H, 2,94 (t, 4H), 2,38 (s, 3H), 1,71 (m, 4H), 1,54 (m, 2H). 464 (M+H)
- 120
- RMN 1H (400 MHz, CDCl3) δ 8,19 (s, 1H), 8,09 (d, 1H), 7,50 (t, 1H), 7,29 (d, 2H), 7,23 (t, 3H), 7,10 (d, 2H), 6,84 (d, 2H), 6,68 (d, 1H), 6,13 (s, 1H), 3,82 (s, 3H), 3,67 (t, 8H), 3,39 (s, 2H), 3,23 (t, 4H), 2,43 (s, 4H), 2,33 (s, 3H) 579 (M+H)
- 121
- RMN 1H (400 MHz, CDCl3) δ 8,33 (d, 1H),7,55 (d, 2H), 7,41-7,40 (d, 1H), 7,35 (t, 3H),7,24-7,20 (m, 1H), 4,55 (t, 2H), 3,68 (t, 2H), 3,3,6-3,31 (m, 5H),1,63 (q, 2H), 0,98 (t, 3H) 315 (M+H)
- 122
- RMN 1H (400 MHz, CDCl3) δ 9,03 (s, 1H), 8,51 (s, 1H), 7,61-7,55 (m, 4H), 7,34 (m, 4H), 7,07 (d, 2H), 6,38 (d, 2H), 5,08 (s, 2H), 3,83 (s, 3H), 3,65 (m, 4H), 3,28 (m, 4H), 2,38 (s, 3H), 2,32 (s, 3H) 552 (M+H)
- 123
- RMN 1H (400 MHz, CDCl3) δ 8,21 (s, 1H), 7,44 (t, 1H), 7,30 (d, 2H), 7,257,18 (m, 3H), 6,64 (d, 1H), 6,54 (d, 1H), 6,39 (s, 1H), 6,30 (s, 1H), 6,13 (s, 1H), 4,40 (t, 2H), 3,74 (t, 2H), 3,65 (t, 4H), 3,33 (s, 3H), 3,22 (t, 4H), 2,38 (s, 3H), 2,37 (s, 3H), 2,23 (s, 3H) 568 (M-H)
- 124
- RMN 1H (400 MHz, CDCl3) δ 8,12 (s, 1H), 7,31(d, 2H), 7,25-7,20 (m, 3H), 7,10 (d, 2H), 6,84 (d, 2H), 6,38 (s, 1H), 6,30 (s, 1H), 6,14 (s, 1H), 3,82 (s, 3H), 3,65 (t, 4H), 3,22 (t, 4H), 2,61 (t, 2H), 2,37 (s, 3H), 2,23 (s, 3H), 1,75 (m, 2H), 1,06 (t, 3H) 534 (M-H)
- 125
- RMN 1H (400 MHz, CDCl3) δ 8,19 (s, 1H), 7,32(d, 2H), 7,29-7,21 (m, 3H, solapamiento del disolvente) 7,10-7,08 (d, 2H), 6,85-6,83 (d, 2H), 6,38 (s, 1H), 6,31 (s, 1H), 6,23 (s, 1H), 5,6 (s, 2H), 3,65 (t, 4H), 3,33 (s, 3H), 3,22 (t, 4H), 2,77 (q, 2H), 2,37 (s, 3H), 2,23 (s, 3H), 1,54 (t, 3H) 552 (M+H)
- 126
- RMN 1H (400 MHz, CDCl3) δ 8,12 (s, 1H), 7,30-7,21 (m, 5H), 6,95 (d, 1H), 6,80 (d, 2H), 6,13 (s, 1H), 4,41 (t, 2H), 3,84 (t, 4H), 3,72 (t, 2H), 3,32 (s, 3H), 3,01 (t, 4H), 2,38 (s, 3H 464 (M-H)
- 127
- RMN 1H (400 MHz, CDCl3) δ 8,87 (s, 1H), 7,90 (d, 1H), 7,69 (d, 1H), 7,497,34 (m, 5H), 7,29-7,22 (m, 3H, solapamiento del disolvente), 7,18 (t, 1H), 6,16 (s, 1H), 3,86 (s, 3H), 2,36 (s, 3H) 387 (M+H)
- 128
- RMN 1H (400 MHz, CDCl3) δ 8,44 (s, 1H), 7,36-7,32 (m, 3H), 7,25-7,15 (m, 3H), 7,05 (d, 1H), 6,92 (d, 1H), 6,52 (d, 1H), 6,13 (s, 1H), 4,13-4,08 (q, 2H), 3,84 (s, 3H), 2,33 (s, 3H), 1,43 (t, 3H). 404 (M+H)
- 129
- RMN 1H (400 MHz, CDCl3) δ 8,20 (s, 1H), 7,31-7,29 (m, 2H), 7,25-7,20 (m, 3H), 7,09 (d, 2H), 6,83 (d, 2H), 6,38 (s, 1H), 6,31 (s, 1H), 6,18 (s, 1H), 3,83 (s, 3H), 3,69 (t, 2H), 3,65 (t, 4H), 3,39 (s, 3H), 3,22 (t, 4H), 2,93 (t, 2H), 2,37 (s, 3H), 2,23 (s, 3H). 552 (M+H)
- 130
- RMN 1H (400 MHz, CDCl3) δ 8,21 (s, 1H), 7,29 (m, 3H), 7,23 (m, 2H), 7,11 (d, 2H), 6,80 (d, 2H),6,55 (s, 1H), 6,48 (s, 1H), 6,32 (s, 1H), 4,48 (s, 2H), 3,86 (t, 7H), 3,40 (s, 3H),3,29 (t, 4H), 2,60 (s, 3H), 2,37 (s, 3H) 536 (M-H)
- 131
- RMN 1H (400 MHz, CDCl3) δ 8,26 (s, 1H), 7,33-7,26 (m, 5H), 7,14 (d, 2H), 6,85 (d, 2H), 6,39 (d, 2H), 6,31 (s, 1H), 5,66 (s, 2H), 4,57 (s, 2H), 3,65 (t, 4H), 3,41 (s, 3H), 3,31 (s, 3H), 3,23 (t, 4H), 2,37 (s, 3H), 2,23 (s, 3H) 568 (M+H)
- 132
- RMN 1H (400 MHz, CDCl3) δ 8,19 (s, 1H), 7,32-7,30 (m, 3H), 7,25-7,24 (m, 2H), 7,10 (d, 2H), 6,85 (d, 2H), 6,38 (s, 1H), 6,30 (s, 1H), 6,18 (s, 1H), 5,65 (s, 2H), 3,66-3,64 (m, 4H), 3,56-3,55 (q, 2H), 3,23-3,21 (m, 4H), 2,42 (s, 3H), 2,37 (s, 3H), 2,23 (s, 3H), 1,19 (t, 3H) 552 (M+H)
- 133
- RMN 1H (400 MHz, CDCl3) δ 8,08 (s,1H), 7,31 (d, 3H), 7,22 (d, 2H), 7,06 (d, 2H), 6,82 (d, 2H), 6,38 (s, 1H), 6,30 (s, 1H), 6,15 (s, 1H), 4,40 (t, 2H), 3,65 (t, 4H), 3,22 (t, 4H), 2,89 (s, 2H), 2,39 (s, 3H), 2,37 (s, 3H), 2,23 (s, 3H), 2,17 (s, 3H) 568 (M+H)
- 134
- RMN 1H (400 MHz, CDCl3) δ 8,04 (s, 1H), 7,31-7,21 (m, 7H), 7,06-7,04 (d, 2H), 6,93 (t, 1H), 6,88-6,81 (dd, 4H), 6,38 (s, 1H), 6,30 (s, 1H), 6,14 (s, 1H), 4,60 (t, 2H), 4,39 (t, 2H), 3,65 (t, 4H), 3,21 (t, 4H), 2,47 (s, 3H), 2,37 (s, 3H), 2,23 (s, 3H) 614 (M+H)
- Ejemplo
- Datos de RMN Espectro de EM
- 135
- RMN 1H (400 MHz, CDCl3) δ 8,21 (s, 1H), 7,33-7,31 (m, 2H), 7,28-7,23 (m, 3H), 7,10 (d, 2H), 6,84 (d, 2H), 6,39 (s, 1H), 6,31 (s, 1H), 6,18 (s, 1H), 5,64 (s, 2H), 3,65 (t, 4H), 3,49 (t, 2H),3,22 (t, 4H), 2,42 (s, 3H), 2,37 (s, 3H), 2,23 (s, 3H),1,53 (q, 2H), 1,36-1,25 (m, 2H), 0,87 (t, 3H) 580 (M+H)
- 136
- RMN 1H (400 MHz, CDCl3) δ 8,13 (s, 1H), 7,31-7,29 (m, 2H), 7,24-7,22 (m, 3H), 7,07 (d, 2H), 6,84 (d, 2H), 6,38 (s, 1H), 6,30 (s, 1H), 6,11 (s, 1H), 4,33 (t, 2H), 3,66-3,64 (m, 4H), 3,50-3,42 (m, 4H), 3,23-3,30 (m, 4H), 2,37 (s, 3H), 2,36 (s, 3H), 2,23 (s, 3H), 2,05-2,02 (m, 2H), 1,20 (t, 3H) 580 (M+H)
- 137
- RMN 1H (400 MHz, CDCl3) δ 8,17 (s, 1H), 7,32-7,22 (m, 5H), 7,09 (s, 2H), 6,84 (d, 2H), 6,38 (s, 1H), 6,31 (s, 1H), 6,18 (s, 1H), 5,41 (s, 2H), 3,65 (t, 4H), 3,22 (t 4H), 2,42 (s, 3H), 2,37 (s, 3H), 2,23 (s, 3H), 2,13 (s, 3H) 552 (M-H)
- 138
- RMN 1H (400 MHz, CDCl3) δ 8,21 (s, 1H), 7,32-7,30 (q, 2H), 7,27-7,25 (m, 4H), 7,08 (d, 2H), 6,84 (d, 2H), 6,39 (s, 1H), 6,31 (s, 1H), 6,19 (s, 1H), 5,72 (s, 2H), 3,68-3,64 (m, 5H), 3,50 (t, 2H),3,35 (s, 3H,) 3,22 (t, 4H), 2,44 (s, 3H), 2,37 (s, 3H), 2,23 (s, 3H) 582 (M+H)
- 139
- RMN 1H (400 MHz, CDCl3) δ 8,21 (s, 1H), 7,33-7,31 (m, 2H), 7,28-7,25 (m, 3H), 7,10 (d, 2H), 6,84 (d, 2H), 6,39 (s, 1H), 6,31 (s, 1H), 6,19 (s, 1H), 5,65 (s, 2H), 3,65 (t, 4H), 3,45 (t, 2H), 3,22 (t, 4H), 2,43 (s, 3H), 2,37 (s, 3H), 2,23 (s, 3H), 1,57 (m, 2H), 0,88 (t, 3H) 566 (M+H)
- 140
- RMN 1H (400 MHz, CDCl3) δ 8,12 (s, 1H), 7,32-7,25 (m, 5H), 7,06 (d, 2H), 6,83 (d, 2H), 6,39 (s, 1H), 6,31 (s, 1H), 6,13 (s, 1H), 4,39 (t, 2H), 3,77 (t, 2H), 3,64 (m, 4H), 3,36 (t, 2H), 3,22 (m, 4H), 2,40 (s, 3H), 2,37 (s, 3H), 2,23 (s, 3H), 1,57-1,51 (m, 2H), 0,87 (t, 3H) 580 (M+H)
- 141
- RMN 1H (400 MHz, CDCl3) δ 8,20 (s, 1H), 7,31-7,22 (m, 5H), 7,08 (d, 2H), 6,83 (d, 2H), 6,39 (s, 1H), 6,31 (s, 1H), 6,14 (s, 1H), 5,73-5,64 (m, 2H), 4,95 (d, 2H), 4,08 (d, 2H), 3,65 (m, 4H), 3,38 (s, 3H) 3,22 (m, 4H), 2,37 (s, 3H), 2,34 (s, 3H), 2,23 (s, 3H) 578 (M+H)
- 142
- RMN 1H (400 MHz, CDCl3) δ 8,14 (s, 1H), 7,31-7,21 (m, 5H), 7,06 (d, 2H), 6,83 (d, 2H), 6,39 (s, 1H), 6,31 (s, 1H), 6,12 (s, 1H), 4,22 (t, 2H), 3,65 (t, 4H), 3,42 (t, 2H), 3,34 (s, 3H), 3,22 (t, 4H), 2,38 (s, 3H), 2,35 (s, 3H), 2,23 (s, 3H), 1,87-1,83 (m, 2H), 1,70-1,65 (m, 2H). 578 (M-H)
- 143
- RMN 1H (400 MHz, DMSO-d6) δ 10,17 (s, 1H), 7,22 (m, 2H), 7,11 (m, 3H), 7,00 (d, 2H), 6,73 (d, 2H), 6,09 (s, 1H), 3,81 (s, 3H), 3,02 (s, 4H), 2,31 (s, 3H), 1,58-1,49 (m, 6H) 400 (M-H)
- 144
- RMN 1H (400 MHz, CDCl3) δ 8,20 (s, 1H), 7,35-7,20 (m, 10H), 7,06 (d, 2H), 6,77 (d, 2H), 6,12 (s, 1H), 3,80 (s, 3H), 3,56 (s, 2H), 3,13 (m, 4H), 2,59 (m, 4H), 2,32 (s, 3H) 493 (M+H)
- 145
- RMN 1H (400 MHz, CDCl3) δ 8,21 (s, 1H), 7,31-7,21 (m, 5H), 7,09 (d, 2H), 6,79 (d, 2H), 6,13 (s, 1H), 3,81 (s, 3H), 3,76 (t, 2H), 3,65 (t, 2H), 3,09 (t, 4H), 2,82 (septet, 1H), 2,33 (s, 3H), 1,15 (d, 6H). 471 (M-H)
- 146
- RMN 1H (400 MHz, CDCl3) δ 8,13 (s, 1H), 7,44 (s, 1H), 7,32-7,29 (m, 2H), 7,25-7,21 (m, 3H), 7,05 (d, 2H), 6,82 (d, 2H), 6,39 (s, 1H), 6,31 (s, 1H), 6,16 (s, 1H), 5,34 (s, 2H), 3,65 (m, 4H), 3,22 (m, 4H), 2,48 (s, 3H), 2,41 (s, 3H), 2,37 (s, 3H), 2,23 (s, 3H) 587 (M-H)
- 147
- RMN 1H (400 MHz, CDCl3) δ 8,44 (s, 1H), 7,91 (d, 2H), 7,68 (s, 1H), 7,317,28 (m, 4H), 7,26-7,21 (m, 4H), 6,15 (s, 1H), 3,83 (s, 3H), 2,34 (s, 3H) 384 (M-H)
- 148
- RMN 1H (400 MHz, CDCl3) δ 8,44 (s ancho, 1H), 7,90 (t, 1H), 7,73 (s, 1H), 7,28-7,20 (m, 7H), 7,01 (d, 1H), 6,15 (s, 1H), 3,83 (s, 3H), 2,34 (s, 3H) 402 (M-H)
- 149
- RMN 1H (400 MHz, CDCl3) δ 8,30 (s, 1H), 7,91 (d, 2H), 7,68 (s, 1H), 7,317,26 (m, 4H), 7,22-7,20 (m, 4H), 6,15 (s, 1H), 4,41 (t, 2H), 3,74 (t, 2H), 3,33 (s, 3H), 2,39 (s, 3H) 428 (M-H)
- 150
- RMN 1H (400 MHz, CDCl3) δ 8,18 (s, 1H), 7,31-7,18 (m, 5H), 7,06 (d, 2H), 6,78 (d, 2H), 6,12 (s, 1H), 3,81 (s, 3H), 3,15-3,08 (m, 4H), 2,73-2,68 (m, 2H), 2,55-2,52 (m, 2H), 2,32 (s, 3H), 2,17-2,14 (m, 1H), 1,72-1,70 (m, 1H), 0,95 (d, 6H), 0,88 (d, 3H) 473 (M+H)
- 151
- RMN 1H (400 MHz, CDCl3) δ 8,18 (s, 1H), 7,30-7,20 (m, 5H), 7,06 (d, 2H), 6,78 (d, 2H), 6,12 (s, 1H), 3,81(s, 3H), 3,51-3,47 (m, 1H), 3,35-3,31 (m, 4H), 3,13 (t, 4H), 2,84-2,79 (m, 1H), 2,73 (t, 4H), 2,32 (s, 3H), 1,10 (d, 3H) 475 (M+H)
- 152
- RMN 1H (400 MHz, CDCl3) δ 8,17 (s, 1H), 7,30-7,22 (m, 6H), 7,06 (d, 2H), 6,78 (d, 2H), 6,28 (s, 1H), 6,12 (s, 1H), 6,04 (s, 1H), 3,81 (s, 3H), 3,13 (m, 4H), 2,98-2,94 (m, 2H), 2,72 (m, 4H), 2,60-2,54 (m, 1H), 2,32 (s, 3H), 1,04 (d, 3H) 511 (M+H)
Resultados de CMI de Aspergillus en mg/l (medio YAG):
Los siguientes resultados de CMI se han dividido en grados. Así, un grado de 1 representa una CMI superior a 10 mg/l. Un grado de 2 representa una CMI de 1 a 10 mg/l. Un grado de 3 representa una CMI inferior a 1 mg/l.
- Ejemplo nº
- A. flavus A. fumigatus 210 de A. fumigatus A. niger A. terreus 49 de A. terreus
- 1
- 3 3 3 3 3 3
- 2
- 3 2 2 1 3 3
- 3
- 2 1 2 1
- 3
- 3
- 4
- 2 2 2 2 1 2
- Referencia 5*
- 2 3 3 2 3 3
- Referencia 6*
- 3 3 3 3 3 3
- Referencia 7*
- 3 3 3 3 3 3
- 8
- 2 3 3 3 2 2
- 9
- 3 3 3 3 3 3
- 10
- 2 1 1 1 1 2
- 11
- 3 3 3 3 3 3
- 12
- 3 3 3 3 3 3
- 13
- 3 3 3 3 3 3
- 14
- 3 3 3 3 3 3
- 15
- 3 3 3 3 3 3
- 16
- 3 3 3 3 3 3
- 17
- 2 2 2 2 2 2
- 18
- 3 3 3 1 3 3
- 19
- 2 1 1 1 1 2
- 20
- 1 1 3 1 3 3
- 21
- 3 3 3 3 3 3
- 22
- 3 3 3 3 3 3
- 23
- 3 3 2 3 3 3
- 24
- 3 3 3 3 3 3
- 25
- 2 3 3 2 2 2
- 26
- 1 3 3 3 3 3
- 27
- 1 3 3 2 2 2
- 28
- 2 3 3 3 3 3
- 29
- 1 1 1 1 1 1
- 30
- 2 2 2 1 2 2
- 31
- 3 2 2 2 3 3
- 32
- 3 2 2 2 3 3
- 33
- 1 1 1 1 1 2
- 34
- 3 3 3 3 3 3
- 35
- 3 3 3 3 3 3
- 36
- 3 3 3 3 3 3
- 37
- 3 3 3 3 3 3
- 38
- 3 3 3 3 3 3
- 39
- 3 3 3 3 3 3
- 40
- 3 3 3 3 3 3
- Referencia 41 a*
- 3 3 3 3 3 3
- Referencia 41 b*
- 1 2 2 1 1 1
- 42
- 1 2 2 1 1 1
- 43
- 3 2 2 1 2 2
- 44
- 3 3 3 3 3 3
- 45
- 3 3 3 3 3 3
- 46
- 3 2 3 1 1 3
- 47
- 3 3 3 2 2 3
79 80 81
- Ejemplo nº
- A. flavus A. fumigatus 210 de A. fumigatus A. niger A. terreus 49 de A. terreus
- 48
- 1 2 3 1 1 1
- 49
- 3 2 2 1 1 3
- 50
- 3 3 3 3 3 3
- 51
- 3 3 3 3 3 3
- 52
- 3 3 3 3 3 3
- 53
- 3 3 3 3 3 3
- 54
- 2 3 3 2 2 3
- 55
- 1 2 2 1 1 2
- 56
- 1 2 2 2 2 2
- 57
- 2 3 3 2 2 3
- 58
- 2 2 2 1 2 2
- 59
- 1 2 2 1 2 2
- 60
- 1 2 2 2 2 2
- 61
- 1 1 2 1 1 1
- 62
- 3 3 3 3 3 3
- 63
- 3 3 3 2 3 3
- 64
- 3 3 3 3 3 3
- 65
- 1 1 1 1 1 1
- 66
- 2 3 2 1 2 3
- 67
- 3 3 3 2 3 3
- 68
- 1 2 1 1 2 2
- 69
- 2 3 3 3 3 3
- 70
- 2 3 3 1 3 3
- 71
- 1 1 1 1 1 2
- 72
- 2 3 3 3 3 3
- 73
- 1 3 3 3 1 2
- 74
- 1 3 3 3 2 2
- 75
- 1 1 1 1 1 1
- 76
- 1 2 2 1 1 1
- 77
- 1 3 3 2 2 2
- 78
- 1 1 1 1 1 2
- 79
- 3 2 2 2 3 3
- 80
- 1 1 1 1 1 1
- 81
- 1 1 1 1 1 1
- 82
- 1 2 2 1 2 2
- 83
- 1 2 2 1 2 2
- 84
- 1 1 1 1 1 1
- 85
- 1 1 1 2 1 1
- 86
- 2 1 1 1 1 1
- 87
- 1 3 3 3 2 3
- 88
- 1 3 3 2 2 1
- 89
- 1 3 3 2 2 2
- 90
- 3 3 3 3 3 3
- 91
- 1 2 2 1 1 2
- 92
- 3 3 3 3 3 3
- 93
- 2 3 3 3 2 2
- 94
- 2 3 3 2 3 3
- 95
- 3 3 3 3 3 3
- 96
- 3 3 3 3 3 3
- 97
- 2 2 3 2 2 2
- 98
- 1 3 3 3 3 3
- 99
- 3 2 3 2 3 3
- 100
- 3 3 2 3 3 3
- 101
- 3 3 3 3 3 3
- 102
- 1 2 1 1 1 1
- Ejemplo nº
- A. flavus A. fumigatus 210 de A. fumigatus A. niger A. terreus 49 de A. terreus
- 103
- 1 3 3 1 2 2
- 104
- 1 2 2 1 2 2
- 105
- 3 3 3 3 3 3
- 106
- 3 3 3 3 3 3
- 107
- 1 3 3 1 1 1
- 108
- 3 3 3 3 3 3
- 109
- 3 3 3 3 3 3
- 110
- 2 3 3 3 3 2
- 111
- 2 3 3 3 3 3
- 112
- 3 3 3 3 3 3
- 113
- 3 3 3 3 3 3
- 114
- 3 3 3 3 3 3
- 115
- 3 3 3 3 3 3
- 116
- 3 3 3 3 3 3
- 117
- 3 3 2 3 3 3
- 118
- 3 3 3 3 3 3
- 119
- 2 3 3 3 3 3
- 120
- 3 3 3 3 3 3
- 121
- 1 1 2 1 2 2
- 122
- 1 3 2 2 1 1
- 123
- 3 3 3 3 3 3
- 124
- 3 3 3 3 3 3
- 125
- 3 3 3 3 3 3
- 126
- 2 3 3 2 3 3
- 127
- 3 1 2 3 3 3
- 128
- 3 3 3 3 3 3
- 129
- 3 3 3 3 3 3
- 130
- 3 3 3 3 3 3
- 131
- 2 2 2 2 2 2
- 132
- 3 3 3 3 3 3
- 133
- 2 3 3 3 3 3
- 134
- 2 2 1 1 2 2
- 135
- 1 3 2 2 2 1
- 136
- 3 3 3 3 2 3
- 137
- 3 3 3 3 3 3
- 138
- 2 3 3 3 3 3
- 139
- 2 3 3 3 2 3
- 140
- 2 2 3 2 2 2
- 141
- 2 3 3 2 2 2
- 142
- 3 3 3 3 3 3
- 143
- 3 3 3 3 3 3
- 144
- 3 3 3 3 3 3
- 145
- 3 3 3 3 3 3
- 146
- 2 3 3 2 2 2
- 147
- 3 3 3 3 3 3
- 148
- 3 3 3 3 3 3
- 149
- 3 3 3 3 3 3
- 150
- 3 3 3 3 3 3
- 151
- 3 3 3 3 3 3
- 152
- 3 3 3 3 3 3
- 153
- 3 3 2 3 2 3
- 154
- 3 3 3 3 3 3
Resultados de CMI de Aspergillus en mg/l (medio RPMI): Los siguientes resultados de CMI se han dividido en grados como se ha definido anteriormente.
- Ejemplo nº
- A. flavus A. fumigatus 210 de A. fumigatus A. niger A. terreus 49 de A. terreus
- 1
- 3 3 3 3 3 3
- 2
- 1 1 1 1 1 1
- 3
- 1 1 1 1 2 2
- 4
- 1 1 1 1 1 1
- 5
- 2 2 2 2 3 3
- 6
- 3 3 3 3 3 3
- 7
- 3 3 3 3 3 3
- 8
- 1 2 2 2 2 2
- 9
- 1 3 3 3 2 2
- 10
- 1 1 1 1 1 1
- 11
- 3 3 3 3 3 3
- 12
- 3 3 3 3 3 3
- 13
- 3 3 3 3 3 3
- 14
- 3 3 3 3 3 3
- 15
- 3 3 3 3 3 3
- 16
- 3 3 2 3 3 3
- 17
- 1 1 1 1 1 1
- 18
- 2 3 3 1 3 3
- 19
- 1 1 1 1 1 1
- 20
- 1 1 1 1 1 2
- 21
- 3 3 3 3 3 3
- 22
- 3 3 3 3 3 3
- 23
- 3 2 2 2 3 3
- 24
- 2 3 3 3 2 1
- 25
- 1 1 2 2 1 1
- 26
- 1 3 3 3 1 1
- 27
- 1 2 2 2 1 1
- 28
- 2 3 3 3 2 2
- 29
- 1 1 1 1 1 1
- 30
- 1 1 1 1 1 1
- 31
- 2 2 2 2 3 3
- 32
- 2 1 1 2 2 2
- 33
- 1 1 1 1 1 1
- 34
- 3 3 3 3 3 3
- 35
- 3 3 3 3 3 3
- 36
- 3 3 3 3 3 3
- 37
- 3 2 2 2 3 3
- 38
- 3 3 3 3 3 3
- 39
- 3 3 3 3 3 3
- 40
- 3 3 3 3 3 3
- 41 a
- 1 2 1 1 2 3
- 41 b
- 1 2 1 1 1 1
- 42
- 1 2 1 1 1 1
- 43
- 2 1 1 1 2 1
- 44
- 3 3 3 3 3 3
- 45
- 3 3 3 3 3 3
- 46
- 1 1 1 1 2 2
- 47
- 2 2 2 2 2 2
- 48
- 1 1 1 1 1 1
- 49
- 2 2 1 1 2 2
- 50
- 3 3 3 3 3 3
82 83 84
- Ejemplo nº
- A. flavus A. fumigatus 210 de A. fumigatus A. niger A. terreus 49 de A. terreus
- 51
- 3 3 3 3 3 3
- 52
- 2 3 3 3 3 3
- 53
- 3 3 3 3 3 3
- 54
- 1 3 2 2 1 1
- 55
- 1 1 1 1 1 1
- 56
- 1 1 1 1 1 1
- 57
- 1 2 2 2 2 2
- 58
- 1 1 1 1 1 1
- 59
- 1 2 2 1 1 1
- 60
- 1 2 2 2 1 1
- 61
- 1 1 2 1 1 1
- 62
- 3 3 3 3 3 3
- 63
- 3 3 3 3 3 3
- 64
- 2 3 3 3 2 3
- 65
- 1 1 1 1 1 1
- 66
- 1 2 2 1 2 2
- 67
- 2 2 2 1 3 3
- 68
- 1 1 1 1 1 1
- 69
- 1 3 3 3 2 2
- 70
- 2 2 2 1 2 2
- 71
- 1 1 1 1 1 1
- 72
- 2 2 2 2 2 2
- 73
- 1 3 3 3 1 1
- 74
- 1 3 3 3 2 2
- 75
- 1 1 1 1 1 1
- 76
- 1 1 2 1 1 1
- 77
- 1 2 2 1 1 1
- 78
- 1 1 1 1 1 1
- 79
- 2 1 1 2 2 2
- 80
- 1 1 1 1 1 1
- 81
- 1 1 1 1 1 1
- 82
- 1 1 1 1 1 1
- 83
- 1 1 1 1 1 1
- 84
- 1 1 1 1 1 1
- 85
- 1 1 1 2 2 2
- 86
- 1 1 1 1 1 1
- 87
- 1 3 3 3 2 2
- 88
- 1 3 3 2 1 1
- 89
- 1 2 2 . 2 1 1
- 90
- 3 3 3 3 3 3
- 91
- 1 1 1 1 1 1
- 92
- 1 3 3 3 1 1
- 93
- 1 2 2 2 I 1
- 94
- 1 3 2 2 2 2
- 95
- 3 3 3 3 3 3
- 96
- 2 3 3 3 3 2
- 97
- 2 3 2 2 2 2
- 98
- 2 3 3 3 3 3
- 99
- 3 3 2 3 3 3
- 100
- 3 3 2 3 3 3
- 101
- 3 3 3 3 3 3
- 102
- 1 1 1 1 1 1
- 103
- 1 2 2 3 2 2
- 104
- 1 1 1 1 1 1
- 105
- 3 3 3 3 3 3
- Ejemplo nº
- A. flavus A. fumigatus 210 de A. fumigatus A. niger A. terreus 49 de A. terreus
- 106
- 3 3 3 3 3 3
- 107
- 1 3 2 1 1 1
- 108
- 3 3 3 3 3 3
- 109
- 3 3 3 3 3 3
- 110
- 2 3 3 2 3 3
- 111
- 2 3 3 3 3 2
- 112
- 3 3 3 3 3 3
- 113
- 2 2 3 3 3 2
- 114
- 2 2 2 3 2 2
- 115
- 3 3 3 3 3 3
- 116
- 1 3 3 3 3 3
- 117
- 1 2 2 3 2 1
- 118
- 3 3 3 3 3 3
- 119
- 2 3 3 3 3 2
- 120
- 3 3 3 3 3 3
- 121
- 1 1 1 1 1 1
- 122
- 1 1 1 2 1 1
- 123
- 3 3 3 3 3 2
- 124
- 2 2 2 1 2 2
- 125
- 2 2 2 2 2 2
- 126
- 1 2 2 1 2 2
- 127
- 3 1 1 3 3 3
- 128
- 3 3 3 3 3 3
- 129
- 3 3 2 2 2 2
- 130
- 3 3 3 3 3 3
- 131
- 1 1 1 2 2 2
- 132
- 1 3 3 3 3 3
- 133
- 1 3 3 3 2 2
- 134
- 1 1 1 1 1 1
- 135
- 1 1 1 1 1 1
- 136
- 2 2 2 2 2 2
- 137
- 2 3 2 2 2 2
- 138
- 2 3 3 2 2 2
- 139
- 1 2 2 2 2 2
- 140
- I 1 1 1 1 1
- 141
- 1 1 1 1 1 1
- 142
- 3 3 3 3 3 3
- 143
- 3 3 3 3 3 3
- 144
- 3 3 3 3 3 3
- 145
- 3 3 3 2 3 3
- 146
- 1 3 1 2 1 1
- 147
- 3 3 3 3 3 3
- 148
- 3 3 2 3 3 3
- 149
- 1 2 2 3 2 2
- 150
- 3 3 3 3 3 3
- 151
- 3 3 3 3 3 3
- 152
- 3 3 3 3 3 3
- 153
- 2 2 2 3 3 3
- 154
- 3 3 3 3 3 3
Claims (11)
-
imagen1 imagen2 imagen3 imagen4 imagen5 N-{4-[4-(4,6-Dimetil-piridin-2-il)piperazin-1-il]-fenil}-2-[3-isobutil-1-(2-metoxi-etil)-1H-pirrol-2-il]-2-oxo-acetamida,Éster etílico del ácido 2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilo amino oxalil}-5-metil-3-fenil-pirrol-1-il)acético, 2-[3-(3-Cloro-fenil)-1-(2-metoxi-etil)-1H-pirrol-2-il]-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxoacetamida, 2-[4-(3-Cloro-fenil)-1-(2-metoxi-etil)-1H-pirrol-2-il]-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxoacetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazina-1-il]-fenil}-2[1-(2-metoxi-etil)-3-tiofen-3-il-1H-pirol-2-il]-2-oxoacetamida,Éster del ácido (2-{4-[4-(4,6-dimetil piridina-2-il)-piperazin-1-il]-fenilamino oxalil}-3-fenilo pirrol-1-il)acético,Éster metílico del ácido (2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilaminooxalil}-3-fenil-pirrol-1-il)-acético, 2-((1-Carbamoilmetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxo-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(1-metil-carbamoilmetil-3-fenil-1-H-pirrol-2-il)-2-oxoacetamida,Éster isopropílico del ácido 2{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilo amino oxalil}-5-metil-3-fenil-pirrol1-il)acético, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[5-isopropil-1-(2-metoxi-etil)-3-fenil-1H-pirrol-2-il]-2-oxoacetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-2-oxo-quinolin-5-il-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[3-(2-metoxi-etil)-5-metil-1-fenil-1H-pirrol-2-il]-2-oxoacetamida, 2-[1-(2-Metoxi-etil)-3-fenil-1H-pirrol-2-il]-2-oxo-N-fenil-1-acetamida, 2-[1-(2-Metoxi-etil)-3-fenil-1H-pirrol-2-il]-2-oxo-N-propil-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[3-isopropil-1-(2-metoxi-etil)-1H-pirrol-2-il]-2-oxoacetamida, 2-[1-(2-Dimetilamino-etil)-3-fenil-1H-pirrol-2-il]-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxoacetamida, 2-[1-(2-Dimetilamino-etil)-4-fenil-1H-pirrol-2-il]-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxoacetamida, 2-[1-(2-Dimetilamino-etil)-5-metil-3-fenil-1H-pirrol-2-il]-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxoacetamida,Éster metílico del ácido (2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilo amino oxalil}-3-tiofen-2-il-pirrol-1-il)acético,Éster metílico del ácido (2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilaminooxalil}-[3-iso propil-pirrol-1-il)acético,Éster metílico del ácido (2-{4-[4-(4,6-dimetil piridina-2-il) piperazina-1-il]-fenilamino oxalil}-3-isobutil-pirrol-1-il)acético, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(4-fluoro-1,5-dimetil-3-fenil-1H-pirrol-2-il)-2-oxo-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-metil-3-fenil-1piridin-2ilmetil-1H-pirrol2-il)-2-oxo-acetamida, N-{2-Cloro-4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(2-metoxi-etil)-5-metil-3-fenil1H-pirrol-2-il]-2-oxo-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-metil-3-fenil-1-piridin-3-ilmetil-1H-pirrol-2-il)-2-oxoacetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[4-fluoro-1-(2-metoxi-etil)-5-metil-3-fenil1H-pirrol-2-il]-2-oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-[2-fluoro-4-(4-piridin-2-il-piperazin-1-il)-fenil]-2-oxo-acetamida, N-[2-Fluoro-4-(4-piridin-2-il-piperazin-1-il)-fenil]-2-[1-(2-metoxi-etil-)-5-metil-3-fenil-1H-pirrol-2il]-2-oxo-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(2-isopropoxi-etil)-5-metil-3-fenil-1Hpirrol-2-il]-2-oxo-acetamida,Éster metílico del ácido (2-{2-cloro-4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilo amino oxalil}-5-metil-3-fenilpirrol-1-il)-acético, 2-((1, 5-Dimetil-3-fenil-1H-pirrol-2-il)-2-oxo-N-(6-pirrolidin-1-il-piridin-3-il)-acetamida, 2-((1, 5-Dimetil-3-fenil-1H-pirrol-2-il)-N-[2-fluoro-4-oxazol-2-il-fenil)-2-oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-(2-fluoro-4-morfolin-4-il-fenil)-2-oxo-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-metil-3-fenil-1-piridin-4-ilmetil-1H-pirrol-2-il)-2-oxoacetamida, 2-[1-(2-Metoxi-etil)-5-metil-3-fenil-1H-pirrrol-2-il]-N-{4-[4-(5-morfolin-4-ilmetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxo-acetamida, 2-[3-Ciclobutil-1-(2-metoxi-etil)-1H-pirrol-2-il]-N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperizin-1-il]-fenil}2-oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-[2-fluoro-4-(4-isobutil-piperazin-1-il)-fenil]-2-oxoacetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-(2-fluoro-4-piperidin-1-il-fenil)-2-oxo-acetamida,Éster metílico del ácido (3-ciclobutil-2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il-]-fenilaminooxalil}-pirrol-1-il)acético,2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{2-fluoro-4-[4-(2-metil-alil)-piperazin-1-il]-fenil}-2-oxoacetamida, N-{2-Fluoro-4-[4-(2-metil-alil)-piperazin-1-il]-fenil}-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol2-il]-2-oxo-acetamida, N-[2-Fluoro-5-(4-isobutil-piperazina-1-il)-fenil]-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2oxo-acetamida,Éster metílico del ácido (2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-2-fluoro-fenilaminooxilil}-5-metil-3-fenilpirrol-1-il)-acético, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(2,2-dimetil-propil)-piperazin-1-il]-2-fluoro-fenil}-2-oxoacetamida, N-{4-[4-(2,2-Dimetil-propil)-piperazin-1-il]-2-fluoro-fenil}-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1Hpirrol-2-il]-2-oxo-acetamida, N-(2-Fluoro-4-piperidin-1-il-fenil)-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-(3-fluoro-4-piperidin-1-il-fenil)-2-oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-[3-fluoro-4-(4-piridin-2-il-piperazin-1-il)-fenil]-2-oxo-acetamida, N-(2-Fluoro-4-morfolin-4-il-fenil)-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxo-acetamida, 2-((1,5-Dimetil-3-phcnyl-1H-pirrol-2-il)-N-[3-fluoro-4(4-isobutil-piperazin-1-il)-fenil]-2-oxo-acetamida, N-(3-Fluoro-4-piperdin-1-il-fenil)-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(5-morfolin-4-ilmetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxoacetamida, 2-[1-(2-Metoxi-etil)-4-fenil-1H-pirrol-2-il]-2-oxo-N-propil-acetamida,Éster metílico del ácido (2-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenilaminooxalil}-4-fenil-pirrol-1-il)-acético, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-2-fluoro-fenil}-2-[1-(2-metoxi-etil)-5-metil-3-fenil1H-pirrol-2-il)-2-oxo-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperizin-1-il]-fenil}-2-[1-metil-3-fenil-5-propil-1H-pirrol-2-il)-2-oxoacetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-etil-1-metoximetil-3-fenil-1H-pirrol-2-il)-2-oxoacetamida, N-(3-Fluoro-4-morfolin-4-il-fenil)-2-[1-(2-metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-(5-fluoro-naftalen-1-il)-2-oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol2-il)-N-(1-etil-4-fluoro-1H-indol-5-il)-2-oxo-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[5-(2-metoxi-etil)-1-metil-3-fenil-1H-pyr-rol-2-il]-2-oxoacetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-metoximetil-1-metil-3-fenil-1H-pirrol-2-il)-2-oxoacetamida, 2-((1,5-Bis-metoximetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazina-1-il]-fenil}-2-oxoacetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(1-etoximetil-5-metil-3-fenil-1H-pirrol-2-il)-2-oxoacetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[5-metil-1-(2-metilsulfanil-etil)-3-fenil-1H-pirrol-2-il]-2-oxoacetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[5-metil-1-(2-fenoxi-etil)-3-fenil-1H-pirrol-2-il]-2-oxoacetamida, 2-((1-Butoximetil-5-metil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(4,6-dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-oxoacetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(3-etoxi-propil)-5-methy-3-fenil-1H-pirrol-2-il]-2-oxoacetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-metil-1-metilsulfanilmetil-3-fenil-1H-pirrol-2-il)-2-oxoacetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(2-metoxietoximetil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxoacetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-(5-metil-3-fenil-1-propoximetil-1H-pirrol-2-il)-2-oxoacetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[5-metil-3-fenil-1-(2-propoxi-etil)-1H-pirrol-2-il]-2-oxoacetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(4-metoxi-but-2-enil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxoacetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[1-(4-metoxi-butil)-5-metil-3-fenil-1H-pirrol-2-il]-2-oxoacetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-2-oxo-N-(4-piperidin-1-il-fenil)-acetamida, N-[4-(4-Bencil-piperazin-1-il)-fenil]-2-(1,5-dimetil-3-fenil-1H-pirrol-2-il)-2-oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-[4-(4-isobutiril-piperazin-1-il)-fenil]-2-oxo-acetamida, N-{4-[4-(4,6-Dimetil-piridin-2-il)-piperazin-1-il]-fenil}-2-[5-metil-1-(2-metil-oxazol-4-ilmetil)-3-fenil-1H-pirrol-2-il]-2oxo-acetamida 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-(4-oxazol-2-il-fenil)-2-oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-[3-fluoro-4-oxazol-2-il-fenil)-2-oxo-acetamida,2-[1-(2-Metoxi-etil)-5-metil-3-fenil-1H-pirrol-2-il]-N-(4-oxazol-2-il-fenil)-2-oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(1,2-dimetil-propil)-piperazin-1-il]-fenil}-2-oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(2-metoxi-1-metil-etil)-piperazin-1-il]-fenil}-2-oxo-acetamida, 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-{4-[4-(2-furan-2-il-1-metil-etil)-piperazin-1-il]-fenil}-2-oxo-acetamida,5 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-2-oxo-N-[4-(5-piperidin-1-ilmetil-oxazol-2-il)-fenil]-acetamida, o 2-((1,5-Dimetil-3-fenil-1H-pirrol-2-il)-N-(4-morfolin-4-il-fenil)-2-oxo-acetamida,o una sal farmacéuticamente aceptable de los mismos.10 10. Una combinación farmacéutica que comprende una combinación de un derivado de pirrol de fórmula (I) o una sal farmacéuticamente aceptable del mismo como se define en una cualquiera de las reivindicaciones anteriores, con un segundo agente antifúngico; y opcionalmente un vehículo o diluyente farmacéuticamente aceptable del mismo, en la que el derivado de pirrol de fórmula (I) o la sal farmacéuticamente aceptable del mismo y el segundo agente antifúngico se formulan preferentemente para administración simultánea o sucesiva.15 - 11. Una combinación según la reivindicación 10, donde el segundo agente antifúngico está seleccionado del grupo que consiste en azoles, polienos, inhibidores del nucleótido purina, inhibidores del nucleótido pirimidina, inhibidores de manano, inhibidores del factor de elongación de proteínas, equinocandinas, alilaminas, anticuerpos anti-HSP90, productos de proteínas bactericidas/inductores de la permeabilidad o polioxinas, o uno de los compuestos AN2690,20 AN2718 o icofungipen.
- 12. Un producto que comprende un derivado de pirrol de fórmula (I) como se define en una cualquiera de las reivindicaciones 1 a 9 o una sal farmacéuticamente aceptable del mismo y un segundo agente antifúngico para el uso separado, simultáneo o secuencial en la prevención o tratamiento de una enfermedad fúngica.25
- 13. Una combinación o producto según una cualquiera de las reivindicaciones 10 a 12 para su uso en el tratamientoo prevención de enfermedad fúngica.14 Un compuesto, combinación o producto según una cualquiera de las reivindicaciones 1 a 9 o 13, donde la30 enfermedad se produce por una especie Aspergillus, preferentemente en la que la enfermedad es causada por un dermatofito fúngico, o en la que la enfermedad es Aspergiliosis Broncopulmonar Alérgica (ABPA) o asma; o un compuesto de acuerdo con la reivindicación 8, en la que la enfermedad es causada por una especie Aspergillus o Candida.35 15. Un kit que comprende, en mezcla o en recipientes separados, un derivado de pirrol de fórmula (I) como se define en una cualquiera de las reivindicaciones 1 a 9 o una sal farmacéuticamente aceptable del mismo y un segundo agente antifúngico.
- 16. Un procedimiento de control de una enfermedad fúngica en una planta, cuyo procedimiento comprende aplicar al40 sitio de la planta un derivado de pirrol como se define en una cualquiera de las reivindicaciones 1 a 9 o una sal agrícolamente aceptable del mismo, y opcionalmente un segundo agente antifúngico.
- 17. Uso de un derivado de pirrol como se define en una cualquiera de las reivindicaciones 1 a 9 o una salagrícolamente aceptable del mismo, opcionalmente junto con un segundo agente antifúngico, como un fungicida 45 agrícola.
- 18. Un compuesto que es un derivado de pirrol de fórmula (I) o una sal farmacéutica o agrícolamente aceptable del mismo:
imagen6 50donde R1, L1, A1 n, R3 y R5 son como se han definido en una cualquiera de las reivindicaciones 1 a 9;R6 representa hidrógeno;R2 representa arilo C6-C10, un grupo heterociclilo de 5 a 12 miembros distinto de benzotiofeno, cicloalquilo C355 C6 sin sustituir, hidrógeno, halógeno, alquilo C1-C8, alquenilo C2-C8, alquinilo C2-C8, cicloalquilo C3-C6, -OR',-SR', -SOR', -SO2R', -SO2NR'R", -SO3H, -NR'R", -NR'COR', -CO2R', -CONR'R", -COR', -OCOR', -CF3, -NSO2R'imagen7 N-(3-Nitro-bifenil-4-il)-2-oxo-2-(1H-pirrol-2-il)-acetamidaÁcido (2S,5R,6R)-3,3-dimetil-6-[2-(1-metil-1H-pirrol-2-il)-2-oxo-acetilamino]-7-oxo-4-tia-1-azabiciclo[3,2,0]heptano-2-carboxílicoÁcido (2S,5R,6R)-3,3-dimetil-7-oxo-6-[2-oxo-2-(1-fenil-1H-pirrol-2-il)-acetilamino]-4-tia-1-aza5 biciclo[3,2,0]heptano-2-carboxílico Ácido (2S,5R,6R)-3,3-dimetil-7-oxo-6-[2-oxo-2-(1H-pirrol-2-il)-acetilamino]-4-tia-1-azabiciclo[3,2,0]heptano-2-carboxílico (2S,5R,6R)-3,3-Dimetil-7-oxo-6-[2-oxo-2-(1-fenil-1H-pirrol-2-il)-acetilamino]-4-tia-1-azabiciclo[3,2,0]heptano-2-carboxilato potásico10 (2S,5R,6R)-3,3-Dimetil-7-oxo-6-[2-oxo-2-(1H-pirrol-2-il)-acetilamino]-4-tia-1-aza-biciclo[3,2,0]heptano-2carboxilato potásico (2S,5R,6R)-3,3-Dimetil-6-[2-(1-metil-1H-pirrol-2-il)-2-oxo-acetilamino]-7-oxo-4-tia-1-azabiciclo[3,2,0]heptano-2-carboxilato potásico N-[2-(Dimetilamino)etil]-2-oxo-2-(1H-pirrol-2-il)acetamida, o15 Sal monosódica del éster acetato del ácido 3-((hidroximetil)-8-oxo-7-[2-(2-pirrolil)glioxilamido]-5-tia-1azabiciclo[4,2,0]oct-2-eno-2-carboxílico. - 19. Un compuesto de acuerdo con la reivindicación 18, donde R2 representa fenilo, hidrógeno, -COO(alquilo C1-C4), halógeno, cicloalquilo C3-C6 sin sustituir, o un grupo alquilo C1-C4, alquenilo C2-C4 o alcoxi C1-C4 que está sin20 sustituir o sustituido con -SMe, -SEt, hidroxilo, di(alquilo C1-C4)amino, -COO(alquilo C1-C4), -CONR'R", NR'CO(alquilo C1-C4), alcoxi C1-C4 sin sustituir o alcoxi C1-C4 sustituido con -OMe u -OEt, en los que R' y R" son iguales o diferentes y representan hidrógeno o alquilo C1-C4 sin sustituir; o R2 representa un grupo alquil (C1-C4) -A5, en el que ninguno o un grupo -CH2-está reemplazado independientemente por -O-, -S-o -NR'-y en el que A5 representa fenilo, piridinilo o oxazolilo.25
- 20. Un compuesto que es un derivado de pirrol de fórmula (IB) o una sal farmacéutica o agrícolamente aceptable del mismo:
imagen8 30 donde A1, L1, n y R1 a R6 son como se ha definido en la reivindicación 8, en la que el compuesto no sea ácido 3-[2(4-fluoro-fenilaminooxalil)-pirrol-1-il]-propiónico o ácido 3-{2-[2-(3,4-dimetoxi-fenil)-etilaminooxalil]-pirrol-1-il}propiónico.35 21. Un compuesto de acuerdo con la reivindicación 18, donde el compuesto es como se ha definido en la reivindicación 6 o 7. - 22. Un compuesto de acuerdo con la reivindicación 18, donde el compuesto es como se ha definido en lareivindicación 9. 40
- 23. Una composición que comprende un compuesto o sal farmacéuticamente aceptable como se define en una cualquiera de las reivindicaciones 18 a 22 y un vehículo o diluyente farmacéuticamente aceptable, o que comprende un compuesto o sal agrícolamente aceptable como se define en una cualquiera de las reivindicaciones 18 a 22 y un vehículo o diluyente agrícolamente aceptable.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0807532 | 2008-04-24 | ||
GB0807532A GB0807532D0 (en) | 2008-04-24 | 2008-04-24 | Antifungal agents |
GB0819696A GB0819696D0 (en) | 2008-10-27 | 2008-10-27 | Antifungal combination therapy |
GB0819696 | 2008-10-27 | ||
PCT/GB2009/001058 WO2009130481A1 (en) | 2008-04-24 | 2009-04-23 | Pyrrole antifungal agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2535516T3 true ES2535516T3 (es) | 2015-05-12 |
Family
ID=40749825
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES09734928.6T Active ES2535516T3 (es) | 2008-04-24 | 2009-04-23 | Agentes antifúngicos de pirrol |
ES13167337.8T Active ES2526083T3 (es) | 2008-04-24 | 2009-04-23 | Agentes antifúngicos de pirrol |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES13167337.8T Active ES2526083T3 (es) | 2008-04-24 | 2009-04-23 | Agentes antifúngicos de pirrol |
Country Status (11)
Country | Link |
---|---|
US (2) | US8993574B2 (es) |
EP (2) | EP2283006B1 (es) |
JP (2) | JP5657524B2 (es) |
AU (1) | AU2009239778B2 (es) |
CA (1) | CA2721944C (es) |
DK (2) | DK2626361T3 (es) |
ES (2) | ES2535516T3 (es) |
NZ (1) | NZ589010A (es) |
PL (1) | PL2283006T3 (es) |
PT (1) | PT2283006E (es) |
WO (1) | WO2009130481A1 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI385169B (zh) | 2005-10-31 | 2013-02-11 | Eisai R&D Man Co Ltd | 經雜環取代之吡啶衍生物及含有彼之抗真菌劑 |
EP2283006B1 (en) | 2008-04-24 | 2015-02-25 | F2G Limited | Pyrrole antifungal agents |
AU2011210765A1 (en) | 2010-01-28 | 2012-09-13 | President And Fellows Of Harvard College | Compositions and methods for enhancing proteasome activity |
EP2636409A1 (en) | 2010-11-05 | 2013-09-11 | Eisai R&D Management Co., Ltd. | Combined pharmaceutical composition as antifungal agent |
ES2724531T3 (es) | 2011-05-12 | 2019-09-11 | Proteostasis Therapeutics Inc | Reguladores de proteostasis |
WO2014116228A1 (en) | 2013-01-25 | 2014-07-31 | President And Fellows Of Harvard College | Usp14 inhibitors for treating or preventing viral infections |
US11039617B2 (en) | 2013-01-30 | 2021-06-22 | Agrofresh Inc. | Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness |
US10070649B2 (en) | 2013-01-30 | 2018-09-11 | Agrofresh Inc. | Volatile applications against pathogens |
BR112015024971B1 (pt) | 2013-04-04 | 2022-09-20 | Janssen Pharmaceutica Nv | Derivados de n-(2,3-di-hidro-1h-pirrolo[2,3-b]piridin-5-il)-4-quinazolinamina e n-(2,3-di-hidro-1hindol-5-il)-4-quinazolinamina como inibidores de perk e composição farmacêutica que os compreende |
WO2015073528A1 (en) | 2013-11-12 | 2015-05-21 | Proteostasis Therapeutics, Inc. | Proteasome activity enhancing compounds |
US10201524B2 (en) * | 2014-11-21 | 2019-02-12 | F2G Limited | Antifungal agents |
JP6570301B2 (ja) * | 2015-04-23 | 2019-09-04 | キヤノン株式会社 | 4−フルオロイサチン誘導体の製造方法 |
EP3426029B1 (en) | 2016-03-07 | 2023-08-30 | AgroFresh Inc. | Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops |
GB201609222D0 (en) * | 2016-05-25 | 2016-07-06 | F2G Ltd | Pharmaceutical formulation |
TW201841890A (zh) * | 2017-04-05 | 2018-12-01 | 日商阿格諾卡那休股份有限公司 | 新穎1-苯基哌啶衍生物及以其為有效成份之農園藝用藥劑 |
GB201814151D0 (en) | 2018-08-31 | 2018-10-17 | Ucl Business Plc | Compounds |
US11819503B2 (en) | 2019-04-23 | 2023-11-21 | F2G Ltd | Method of treating coccidioides infection |
CN112898316A (zh) | 2019-12-03 | 2021-06-04 | 微境生物医药科技(上海)有限公司 | 新型吡咯化合物 |
CN111393349A (zh) * | 2020-05-15 | 2020-07-10 | 上海毕得医药科技有限公司 | 一种4-碘-1h-吡咯-2-甲醛的合成方法 |
CN114644634B (zh) * | 2020-12-21 | 2023-06-20 | 深圳市祥根生物医药有限公司 | 一种吡咯衍生物及其制备方法和用途 |
CN113429396A (zh) * | 2021-06-08 | 2021-09-24 | 深圳市祥根生物医药有限公司 | 一种五元杂芳环衍生物及其制备方法和用途 |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3202654A (en) | 1962-04-27 | 1965-08-24 | Bristol Myers Co | 6-[alpha-hydroxy-and alpha-amino-alpha-pyrrolylacetamido] penicillanic acids and salts thereof |
GB1051723A (es) * | 1962-04-27 | |||
US3252970A (en) | 1963-02-27 | 1966-05-24 | Ciba Geigy Corp | Aromatization |
BE631632A (es) | 1963-04-26 | |||
US3268558A (en) | 1964-11-05 | 1966-08-23 | Ortho Pharma Corp | 1-r-2, 4-dinitropyrroles |
US3458515A (en) | 1966-07-21 | 1969-07-29 | American Home Prod | Piperazine substituted pyrroles |
GB1208014A (en) | 1967-03-23 | 1970-10-07 | Glaxo Lab Ltd | Cephalosporins |
US3573294A (en) * | 1968-03-14 | 1971-03-30 | Glaxo Lab Ltd | 7 - (arylglyoxamido)cephalosporanic acids and their salts and alpha-carbonyl derivatives |
JPS5549575B2 (es) * | 1971-10-30 | 1980-12-12 | ||
BE790747A (fr) | 1971-10-30 | 1973-02-15 | Whitefin Holding Sa | Stereo-isomeres du 1-(1'-(0-chloro-benzyl)-pyrrol-2'-yl) -2-dibutyl sec.-amino-ethanol et procede pour leur preparation |
GB1476503A (en) | 1973-06-21 | 1977-06-16 | Sterling Drug Inc | 1-arylamino-and 1-arylimino-pyrroles and preparation thereof |
BE848465A (fr) * | 1976-11-18 | 1977-03-16 | Stereo-isomeres de 1-(1'-benzyl-2' pyrryl)-2-disec.butylaminoethanols a activite analgesique et preparations pharmaceutiques qui les contiennent | |
US4316900A (en) | 1977-10-05 | 1982-02-23 | Ciba-Geigy Corporation | Piperazinopyrrolobenzodiazepines |
JPS57142966A (en) | 1981-02-27 | 1982-09-03 | Sagami Chem Res Center | (1-alkyl-2-pyrrolyl)glyoxylic acid amide derivative |
JPS57144255A (en) | 1981-03-03 | 1982-09-06 | Sagami Chem Res Center | Alpha-methylthio(1-alkyl-2-pyrrolyl)acetamide derivative |
US4761424A (en) | 1985-10-01 | 1988-08-02 | Warner-Lambert Company | Enolamides, pharmaceutical compositions and methods for treating inflammation |
FR2601368B1 (fr) | 1986-07-08 | 1989-04-07 | Synthelabo | Derives de nitrofuranne, leur preparation et leur application en therapeutique. |
DE69531864T2 (de) | 1994-07-21 | 2004-07-22 | Shionogi & Co., Ltd. | Indolizin spal2 inhibitoren |
CA2218479C (en) | 1995-04-28 | 2008-01-15 | Banyu Pharmaceutical Co., Ltd. | 1,4-di-substituted piperidine derivatives |
EP0747756B1 (en) | 1995-06-06 | 2000-05-24 | Agfa-Gevaert N.V. | Photographic materials |
JPH09249669A (ja) | 1996-03-13 | 1997-09-22 | Ono Pharmaceut Co Ltd | 縮合ピロール誘導体、およびそれらを有効成分として含有する薬剤 |
PL194262B1 (pl) | 1998-06-03 | 2007-05-31 | Amgen Inc | Kwasy karboksylowe i izostery kwasów karboksylowych związków N-heterocyklicznych |
US6331537B1 (en) | 1998-06-03 | 2001-12-18 | Gpi Nil Holdings, Inc. | Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds |
US7202239B2 (en) | 2001-04-12 | 2007-04-10 | Wyeth | Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists |
US6825201B2 (en) | 2001-04-25 | 2004-11-30 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic amidopiperazine derivatives |
US7078209B2 (en) | 2001-06-06 | 2006-07-18 | Vertex Pharmaceuticals Incorporated | CAK inhibitors and uses thereof |
MXPA03011951A (es) | 2001-06-20 | 2004-03-26 | Daiichi Seiyaku Co | Derivados de diamina. |
TW200306819A (en) | 2002-01-25 | 2003-12-01 | Vertex Pharma | Indazole compounds useful as protein kinase inhibitors |
WO2003072028A2 (en) | 2002-02-23 | 2003-09-04 | Bristol-Myers Squibb Company | Method of treating hiv infection by preventing interaction of cd4 and gp120 |
WO2004082606A2 (en) | 2003-03-13 | 2004-09-30 | Synta Pharmaceuticals Corp. | Fused pyrrole compounds |
EP1680401A2 (en) * | 2003-10-24 | 2006-07-19 | Schering Aktiengesellschaft | Indolinone derivatives and their use in treating disease-states such as cancer |
US20060058286A1 (en) | 2004-09-16 | 2006-03-16 | Mark Krystal | Methods of treating HIV infection |
MX2007012234A (es) | 2005-03-31 | 2008-03-18 | Johnson & Johnson | Compuestos de pirazol biciclico como agentes antibacterianos. |
AR053713A1 (es) | 2005-04-20 | 2007-05-16 | Xenon Pharmaceuticals Inc | Compuestos heterociclicos y sus usos como agentes terapeuticos |
AU2006248812B2 (en) | 2005-05-18 | 2012-02-16 | F2G Ltd | Antifungal agents |
WO2007015866A2 (en) | 2005-07-20 | 2007-02-08 | Kalypsys, Inc. | Inhibitors of p38 kinase and methods of treating inflammatory disorders |
US7601844B2 (en) | 2006-01-27 | 2009-10-13 | Bristol-Myers Squibb Company | Piperidinyl derivatives as modulators of chemokine receptor activity |
WO2008046082A2 (en) | 2006-10-12 | 2008-04-17 | Xenon Pharmaceuticals Inc. | Use of heterocyclic compounds as therapeutic agents |
GB0623209D0 (en) * | 2006-11-21 | 2007-01-03 | F2G Ltd | Antifungal agents |
CN101260086B (zh) * | 2007-03-06 | 2011-08-10 | 中国科学院上海药物研究所 | 蛋白酪氨酸磷酸酯酶1b抑制剂及其制备方法和用途 |
GB0710121D0 (en) * | 2007-05-25 | 2007-07-04 | F2G Ltd | Antifungal agents |
EP2283006B1 (en) | 2008-04-24 | 2015-02-25 | F2G Limited | Pyrrole antifungal agents |
-
2009
- 2009-04-23 EP EP09734928.6A patent/EP2283006B1/en active Active
- 2009-04-23 DK DK13167337.8T patent/DK2626361T3/en active
- 2009-04-23 JP JP2011505591A patent/JP5657524B2/ja active Active
- 2009-04-23 EP EP13167337.8A patent/EP2626361B1/en active Active
- 2009-04-23 PT PT97349286T patent/PT2283006E/pt unknown
- 2009-04-23 AU AU2009239778A patent/AU2009239778B2/en active Active
- 2009-04-23 WO PCT/GB2009/001058 patent/WO2009130481A1/en active Application Filing
- 2009-04-23 ES ES09734928.6T patent/ES2535516T3/es active Active
- 2009-04-23 US US12/989,410 patent/US8993574B2/en active Active
- 2009-04-23 NZ NZ589010A patent/NZ589010A/xx unknown
- 2009-04-23 PL PL09734928T patent/PL2283006T3/pl unknown
- 2009-04-23 ES ES13167337.8T patent/ES2526083T3/es active Active
- 2009-04-23 DK DK09734928.6T patent/DK2283006T3/en active
- 2009-04-23 CA CA2721944A patent/CA2721944C/en active Active
-
2014
- 2014-10-10 JP JP2014208999A patent/JP5903475B2/ja active Active
-
2015
- 2015-02-18 US US14/625,532 patent/US9452168B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2009239778B2 (en) | 2014-03-13 |
US20150238500A1 (en) | 2015-08-27 |
EP2626361B1 (en) | 2014-10-15 |
CA2721944A1 (en) | 2009-10-29 |
US8993574B2 (en) | 2015-03-31 |
DK2283006T3 (en) | 2015-05-26 |
US9452168B2 (en) | 2016-09-27 |
JP2015051984A (ja) | 2015-03-19 |
JP2011518818A (ja) | 2011-06-30 |
AU2009239778A1 (en) | 2009-10-29 |
PL2283006T3 (pl) | 2015-08-31 |
US20110152285A1 (en) | 2011-06-23 |
PT2283006E (pt) | 2015-06-29 |
ES2526083T3 (es) | 2015-01-05 |
DK2626361T3 (en) | 2015-01-19 |
CA2721944C (en) | 2016-06-07 |
EP2283006A1 (en) | 2011-02-16 |
JP5903475B2 (ja) | 2016-04-13 |
EP2283006B1 (en) | 2015-02-25 |
NZ589010A (en) | 2012-11-30 |
WO2009130481A1 (en) | 2009-10-29 |
EP2626361A1 (en) | 2013-08-14 |
JP5657524B2 (ja) | 2015-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2535516T3 (es) | Agentes antifúngicos de pirrol | |
CN111225915B (zh) | 作为pad抑制剂的咪唑并吡啶化合物 | |
ES2524422T3 (es) | Derivados de estrigolactamas y su uso como reguladores del crecimiento vegetal | |
ES2779225T3 (es) | Reactivos de merilformilo sustituido y procedimiento de uso de los mismos para modificar propiedades fisicoquímicas y/o farmacocinéticas de compuestos | |
CN101087601A (zh) | 用于抑制含铜胺氧化酶的化合物及其应用 | |
CN109705071B (zh) | Hdac抑制剂及其制备方法和用途 | |
JPS58203958A (ja) | オキシムエ−テル、その製造方法、該化合物を含有する栽培植物保護用組成物および栽培植物保護方法 | |
WO2013066838A1 (en) | Compounds and methods | |
CN109574945A (zh) | 异噁唑啉衍生物及其在农业中的应用 | |
ES2650393T3 (es) | Compuestos reguladores del crecimiento vegetal | |
FR2943669A1 (fr) | Derives de nicotinamide,leur preparation et leur application en therapeutique | |
ES2695243T3 (es) | Compuestos reguladores del crecimiento vegetal | |
ES2614997T3 (es) | Compuestos reguladores del crecimiento vegetal | |
ES2406130T3 (es) | Nuevos microbiocidas | |
WO2018187845A1 (en) | Heterocyclic inhibitors of lysine biosynthesis via the diaminopimelate pathway | |
JPH03190861A (ja) | 置換1,8―ナフタリンジカルボン酸イミドおよび該化合物を含有する除草剤 | |
Komiya et al. | Synthesis and structure based optimization of 2-(4-phenoxybenzoyl)-5-hydroxyindole as a novel CaMKII inhibitor | |
JPS62169785A (ja) | ナフチリジン−誘導体、その製法及びこれを含有する除草剤 | |
Bheemanapalli et al. | Synthesis and Antibacterial Activity of a New Series of 2, 3, 5, 7-Substituted-pyrido [2, 3-d] pyrimidin-4 (3H)-one Derivatives | |
WO2013066834A1 (en) | Compounds and methods | |
CN109400601B (zh) | 一种含吡唑基取代的吡唑衍生物及其制备和用途 | |
CS253747B2 (en) | Fungicide and process for preparing active compound | |
AU2023204968A1 (en) | Novel isoindolinone derivative compounds as caspase inhibitors | |
JP2005350428A (ja) | 6員複素環を有するアミド化合物とその用途 |